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(Under the direction of Kristen Hassmiller Lich) 
The high prevalence of chronic pain and the rising opioid prescription rate impact the 
quality of life of older adults. Clinical guidelines recommend non-pharmacologic treatments over 
opioids for chronic pain. Evidence shows that opioids are used more than non-pharmacologic 
treatments, and opioid prescription practices differ geographically. Healthcare system 
characteristics can encourage or deter pain management practices. Therefore, the research 
objective was to understand if and how access to non-pharmacologic pain treatments is 
associated with opioid prescriptions patterns for older adults with a new episode of persistent 
musculoskeletal pain (lasting > three months). 
From a 5% sample of fee-for-service Medicare beneficiaries enrolled from 2007-2014, 
we constructed a cohort of beneficiaries over 65 with a new episode of persistent 
musculoskeletal pain and no opioid prescriptions within the prior six months. Using claims data 
and the Area Health Resource File, we defined access as the provider supply and service use for 
two common non-pharmacologic services, physical therapy (PT) and mental health (MH). In 
Aim 1, greater supply of non-pharmacologic providers was associated with lower odds of an 
opioid prescription in the first three months of an episode. PT during the first three months of an 
episode was associated with lower odds of an opioid prescription in following three months. In 
Aim 2, greater supply of MH providers was associated with lower odds of long-term 
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prescriptions (≥90 days’ supply) and high-dose prescriptions (≥50 Milligrams Morphine 
Equivalent). 
In Aim 3, we explored how primary care providers in North Carolina operationalize 
caring for chronic pain patients as discrete responsibilities and the needs, supports, barriers, and 
priorities for change associated with each responsibility. Provider reported struggling to avoid 
prescribing opioids while trying to recommend non-pharmacologic treatments and discuss the 
relationship between pain and MH. Common supports included published literature, patient 
education, allied health professionals, electronic health records, and prescribing policies. Key 
barriers included poor insurance coverage and limited time. Priorities to improve chronic pain 
care were better patient education materials and more MH professionals. 
Taken together, the findings support polices that reduce shortages and engage patients in 
non-pharmacologic services to improve opioid prescribing practices for chronic pain.
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CHAPTER 1: INTRODUCTION 
For over 100 million adults in the United States (US), chronic pain has a significant 
health and economic burden, especially for older adults (adults over 65 years old).1 Pain is 
considered to be chronic when the duration of pain is more than three months, which is 
equivalent to the average amount of time needed for tissue to heal.2 An estimated 19% to 57% of 
older adults suffer from chronic pain,1 and almost two-thirds of older adults report 
musculoskeletal pain such as back pain, knee pain, and osteoarthritis.3 From 2012 to 2014, the 
direct healthcare costs and indirect costs due to lost wages for musculoskeletal pain exceeded 
$320 billion dollars with older adults accounting for 37% of the cost.3  
Opioids are a common strategy to relieve musculoskeletal pain, and almost a third of 
older adults received at least one opioid prescription in 2016.4 One study found that from 1999 to 
2010, the opioids prescription rate for older adults with an outpatient visit increased from 4.1% 
to 9.0%.5 Short term opioid use for chronic pain management may lead to high-risk use such as 
long-term use and high doses which may exacerbate the harms of opioids such has overdose and 
mortality.6-16  Furthermore, there is a dearth of evidence supporting the efficacy of long-term and 
high-dose opioid use.9,17,18 In 2014, for every 100,000 older adults, 21 were hospitalized and nine 
had an emergency department visit because of opioids.4 In 2015, the opioid-related death rate for 
older adults was 1.5 deaths per 100,000 people.4  
To prevent the risks associated with opioid prescriptions and promote safe pain practices, 
the Centers for Disease Control and Prevention (CDC) and the American College of Physicians 
have the following recommendations: 1. Use non-pharmacologic therapies and non-opioid 
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medications before opioids; 2. Opioids are appropriate when the potential for pain relief is 
greater than the potential for risks and if other treatments are unsuccessful; 3. Multi-modal 
treatments should be used.18,19 
Non-pharmacologic treatments address the biological, social, and psychological factors 
that contribute to the experience of pain by encouraging the development of positive self-
management behaviors such as exercise, weight loss, coping strategies, and reduced reliance on 
medications.20-24 Such strategies improve levels of pain and functional outcomes among older 
adults and also have fewer side effects than medications.23,25-27  
Despite evidence regarding non-pharmacologic treatments and opioids for chronic pain 
for older adults, current trends show that opioids are used more frequently than non-
pharmacologic treatments.26,28-32  From 2000-2007, the opioid prescription rate was twice the 
referral rate of psychotherapy and almost seven times the referral rate of physical therapy for 
ambulatory visits for chronic pain for adults.31 Furthermore, there is geographic variation in 
opioid prescriptions and opioid-related outcomes.33-37 In 2015, the state opioid prescribing rates 
ranged from 41.9 (Hawaii) to 121.0 prescriptions (Alabama) for every 100 people.38 Opioid-
related death rates in 2016 ranged from 0.9 (Texas) to 30.3 (New Hampshire) deaths per 100,000 
persons.39 Several studies have documented geographic differences in the rates of high-risk 
opioid prescription patterns such as long-term prescriptions and high-doses in adult 
populations.33,36,37   
Determinants of non-pharmacologic treatment use and opioid prescriptions may be due to 
patient, provider, and health care system characteristics.40,41 For example, older adults may have 
clinical barriers include physical and cognitive impairments associated with aging, multiple 
chronic conditions, multiple medications, and fragmented care.42-48 Furthermore, income, 
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knowledge, and preferences also determine non-pharmacologic service use.49,50 Providers may 
not always refer patients to non-pharmacologic services, doubt the efficacy of non-
pharmacologic treatments, or lack knowledge about safe opioid prescribing practices.48,50-52 
Barriers in the health care system, such as insurance coverage and supply of providers, may also 
hinder the use of non-pharmacologic services.29,51,53,54 
A critical gap in research on the delivery of pain care is how the health care system may 
encourage or deter the use of certain pain management strategies over others, particularly the use 
of opioids and non-pharmacologic treatments. For example, limited availability of non-
pharmacologic treatments may partially explain why non-pharmacologic services are 
underutilized.29,51,53,54 However, little is known about whether limited access to non-
pharmacologic treatments is related to opioids prescription patterns. Understanding the potential 
sources of the geographic disparities in opioid prescriptions for pain management could inform 
future policies to promote safe pain management practices, implement clinical guidelines, and 
reduce opioid risky prescriptions.18,19,55 
Specific Aims 
This dissertation explores whether access to non-pharmacologic treatments is associated 
with short-term and long-term opioid prescriptions. Access measures include (1) the supply of 
providers and (2) use of services. Out of the many types of non-pharmacologic treatments, 
physical therapy and mental health services were selected based on strong evidence supporting 
their use.18,23,26,27 The long-term goal is to study the context of treatment decisions for pain 
management and support decision-making in primary care settings. The overall objective is to 
understand if and how access to non-pharmacologic pain management treatments is associated 
with short-term and long-term opioid prescriptions for older adults with a new episode of 
musculoskeletal pain that lasts at least three months. The central hypothesis is that limited access 
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to non-pharmacologic providers is associated with greater opioid use. To carry out the objective, 
a mixed-method dissertation study with the following aims was conducted: 
Quantitative Studies 
Aim 1: Examine the relationship between access to non-pharmacologic providers 
and opioid prescription patterns during the first six months of new episode of 
persistent musculoskeletal pain among older adults.   
a. Hypothesis 1a: The county supply of non-pharmacologic providers will not be 
associated with filling an opioid prescription during Phase One (three months 
after an index pain diagnosis).  
b. Hypothesis 1b: A greater county supply of non-pharmacological providers will be 
associated with lower odds of an opioid prescription during the Phase Two (three 
months after Phase One).  
c. Hypothesis 1c: Mental health and physical therapy use in the Phase One will be 
associated with a lower odds of filling an opioid prescription in the Phase Two.  
d. Hypothesis 1d: The association between access to non-pharmacologic services 
and opioid prescriptions in either phase will differ by urban and rural counties.  
Aim 2: Examine the relationship between access to non-pharmacologic providers 
and high-risk opioid prescription, such as long-term (≥ 90 days supply) and high-
dose prescriptions (≥50 Milligrams Morphine Equivalent (MME)), during the year 
of new episode of persistent musculoskeletal pain among older adults.   
a. Hypothesis 1: A greater supply of non-pharmacologic providers will be associated 
with lower odds of high-risk opioid prescription patterns.  
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b. Hypothesis 2: Use of non-pharmacologic services during the first three months of 
a new episode of persistent pain will be associated with lower odds of high-risk 
prescriptions. 
Qualitative Study 
Aim 3: Document the role, responsibilities, needs, supports, barriers, and priorities 
of primary care providers who care for older adults with chronic musculoskeletal 
pain and assess how these components might vary by urban and rural settings. 
This study qualitatively describes how the health care context supports what providers do 
to care for older adults with chronic musculoskeletal pain and their priorities for how health 
systems can better support them. The results will guide recommendations and changes that can 
be applied to local settings such as changes in reimbursement, additional training, and 
information about best practices, or community resources. 
Rationale 
Significance  
a. Caring for older adults with chronic pain is a complex and significant public health challenge 
facing the US health care system. 
Chronic pain is a prevalent condition with a significant impact on an individual’s quality 
of life, especially for older adults.1,46,56 More than half of older adults suffer from chronic 
musculoskeletal pain, which is a subset of chronic pain.3 The burden of chronic musculoskeletal 
pain on the health system is significant, and one study found that adults with chronic 
musculoskeletal pain may use more health services (e.g. emergency department visits, 
hospitalizations, and opioids), and are more likely to have mental or substance use illnesses.57    
The experience of pain is described by the biopsychosocial model, which posits that 
physiological, psychological, and social factors can exacerbate or ameliorate pain symptoms in 
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chronic pain patients.20 To address the biopsychosocial factors, treatment should enable self-
management of pain and utilize both pharmacologic and non-pharmacologic 
strategies.1,18,19,25,58,59 Comprehensive pain management often requires the coordination of 
multiple providers (e.g. primary care providers, physical therapists, mental health providers, etc.) 
to deliver various treatment strategies (Figure 1.1).1 However, many system and organization 
barriers (e.g. access to physical therapy, mental health, or pain specialists, cost of treatment, and 
time) impede the implementation of comprehensive and adequate pain treatment.1 Addressing 
the barriers to pain care may improve patient quality of life and reduce costs.1 
Chronic pain management is complex for older adult populations because older adults are 
more likely to have multiple chronic conditions,45 may use multiple medications,42 and may have 
fragmented care across multiple providers.43 Furthermore, older adults may also report pain less 
frequently and may be at risk for under-treatment, which can worsen their quality of life.1,60 
Furthermore, both opioid and non-opioid medications are associated with increased risk of 
adverse events for older adults.55 Multiple modalities of treatment may be necessary to address 
the biopsychosocial factors associated with pain even if opioids are appropriate.18,20,25,55,59 
b. Even though opioids are the leading pain management strategy, opioids are risky and can be 
ineffective for long-term pain management.  
Older adults are more likely have long-term opioid use to manage chronic pain.61 From 
2007-2012, the rate of opioid treatment with more than 90 days’ supply of opioids increased 
from 4.6% to 7.4% among older adults.62 Although the rate of misuse and abuse of opioids is 
lower for older adults, compared to younger adults, opioid use in older adults is associated with 
an increased risk of fractures, falls, cardiovascular disease, and respiratory failure.10,63-69 From 
1999 to 2010, sales of opioids quadrupled,70 which has led to increases in opioid-related 
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mortality; both trends are evident among older adults.5,39,66,71 While opioids may be an effective 
way to manage pain in the short-term, long-term opioid use is not associated with improved pain 
outcomes.9,72,73 The risk of adverse events associated with long-term opioid use is correlated with 
increases in opioid dose.73 One fifth of Medicare beneficiaries with “chronic opioid use” have an 
average daily dose greater than 100 MME, more than twice the maximum dose recommended by 
the CDC.18,74 Both long-term and high-dose opioid use increase the risk of overdose and 
mortality.10-16 Opioids are especially risky for older adults who may have multiple chronic 
conditions, multiple medications, physical and cognitive impairments associated with aging, and 
fragmented care.42-47   
c. Improving access to non-pharmacologic pain management is critical to curb opioid use and 
promote safe and effective pain management practice.  
Implementing guideline concordant care by recommending non-pharmacologic pain 
treatments can reduce the use of ineffective, long-term treatments, such as opioids, and improve 
patient outcomes.75-78 Both physical therapy and mental health services represent evidence-based 
approaches to pain management that should be integrated to provide high quality pain 
management treatment.18,23,26 Evidence on non-pharmacologic treatments in older adult 
populations demonstrates that such services may reduce pain intensity.26 For example, physical 
therapy not only improves physical function and reduces pain, it is associated with reductions in 
opioid use, emergency department use, and surgery.18,23,78,79 Mental health services, in various 
forms including cognitive behavioral therapy, relaxation training, supportive psychotherapy, 
group therapy, or counseling, address a patient’s pain experience and ability to perform self-
management tasks.18,21-23 These services support patients with long-term pain management needs 
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by motivating patients to perform positive behaviors, such as exercise, and have been associated 
with reductions in opioid use.21,22,73,80  
Policy approaches that focus on limiting access to opioids could lead to undertreated and 
poorly managed pain.81 For example, the Comprehensive Addiction Recovery Act of 2016 
creates a program designed to restrict individuals with high opioid use to one prescriber and 
pharmacy for Part D Medicare beneficiaries.82 The consequences of such policies may be 
exacerbated when there is a lack of access to non-pharmacologic services, and additional pain 
management strategies will be needed to support individuals with chronic pain and promote 
more appropriate opioid use.81 Policies that only address provider prescribing behaviors without 
considering the structure of the health care system may not change pain management treatment 
patterns.83 As the US population ages, the burden of chronic pain is likely to increase and 
policies will need to address the health care system’s capacity to support individuals with chronic 
pain.76,84 Therefore, understanding whether limited access to non-pharmacologic services 
promotes opioid use is critical to supporting individuals with chronic pain and preventing 
unintended consequences of policies restricting opioid use. 
Innovation 
 This study was innovative in several ways. First, this study described how older adults 
with persistent musculoskeletal pain use of physical therapy, mental health services, and opioid 
prescriptions. Previous research shows that non-pharmacologic pain management strategies are 
used less often than opioids, especially for older adults.29,31,32,57 However, these studies primarily 
rely on self-reported data about use of non-pharmacologic services which could be subject to 
reporting bias or use data that does not generalize to older adults.29,31,32,53,57,85 While there have 
been several studies that have examined opioid prescriptions among Medicare beneficiaries, 
studies have mostly focused on disabled beneficiaries.33,36 Of the recent studies on opioid 
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prescription patterns that include older adult Medicare beneficiaries, most consider a sample of 
all beneficiaries who were prescribed opioids and do not isolate populations by indication (e.g. 
chronic musculoskeletal pain).62,74 Even studies on opioid use among Medicare beneficiaries 
with musculoskeletal pain have limited generalizability to the US population due to use of state-
specific data before the rise in opioid prescriptions.86,87  
 Second, this study explored access to non-pharmacologic services as a potential source of 
geographic variation in prescription opioid use among older adults with persistent 
musculoskeletal pain. Current research on opioid prescription patterns such as initiation of opioid 
treatment, long-term opioid use, and high doses of opioids have largely focused on individual 
factors (e.g. age, sex, comorbidities, characteristics of the first prescription, and indicators of 
socioeconomic status).6,8,33,62,74,88-93 A few studies have found lower opioid use among adults 
with chronic pain who use non-pharmacologic services, but evidence on older adults with 
persistent musculoskeletal pain is lacking.79,80,94,95 Some studies using county-level models have 
shown that the availability of healthcare measured as the supply of providers (e.g. the number of 
physicians, surgeons, dentists, and pharmacists) was positively associated with overall county-
level opioid prescription rates.34,35,37,40 A previous study on older adults with an opioid 
prescription found significant state-level variation in long-term opioid use.62 Disparities in opioid 
prescriptions rates for urban and rural counties has also been observed, and lack of access to 
services may be one reason for the disparity.62,96 Yet, little is known about whether limited 
access to non-pharmacologic treatments contributes to geographic variation in opioid 
prescriptions rates, high-dose prescriptions, and long-term prescriptions persists among older 
adults with persistent musculoskeletal pain. 
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This dissertation was innovative because it leveraged a mixed methods study design to 
understand the multi-level determinants of opioid prescription patterns. This study empirically 
tested if access to non-pharmacologic pain management services is associated with opioid 
prescription patterns. Then, the qualitative results were used to bolster the empirical findings to 
understand what components of the health care system support or hinder safe pain management 
practices.  
Conceptual Model 
Donabedian’s model for quality of care has been adapted to provide a framework for 
assessing the quality of care delivered to chronic pain patients as a function of the health care 
system’s structure, the process of delivering comprehensive pain management, and the outcomes 
of delivering care (Figure 1.2).97  
The structure of care is defined as characteristics of the health care system in a county 
and characteristics of the setting of care. The structure directly influences the process of pain 
management, as shown by Aim 1, by influencing the services a provider recommends and the 
services a patient uses, and indirectly influences the process of care by affecting the provider’s 
knowledge of the health care system in the short-term. The structure also directly influences 
high-risk prescription patterns, defined as long-term or high dose opioid prescriptions, and 
indirectly influences high-risk use through the process of care as shown by Aim 2.  
Aim 3 seeks to understand the process of care defined as the care recommended by the 
provider and care used by the patient. The process of care influences short-term opioid use, high-
risk opioid use, and ultimately, health outcomes. The process of care also reflects a feedback 
loop where evaluations of pain severity and health outcomes may change the pain management 
strategies that are used over time.  
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Finally, the model shows that although guideline concordance is a function of referrals, 
which is unobserved, actual service use was used a proxy for referrals. This study does not 
formally study outcomes such as overdose and mortality, but these harms are directly and 
significantly related to high-risk opioid use.12-16,69 The conceptual model also shows that 
substance use treatment, which addresses opioid addiction, differs from mental health care 
treatments recommended for chronic pain management. Finally, the model shows that both 
characteristics of the primary care provider and the patient may influence the care processes and 
opioid use.  
Approach Overview 
To test the hypotheses for Aims 1 and 2, we identified a cohort of Medicare beneficiaries 
with a new episode of persistent musculoskeletal pain. Due to ambiguous definitions of chronic 
pain in the literature and the desire to focus on how pain patients interact with the health care 
system, we refer to the presence of multiple pain diagnoses at least 90 days apart as an episode of 
persistent pain. A retrospective cohort study was conducted of a cohort of Medicare beneficiaries 
older than 65 with a new episode of persistent musculoskeletal pain that lasts more than 90 but 
less than 365 days. Beneficiaries did not have a pain diagnosis in the year prior to the index pain 
diagnosis and did not have an opioid prescription six months prior to the index pain diagnosis. 
This study used Medicare Fee for Service (FFS) claims for Parts A, B, and D from 2007 to 2014 
to identify demographic characteristics, medical comorbidities, and health care service use (e.g. 
physical therapy visits, mental health service visits, and opioid prescriptions). Referencing the 
beneficiaries’ county of residence and the index date from the claims data, the Area Health 
Resource File (AHRF) was used to assign county characteristics to beneficiaries.98 Generalized 
estimating equations and multinomial equations were used to test the association between access 
to non-pharmacologic treatments and opioid prescription patterns.  
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For Aim 3, interviews with primary care providers from North Carolina were conducted 
to explore their role, responsibilities, needs, supports, barriers, and priorities using a Systems 
Thinking Method called System Support Mapping.99 Differences in pain management practices 
for chronic musculoskeletal pain by urban and rural counties are described.  
Conclusion 
This research provides empirical evidence on whether access to non-pharmacologic pain 
management treatments, such as mental health services and physical therapy, explains the 
variation in opioid prescriptions for an older adult population with persistent musculoskeletal 
pain. By focusing on a population that is vulnerable to undertreated pain due to age-related 
treatment barriers, the findings can demonstrate how lack of access to alternatives may harm this 
population.25 This dissertation innovates by focusing on two critical but potentially underutilized 
pieces of clinical practice, mental health services and physical therapy.41 This work is timely 
because it examines the intersection of two growing problems in public health: chronic pain and 
prescription opioid use. 
 This dissertation contains the following sections. Chapter 2 describes the literature about 
the burden of chronic pain among older adults and the evidence on chronic pain treatments, 
focusing on opioid and non-pharmacologic treatments. It also discusses the gaps in literature 
related to the predictors of opioid prescription patterns (initiation of opioids, long-term 
prescriptions, and high-dose prescriptions) as well as the gaps related to the practice of chronic 
pain management in primary care settings. Chapters 3, 4, and 5 are the manuscripts that 
correspond to Aims 1, 2, and 3, respectively. Chapter 6 discusses the main findings from each 
aim, the implications for practice and policy, limitations, and areas for future research. Tables 
and figures are presented at the end of each chapter, and references are at the end of the 


















CHAPTER 2: LITERATURE REVIEW 
 The following topics are presented in this literature review: burden of chronic pain 
among older adults, chronic pain treatment options and summary of clinical guidelines, trends in 
utilization of pain management strategies among older adults, predictors of opioid prescriptions 
patterns, and chronic pain management in the context of primary care.  
Overview of Chronic Pain among Older Adults 
One of the most significant conditions impacting older adults is chronic pain, which 
occurs when pain continues for at least three months or more.1,2 Prevalence estimates of chronic 
pain for older adults vary from 19% to 57%.1 The incidence of chronic pain for older adults is 
4.69 per 100 person years.100 Almost two-thirds of older adults report musculoskeletal pain such 
as back pain, knee pain, and osteoarthritis.3 Consequences of chronic pain include decreased 
activity levels, falls, mood disorders, isolation, and disability, which may worsen if pain is 
undertreated.46,60,101 Furthermore, pain may become worse when other comorbidities such as 
obesity, diabetes, cancer, and surgery are present.1,60,100 Another concern for older adults is that 
pain may be undertreated or underreported.1,60,102 Chronic pain management is complex for older 
adult populations because older adults may have multiple chronic conditions,45 use multiple 
medications,42 and have fragmented care across multiple providers.43 
Chronic pain affects all facets of quality of life for older adults.1,46,56 The biopsychosocial 
model describes the experience of chronic pain as a product of physiological, psychological, and 
social factors can exacerbate or ameliorate pain symptoms.20 Biological factors are genetic or 
physical processes that occur with a pain exeperience.20 Psychologic factors include the 
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emotional aspects of pain such as anxiety or depression as well as cognitive abilities.20 Finally, 
the social factors can include aspects of an individual’s environment, their social supports, and 
available resources (e.g. income, insurance, or transportation).20  
Pain is a costly condition, and in the US, chronic pain costs $560 to 630 billion in total 
costs, with $261 to $300 billion in direct healthcare costs for chronic pain treatment.103 Medicare 
pays for a quarter of all pain treatments, which was estimated to be $65.3 billion.1,103 From 2012 
to 2014, the direct healthcare costs and indirect costs due to lost wages for musculoskeletal pain 
exceeded $320 billion dollars with 37% of the cost attributed to older adults.3 .  
Treatment for Chronic Pain 
The biopsychosocial factors that contribute to chronic pain can be addressed through self-
management techniques and both pharmacologic (both opioid and non-opioid) and non-
pharmacologic treatments.1,58,59 Self-management strategies for chronic pain include symptom 
management (e.g. pain and fatigue), emotional management (e.g. anger, depression), coping 
skills, and lifestyle changes (e.g. exercise, relaxation).104,105 Examples of non-pharmacologic 
treatments include exercise, acupuncture, psychological therapies, tai chi, yoga, physical therapy, 
and spinal manipulation.106 Non-pharmacologic treatments also include Complementary and 
Alternative Medicine, such as acupuncture or chiropractic care.19 Pharmacologic treatments 
include non-opioids (e.g. acetaminophen and ibuprofen) and opioid medications (e.g. 
hydrocodone, oxycodone, and morphine).18,19,55 Multiple modalities may be more effective than 
a single strategy on its own.107 This literature review focuses the evidence for on physical 
therapy, mental health services (e.g. behavioral treatments), and opioid medications.  
Evidence on Non-Pharmacologic Management Strategies 
Evidence on non-pharmacologic treatments  (e.g. exercise, acupuncture, psychological 
therapies, tai chi, yoga, physical therapy, and spinal manipulation) indicates that several non-
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pharmacologic treatments are associated with small, short-term pain relief, improvements in 
functioning, and reductions in disability.18,106 For patients with chronic low back pain, behavioral 
therapy improved short-term pain symptoms.108 Another review found that cognitive behavioral 
therapy for patients with low back pain improved long-term outcomes such as pain, disability, 
and quality of life.27 Benefits of exercise therapies for different conditions of chronic pain (e.g. 
back pain, osteoarthritis) include improved pain and function.109-111 Among older adults, the 
evidence supporting non-pharmacologic approaches is limited, but modest improvements in pain 
and function are associated with these treatments.26,112,113 
Non-pharmacologic treatments may reduce the risk of adverse events related to 
medications, and evidence supporting the benefits of non-pharmacologic treatments on opioid 
use is limited but promising.26 One systematic review found that among opioid users with 
chronic pain, psychosocial therapies (e.g. acupuncture, mindfulness, cognitive behavioral 
therapy) reduced opioid use in three studies.80 Several studies of adult populations found that 
early use of physical therapy was associated with lower opioid use.79,94,95 However, among older 
adults with low back pain, “early use” of physical therapy was not associated with a difference in 
opioid use.114 Although patients who received “guideline adherent physical therapy” had lower 
opioid use compared to patients who did not, this difference was not statistically significant.78 
Evidence on Pharmacologic Management Strategies 
 Both opioid and non-opioid medications are used for chronic pain management; however, 
both types of medications carry risk for side-effects and adverse events for older adults.18,55 
Acetaminophen, a non-opioid medication, is considered as the first-line of treatment and has a 
low risk for side effects for older adults.55 Nonsteroidal anti-inflammatory drugs (NSAIDs), 
another non-opioid medication, are associated with greater risk for cardiovascular and renal side 
effects, so they are not typically recommended for older adults.55 
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The evidence regarding the efficacy of opioids is limited for older adults.55 While short-
term opioid use in older adults was improved pain and functioning, it is also associated with 
nausea, constipation, dizziness, falls, fractures, cardiovascular disease, respiratory failure, 
hospitalization, misuse/abuse, lower self-rated mental health, and opioid-related mortality.10,63-69 
Furthermore, compared to younger populations, adverse events such as respiratory depression 
and overdose may occur at lower doses for older adults.18 The efficacy of long-term opioid 
treatments and long-acting opioids (compared to short-acting opioids) has not been studied 
among older adults.10  
Summary of Clinical Guidelines for Chronic Pain Management 
 The Centers for Disease Control and Prevention (CDC) and the American College of 
Physicians put forth clinical guidelines for chronic pain management.18,19 These guidelines have 
a strong recommendation for non-pharmacologic and non-opioid treatment as the first-line of 
treatment for pain.18,19 If non-pharmacologic treatments or non-opioid treatments are 
unsuccessful or ineffective, opioids may be an option if the benefits are greater than the risks of 
opioids.18,19 Clinicians should prescribe the “lowest effective dose.”18 Opioid treatments should 
be supervised, especially for dose escalations and when doses exceed 50 Milligrams Morphine 
equivalent (MME) or 90 MME.18 Before opioid treatment, prescribers should develop treatment 
goals for pain and function, and determine the length of treatment.18  
 The American Geriatrics Society recommends that opioids can be used by older adults 
who have pain that interferes with activities of daily living and when pain is “moderate to 
severe”.55 However, doses need to be carefully monitored since the adverse events could occur a 
lower doses compared to younger adults.18 Clinicians should consider potential interactions 
between opioids and other medications or comorbidities.18 Opioids can be risky if older adults 
have cognitive difficulties that could result in medication errors and overdose.18,46 Multimodal 
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treatment plans which use both pharmacologic and non-pharmacologic strategies are 
recommended for chronic pain management among older adults.25,55,59 
Trends in Chronic Pain Management among Older Adults 
Patients with chronic pain use more health care services and medications compared to 
those without.57 According to one study of commercially insured adults, those with chronic low 
back pain were prescribed opioids two times more than those without chronic low back pain.57  
Furthermore, chronic low back pain patients were more likely to visit physical therapists, 
orthopedists, chiropractors, and rheumatologists.57  
Despite the range of non-pharmacologic and pharmacologic treatment strategies available 
for chronic pain patients, almost all patients with chronic pain receive medications and only a 
quarter receive non-pharmacologic services.31 A study using nationally representative data on 
adults with chronic pain who had a primary care visit from 2000 to 2007 found that they use 
mental health services (8.6%) and physical therapy (2.7%) less frequently than opioids 
(14.3%).31 Furthermore, temporal trends from 1997-2010 indicate increases in the opioid 
prescription rate among adults with musculoskeletal pain while physical therapy referral rates did 
not fluctuate.32,115 Similarly, the opioids prescription rate among older adults with an outpatient 
visit also increased from 4% to 9% from 1999 to 2010.5 Older adults over 65 have the highest 
opioid prescriptions rates, and in 2016, there were 28.9 prescriptions for every 100 older adults.4 
According to one study, the rate of long-term opioid use was greater for adults over 65 compared 
to adults younger than 65.61 Over the course of five years, long-term opioid use grew from 4.6% 
to 7.4% in 2012 for older adults.62 Among all Medicare beneficiaries, about 5% had a dose 
greater than 100 MME.74 Nearly 25% of long-term users with Medicare had a dose greater than 
100 MME.74 Estimates for opioid prescription rates among older adults with musculoskeletal 
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pain range from 7% to 40%, with as much as 4% of beneficiaries with more than six thirty-day 
prescriptions in the follow-up year.86,87   
Utilization rates for non-pharmacologic services may differ between younger and older 
adults. In one study of nationally representative adults with low back pain, the physical therapy 
rate for adults aged 45 to 59 years was twice the referral rate for adults aged 60 to 90 years 
(18.9%).32 Furthermore, having Medicare was significantly associated lower odds of a physical 
therapy visit.32 According an analysis of the Medicare Current Beneficiary Survey, only 5% of 
older adults used physical therapy and the average number of visits was 10 per year (standard 
deviation 15 visits).53 Another study found that 30% of North Carolinians with chronic low back 
pain used physical therapy, but utilization rates did not differ by age groups.29 Among chronic 
pain patients, older adults used mental health services less frequently than younger adults (2% 
(age 60+) vs 9% (18-60 years)).29,85 
Predictors of Opioid Prescription Patterns 
Several literature reviews have focused on opioid use behaviors such as misuse or abuse, 
or outcomes of opioid use such as overdose.11,67,116,117 However, little is known about the factors 
associated with initiation of prescription opioid therapies as well as high-risk opioid prescriptions 
such as long-term or high-doses, which are not typically categorized as misuse or abuse.  
Many characteristics are associated with opioid prescriptions. In a study using nationally 
representative survey data of adults with chronic pain, adults older than 65 years had a lower 
odds of reporting an opioid prescription compared to younger adults age 18-34 years.118 Having 
Medicare (compared to private insurance), living in the South (compared to the North), and 
seeing a primary care provider (compared to a specialist) were all associated with greater odds of 
reporting an opioid prescription.118 In another a study of individuals with chronic pain, greater 
odds of an opioid prescription was also associated with living in a rural county and being non-
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White minority.96 This study hypothesized that rurality could indicate a lack of access to 
healthcare could contribute to the differences in opioid prescribing rates in rural and urban 
counties.96  
 Among older adult, Medicare beneficiaries with osteoarthritis, being younger was 
associated with greater odds of an opioid prescription.86 Furthermore, being female, reporting 
poorer health, or having functional limitations were also associated with greater odds of opioid 
prescriptions.86  
Prescriber specialty may also be associated with opioid prescriptions. In a study 
examining North Carolina Medicaid patients with chronic pain, patients who saw orthopedists, 
dentists, and emergency medicine providers had greater odds of filling an opioid prescription 
compared to patients who saw a general practitioners.119 However, the greatest proportion of 
opioid prescriptions for Medicare beneficiaries came from primary care providers (family 
medicine and internal medicine).74 According to one study of older adults, primary care 
providers were two times more likely to prescribed opioids than surgeons.5  
Initiation of Opioid Prescriptions 
Only three studies examined characteristics associated with initiating opioid 
prescriptions.89,91,120 In one study of commercially insured adults, 9% of patients who sought 
healthcare for a new pain diagnosis had an opioid prescription within one week of the first 
visit.91 The opioid prescription rate varied by pain type: 6.6% for joint pain, 14.5% for back pain 
without radiculopathy, 10.2% for neck pain, 4.9% for tendonitis, 10.0% for muscles 
sprain/strain, and 20.2% for back pain with radiculopathy.91 While age was not significantly 
associated with an opioid prescription fill during the week of a first visit, the odds of an opioid 
prescription with more than a week’s supply was greatest for older adults (adjusted OR: 1.79).91 
Almost half of the patients with an opioid prescription had an opioid prescription at the first visit 
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for pain that covered more than seven days.91 Visits with mid-level providers (nurse practitioners 
or physician assistants) were associated with greater odds of an opioid prescription within the 
first week after a pain visit.91 While this study uses nationally representative data, the results may 
not generalize older adults.91 Furthermore, the study describes state level variation but does not 
examine potential characteristics that could lead to differences in prescribing rates across 
states.91  
A study of Medicare beneficiaries discharged from the hospital found that filling an 
opioid prescriptions a week after discharge was more likely for beneficiaries in rural regions, as 
well as those with low socioeconomic status (e.g. low-income subsidy recipients, patients with 
both Medicare and Medicaid).89 Older beneficiaries were less likely to receive an opioid 
prescription a week after discharge.89 A higher proportion of patients reporting “well-managed 
pain” was also associated with greater hospital rates of opioid prescriptions within the week of a 
discharge.89 The results from this study highlight potential factors that are associated with opioid 
prescriptions, but do not encompass the entire population of beneficiaries who suffer from pain, 
particularly those who receive outpatient care.89 
In another study of individuals with low back pain receiving workers’ compensation, a 
multilevel model was used to estimate the odds of filling an opioid prescription within two 
weeks of the diagnosis (“early”) with multi-level characteristics.120 Characteristics such as 
severity of injury and individual and state level measures of socioeconomic status were 
associated with greater odds of an early opioid prescription.120 The supply of physicians 
(including surgeons) was associated with lower odds of an early opioid prescription.120 While 
this study examines the multi-level characteristics associated with early opioid prescribing, it 
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does not distinguish between type of physician and the results may not be generalizable to an 
older adult population.120   
Predictors of High-Doses of Opioids 
 High-doses of opioids have been associated with increased risk of overdose and other 
adverse events.11,69 One study of patients with musculoskeletal pain and opioid use for more than 
90 days found positive associations with the odds of dose >100 MME/day for being male, 
presence of multiple comorbidities, diagnoses of mental illness, a prescription for a sedative-
hypnotic, having Medicare, emergency room visits, and pain clinic visits.8 Another study of 
patients with chronic pain in a primary care clinic found that patients with resident physicians 
(compared to nurse practitioners or faculty physicians) were associated with lower odds of a dose 
> 50 MME/day of opioids.121 Furthermore, age and being female were associated with lower 
odds of a dose > 50 MME/day of opioids, while a diagnoses of mental illness were associated 
with greater odds of a dose > 50 MME/day of opioids.121 In a study of veterans with chronic 
pain, having a neuropathy, back pain, and nicotine disorder were all independently associated 
with greater odds of a dose > 180 MME/day for > 90 consecutive days.92 Among disabled 
Medicare beneficiaries, opioid prescribing laws (e.x. “prescription limits, prohibiting ‘doctor 
shopping’, pain clinic regulations, require patient identification, requiring physical exams, 
requiring tamper-resistant prescription forms, prescription drug monitoring programs, and 
requiring pharmacist verification”) were not associated with rates of prescription > 120 MME.90 
While these studies examine a range of characteristics, limitations include examining doses that 
are well above the CDC threshold (50 MME), studying average daily doses instead of individual 
prescription doses, and samples with limited generalizability to older adults.8,90,92,121 
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Predictors of Long-Term Opioid Use 
Long term-opioid use is associated with several adverse events including falls, fractures, 
and overdose.69 Two recent studies examining the predictors of long-term use using national 
prescription claims data for commercially insured patients who were opioid-naïve and did not 
have cancer.6,93 Compared to opioid use for less than a year, long-term opioid use (opioid use for 
more than one year) was more likely among females, older ages, and those with Medicare or 
Medicaid.6 Characteristics of the first opioid prescription, such as high doses, greater days’ 
supply, long-acting opioids, and tramadol prescriptions were associated with long-term opioid 
use.7,93 A greater number of opioid prescriptions and higher doses during the first month of 
opioid treatment was also associated with more than six fills in a year.7 Furthermore, a diagnosis 
of chronic pain is positively associated with long-term opioid use.93 Compared to surgery, 
patients with chronic pain were less likely to discontinue opioid prescriptions.93 Musculoskeletal 
pain patients who received an opioid prescription greater than 7 days were more likely to have 
opioid prescriptions for more than six months.91 One study examining self-reported outcomes 
found among patients with long-term opioid use, high Problem Opioid Use Risk scores at 
baseline and high self-rated likelihood of long-term opioid use were associated with greater odds 
of opioid use for more than a month.122 Another study of adults residing in Olmsted County, 
Minnesota found that greater odds of long-term use (“>120 days’ supply and > 10 prescriptions”) 
or episodic use (“> 90 days with >120 days’ supply and <10 prescriptions”) was associated with 
presence of mental illness, substance abuse, and nicotine use.123 
Several studies have examined predictors of long-term opioid use in the Medicare 
population.62,87-90 In one study examining opioid prescriptions for opioid naïve, Medicare 
beneficiaries with an emergency department visit, seeing a provider who frequently prescribed 
opioids was associated with greater odds of opioid use lasting longer than 180 days.88 Another 
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study of Medicare beneficiaries who filled an opioid prescription within a week of a hospital 
discharge found that living in a rural county, low-income subsidy, and having both Medicare and 
Medicaid were all independently associated with greater than 90 days of opioid prescriptions 
after hospital discharge.89 Long-term prescription rates (>90 days) for hospitals were positively 
correlated with the proportion of patients reporting well-managed pain.89 Other hospital 
characteristics, such as government ownership, system affiliation, and teaching status were also 
associated with an opioid prescription 90 days after discharge.89  
Two studies examined long-term opioid use among older adults.62,87 A 2005 study found 
that among older adults with musculoskeletal pain, use of medications for mental illness, like 
benzodiazepines, greater number of doctor visits, and nursing home residence were associated 
with opioid use for more than 180 days (consecutively), while presence of a mental illness and 
being African American was associated with lower odds.87 One study specifically examined 
long-term opioid use (greater than 90 days’ supply) among older adult, Medicare beneficiaries 
who were opioid naïve and had non-cancer pain.62  Rates of long-term opioid use differed by 
state (2.84% in New York to 10.93% in Utah).62 The odds of long-term use were associated with 
greater for beneficiaries with Medicaid, living in rural counties, having more than one 
hospitalization, cardiovascular comorbidities, diabetes, liver disease, arthritis, obesity, drug 
abuse, psychoses, and depression.62 Older age and being a minority was associated with lower 
odds of long-term opioids use.62  This study also examined regulations relating to opioid 
prescriptions, and found that pain clinic regulations were associated with lower odds of long-
term opioid use.62 While both studies examine older adults, these studies primarily focus on 
individual characteristics associated with various definitions of long-term use.62,87 
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 Two studies examined long-term opioid use among disabled Medicare beneficiaries.36,90 
One study found that indicators of low socioeconomic status (household income, unemployment 
rate, and Gini Index) of the county were positively associated with having at least six opioid 
prescriptions in a year.36 Another study found that opioid prescribing laws (“e.x. prescription 
limits, prohibiting “doctor shopping”, pain clinic regulations, require patient identification, 
requiring physical exams, requiring tamper-resistant prescription forms, prescription drug 
monitoring programs, and requiring pharmacist verification”) were not associated with lower 
rates of long-term use defined as an opioid prescription during every quarter within a year.90 
Geographic Variation in Opioid Prescriptions 
 Several studies examine sources of geographic variation including demographic 
characteristics, health care service characteristics, health status characteristics, and geographic 
characteristics. One study using national opioid prescription records from 2008 found that the 
amount of opioids prescribed varies greatly by county, and county characteristics account for a 
third of the variation in the amount of opioids prescribed.35 Positive predictors of the amount of 
opioids prescribed per county included county size, percent of county classified as urban, percent 
white, percent African-American, poverty rate, percent less than 65 years and without insurance, 
and number of physicians.35 Furthermore, percent of population with a high school diploma and 
number of psychiatrists were negatively associated with the amount of opioids prescribed.35 The 
presence of a prescription drug monitoring program in the state was not associated with the 
amount of opioids prescribed.35 
In a similar study using national retail prescription data from 2006 to 2015, a greater 
proportion of non-Hispanic whites, proportion uninsured, proportion without a high school 
diploma, proportion disabled, and city residence were associated with more opioid 
prescriptions.37 Furthermore, the supply of primary care providers and dentists were also 
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independently associated with greater opioid doses, along with the prevalence of diabetes, 
arthritis, and the suicide death rate.37  
In another study on national opioid prescription claims, the prescription drug monitoring 
program in a state and the prevalence of older adults were negatively associated with the county 
opioid prescription claim rate, while the supply of surgeons per capita and population illicit drug 
use rate were positively associated with the opioid prescription claim rate.34  
According to a study examining prescription data in Indiana, the percent of the 
population over 45 years, percent with private health insurance and under 65 years, percent with 
Medicaid, supply of dentists per capita, supply of pharmacists per capita, and average per capita 
opioid prescription rate for neighboring counties were significantly associated with greater 
county-level opioid prescription rates.40  
Socioeconomic indicators are also associated with opioid prescribing patterns.35-37 Based 
on data from 2008, one study found that the poverty rate was positively associated with the 
amount of opioids prescribed.35 However a more recent study using data from 2006 to 2015 
found that, the proportion in poverty was negatively associated with the amount of opioids 
prescribed.37 Similarly, in a study on disabled Medicare beneficiaries, indicators of low 
socioeconomic status (household income, unemployment rate, and Gini Index) of the county 
were positively associated with greater doses of opioids.36 
Though these studies both use administrative data to estimate opioid prescription patterns 
across the country, the models use county-level analyses which limit inferences about individual 
behaviors.34,35,40 In general, the supply of health care providers was positively associated with 
greater opioid prescribing, with the exception of psychiatrists which was negatively associated 
with opioid prescribing.34,35,37,40 However, these studies do not investigate all types of providers 
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typically involved in pain care (e.g. physical therapists or pain specialists). Furthermore, these 
studies do not distinguish between different patient populations and indications for pain, so 
results may not be generalizable to an older adult population with persistent musculoskeletal 
pain.  
Chronic Pain Management in Primary Care 
Chronic pain management often begins in the primary care setting.101 According to one 
study of older adults with chronic low back pain, nearly 60% of patients received care from a 
primary care provider.29 Therefore, primary care providers play an essential role in coordinating 
care between pain specialists, physical therapists, and mental health providers as well as 
recommending effective strategies.1 In developing treatment plans for patients, primary care 
providers must consider the risk of undertreating pain, the risks of using opioids, and develop 
realistic goals with the patient in managing pain.25,101,124 Implementing guideline concordant care 
by recommending non-pharmacologic pain treatment strategies can reduce the use of ineffective 
long-term treatment strategies, such as opioid treatments, and improve patient outcomes.75-78  
Failure to adhere to guidelines may be a result of characteristics of the healthcare system 
which create a complex system where provider decisions regarding pain management strategies 
are influenced by incentives, knowledge, objectives, and constraints.125 For example, patient, 
provider, and community characteristics can guide specialty referral decisions.1,126 As a 
community characteristic, one of the key barriers to comprehensive, high quality, pain 
management is access to specialty care such as physical therapy, mental health providers, and 
pain specialists.1,126,127 Access to services may be conceptualized as provider availability, 
distance to the service, ease of accommodation, and patient acceptability.128,129 While, provider 
availability does not always equate to use of services, the supply of specialists may determine 
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whether a provider refers a patient to that service because as the supply increases, it is easier for 
patients to see a specialist and patients expect and demand specialty care.127,128  
Several qualitative studies explored the various aspects of pain management practices in 
primary care including opioids prescriptions and use of non-pharmacologic services from the 
perspectives of patients and providers. One systematic review found that most providers 
recommend non-pharmacologic and non-opioid treatments before prescribing opioids (98%), 
prescribed doses that are less than 90-200 MME/day (89%), and educate patients about the risk 
and benefits of long-term opioid use (76%-84%).130 However, the majority of providers do not 
assess pain before and after starting long-term opioid treatment, screen for comorbidities, use 
urine drug screen tests, use opioid treatment agreements, or stop opioids if it does not work.130 
The following section describes the barriers and facilitators present at the following levels: 
patient, provider, within the patient-provider relationship, and health system.  
Patient Level 
Several studies found that patient characteristics interfered with pain management. 50-
52,54,131-134  For example, providers report that patients may have difficulties with various aspects 
of pain self-management such as motivation, finding time to relax, and exercise.51,52 Providers 
felt that patients were unwilling to change lifestyle habits or try non-pharmacologic treatments 
and that patients often expected to be pain free after treatment.51,54 Furthermore, providers were 
more likely to prescribe opioids when they thought patient’s wanted quick pain remedies, but 
both patients and providers thought that opioids were not an effective long-term therapy.54 
Presence of mental illness and failure to follow treatment plans also make it difficult for 
providers to manage pain and prescribe opioids.52,54,131 The possibility that patients may diverge 
opioids was also another concern that providers had when they prescribed opioids.52,133  
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Providers frequently cited the risk of addiction, misuse, and abuse as a major concern for 
pain management, especially when prescribing opioids.52,54,131-133 To address this concern, one 
study discussed how providers identified “red flags” by getting information from the patient 
about the potential for misuse, abuse, addiction, substance use history, and readiness to try non-
opioid treatments.134 However, some patients reported that they were not at risk for addiction, 
while others were very concern about addiction.54,132 Some patients also reported that opioids 
were the only medication that could relieve pain quickly, and others reported that opioids did not 
always work and that there were side effects.51,54,132 
There were also patient barriers to using non-pharmacologic services. For example, 
patients did not always believe that non-pharmacologic treatments would be effective or 
understand how non-pharmacologic treatments worked.50,51 Furthermore, non-pharmacologic 
treatments were difficult for patients, took time, and required motivation.51,54 Some patients 
thought non-pharmacologic services, like acupuncture and chiropractic care, provided short-term 
pain relief for acute pain and did not have side-effects.54  
Provider Level 
Studies also described provider-related barriers that primary care providers faced when 
caring for patients with chronic pain.51,52,54,131,133-137 According to one systematic review of 
clinician perspectives on chronic pain guideline implementation, unfamiliarity with the creation 
of guidelines, the perception that guidelines do not allow for clinical judgement, time to 
implement guidelines, and limited access to specialty care made it difficult to implement clinical 
guidelines.135 About 40% of primary care providers reported difficulties in treating pain and 
other comorbidities and coordinating treatments.52 When trying to care for patients with chronic 
pain, providers experienced negative emotions (e.g. frustration, inadequate success with 
treatment, or stress).136 Sometimes, providers were not interested in treating pain and avoided 
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it.131,134 One major challenge for providers was assessing pain and determining whether the pain 
was real.131,133,134,136 Often, they found that it was difficult to get accurate information about pain 
from physical exams or tests.134,136  
With respect to opioid prescriptions, only 30% of providers reported that they felt 
comfortable prescribing opioids, and a third of providers reported that they were not sure about 
when to prescribe opioids.52 Providers thought that opioids were a fast and easy option for pain 
relief.54 Furthermore, providers found it difficult to balance the risks and benefits of opioids, 
lacked time to fully assess pain, and had limited training about managing pain and 
addiction.131,134  
Providers also faced barriers when trying to recommend non-pharmacologic 
services.50,51,137 Two studies found that providers did not educate patients about non-
pharmacologic treatments.50,137 For example, providers reported that limited knowledge about 
acupuncture and chiropractic care services which made it difficult to make referrals.137 
Furthermore, providers did not always believe that non-pharmacologic treatments would be 
effective, and often thought that these treatments were only effective because the placebo 
effect.51,137 
Studies also discussed facilitators for chronic pain management at the provider 
level.131,134,135 For example, facilitators to chronic pain guideline implementation include a 
positive perspective about the clinical guidelines, relationships with colleagues, and using 
imaging as a tool to set expectations and teach patients about pain.135 Providers reported that they 
preferred to use their own professional experience instead of clinical guidelines to make 
treatment decisions.135 Physicians used opioid treatment agreements and long-term follow up to 
set expectations and ensure patients adhered to treatments.131 Providers used urine drug tests to 
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build trust with patients.134 They also used information about functioning to set goals and 
expectations about pain.134 
Patient-Provider Relationship Level  
The relationship between the patient and the primary care provider is another critical 
component to pain management.50-52,54,132-134,136-138 Important elements of this relationship 
include empathy, trust, validation, and shared decision making.132,133 To facilitate a positive 
patient-provider relationship, patients reported that providers should listen, understand the 
patient’s pain, have adjustable prescribing practices, understand the medication related 
outcomes, and educate patients about medications.133 Patients reported that opioid prescriptions 
were the only way providers confirmed their pain, and that non-pharmacologic treatments were 
not effective pain management strategies.51,132,138 Additionally, patients reported that were 
sometimes uncomfortable with non-pharmacologic providers.51 
Building trust and a long-term relationship made it easier for providers to determine 
whether opioids were appropriate.134,136 Providers were more likely to trust patients who adhered 
to recommendations and worked towards treatment goals compared to patients who failed drug 
screens or were did not follow recommendationss.132 Patients who trusted their provider believed 
that their provider was concerned for their health and were willing to follow their provider’s 
recommendations even when providers did not prescribe opioids or chose to discontinue them.138 
Providers reported that changes in treatment regimens and lack of patient adherence contributed 
to difficult patient-provider relationships.136 Concerns about diversion and asking for disability 
benefits made it difficult for providers to trust patients.136 
Communication between patients and providers was another barrier.52,133 For example, 
one study found that providers felt that language barriers may also contribute to inadequate pain 
management.52 Discussing topics like misuse, abuse, addiction, and diversion made patients feel 
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like their providers did not trust them.133 As a result, providers reported that they feared conflict 
and confrontation in discussions about discontinuing opioids.54 Furthermore, patients thought it 
was difficult to talk about opioids because they feared  that their provider perceived them as 
addicts or drug seekers.138 Poor communication between patients and providers also hindered the 
use of non-pharmacologic treatments.50 Patients did not always talk about non-pharmacologic 
treatments with their providers because they thought that providers may understand the treatment 
or that the information from non-pharmacologic treatments was not important for providers.50,137 
Healthcare System Level 
Healthcare system barriers to pain management reported by both patients and providers 
included difficulties with accessing pain management and addiction specialty referrals, lack of 
patient compliance with referrals, lack of diagnostic testing, limited time in visits, long wait 
times for specialty services, lack of appropriate non-pharmacologic treatments, limited 
transportation to treatments, and poor insurance coverage for non-pharmacologic services 
services.51,54,131,134 Limited access to resources like urine drug screens also made it difficult to 
monitor patients and provide comprehensive care.134 In one study of patients and providers in an 
integrated health system, both patients and providers tried to avoid opioids but felt that there 
were no suitable alternatives available.54 Providers also felt that the culture of medicine added to 
the pressure to prescribe medications, especially opioids.51,54,136  
For non-pharmacologic treatments, older adult patients discussed how a lack of resources 
such as community providers, lack of transportation, poor insurance coverage, and high 
treatment cost were all barriers to accessing those treatments.50 Furthermore, poor 
communication with other non-pharmacologic providers also made it difficult for providers to 
complete referrals and follow-up with non-pharmacologic providers about the patient’s 
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progress.137 Finally, lack of social support from caregivers, other pain providers, and community 
resources was also another barrier for non-pharmacologic treatment use.51  
Challenges with Pain Management for Older Adults 
Managing pain in an older adult population may require special considerations. For 
example, compared to internal medicine specialists, geriatricians were more concerned about 
undertreating pain in older adults and less concerned about illegal activities.139 Similarly, another 
study found that providers were concerned about the potential side effects and that caregivers 
may misuse or abuse opioids when they prescribed opioids to older adults.48 This study also 
found that providers agreed that opioids should not be used as the first line of treatment but may 
be appropriate in some situations.48 Providers reported that they would be more likely to 
prescribe opioids if both the patient and their caregivers were trustworthy and if opioids were 
successfully used in the past.48 They were less likely to prescribe opioids when they could not 
trust the patient or caregiver, if the patient had multiple medications, and if the patient had 
cognitive difficulties.48 Finally, another barrier to prescribing opioids was the patients’ and 
caregivers’ hesitation to start opioids when opioids were the appropriate treatment.48  
We did not find any studies that explored the use of non-pharmacologic treatments 
among older adults from the perspective of primary care providers. However, older adults 
reported many of the same barriers to non-pharmacologic treatment as younger 
populations.50,51,54,137 For example, patient level barriers for non-pharmacologic treatments 
included lack of information about treatments, expectations and acceptance of pain, presence of 
comorbidities (e.g. depression), and difficulties in movement for the patient.50 Some patients, 
especially older adults, were also afraid that the treatment could result in pain, fatigue, or 
injury.50,51 Embarrassment and difficulties with exercise were other barriers mentioned by older 
 
35 
adults.50 Facilitators included a motivation, optimism, the joy of using non-pharmacologic 
treatments, and social support in the form of family and community supports.50 
Conclusion 
 This literature review demonstrates several gaps in the literature. First, there is very little 
knowledge about treatment patterns for older adults with a new episode of persistent 
musculoskeletal pain and no recent history of opioid use. Previous studies on trends with non-
pharmacologic service use have not isolated pain by acute or persistent subgroups or have been 
limited to older data or state-based data.29,32,53,85 Some studies primarily use self-reported data 
about use of non-pharmacologic services which could be subject to reporting bias.29,32,53,85 
Furthermore, evidence on opioid prescription patterns for older adults, is limited to beneficiaries 
who are prescribed opioids, and do not examine all beneficiaries with a pain diagnosis, 
regardless of opioid use or differentiate between acute and persistent pain.5,62,74 Studies on opioid 
use for Medicare beneficiaries with musculoskeletal pain have limited generalizability to the 
current US population due to use of state-specific data before the rise in opioid prescriptions.86,87 
Understanding utilization rates for opioid and non-pharmacologic services is important to 
identify potential gaps in guideline adherence. 
 Second, there is limited evidence on the predictors of opioid prescription patterns 
(initiation rates, long-term prescriptions, and high-dose prescriptions), especially among older 
adults with persistent musculoskeletal pain. Only a few studies examined opioid prescription 
patterns the older adult population, but these studies primary focused on individual predictors 
and do not examine multi-level risk factors.6-8,62,74,86-89,91-93,121 Studies have found differences in 
opioid prescription patterns based on rural designation, and hypothesized that lack of access to 
services may be one reason for the disparity.62,96 In studies that explored geographic variation, a 
greater supply of providers was associated with greater opioid use, with the exception of one 
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study that found a negative correlation between the supply of providers and the odds of initiating 
opioid treatment.34,35,37,40,120 However, most studies use county-level analyses which limits 
conclusions about individual opioid prescription behaviors.34,35,37,40 Furthermore, these studies do 
not always distinguish the subgroups or include all types of providers who might be involved in 
the delivery of pain care.34,35,37,40 While preliminary evidence regarding use of non-
pharmacologic services and opioid use shows lower opioid use among adults who use non-
pharmacologic services, evidence on older adults with persistent musculoskeletal pain is 
limited.79,80,94,95 While one study found that early use of physical therapy was not associated with 
a difference in opioid use among older adults, this study did not distinguish between acute and 
persistent pain and only had patients in an integrated care setting.114 Aims 1 and 2 fill an 
important gap in the research by exploring whether access to non-pharmacologic treatments, 
conceptualized as the supply and use of services, is related to opioid prescriptions patterns 
(initiation of opioid treatment, long-term prescriptions, and high-doses) for a population that is 
vulnerable to undertreated pain. 
 Third, little is known about what does and does not support providers who care for older 
adults with chronic pain. One systematic review showed that guideline adherence for opioid 
prescribing practices for providers varied greatly, and while most providers prescribe opioids 
after other treatments have failed, a majority do not follow all of the guidelines related to opioid 
treatment monitoring.130 Previous studies explored the use of pain management strategies, such 
has opioid prescribing or use of non-pharmacologic services, by only examining one strategy at a 
time.48,50,51,131,132,134,137,138,140  Studies have focused on the role of patient characteristics regarding 
provider’s decisions to prescribe opioids48,52,54,131,132,134  or non-pharmacologic treatments.51,54,137 
In addition to patient characteristics, a few studies mention how access to non-pharmacologic 
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treatment, time, and resources, may influence PCPs’ recommendations.51,54,131,134 The results of 
may have limited generalizability because they either took place in an integrated care setting, 
before the release of the CDC Guideline, or did not specifically focus on older adults.18,54,131 Two 
studies focused on opioid prescriptions and non-pharmacologic service use for older adults, but 
these studies did not consider the range of potential chronic pain treatments.48,50 Aim 3 extends 
previous research by providing a holistic understanding of the system of chronic pain care to 
identify the gaps between what primary care providers need to do to care for patients with 
chronic pain and what can accomplish. Taken together, these aims improve the understanding 
about the relationship between access to non-pharmacologic services and opioid use which will 
be important to facilitate guideline implementation and to guide future policy efforts to improve 
the delivery of pain care and curb opioid use.  
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CHAPTER 3: THE ASSOCIATION BETWEEN ACCESS TO NON-PHARMACOLOGIC 
PAIN MANAGEMENT TREATMENTS AND INITIAL OPIOID PRESCRIBING 
PATTERNS FOR MEDICARE BENEFICIARIES WITH PERSISTENT 
MUSCULOSKELETAL PAIN1 
Overview 
 In this retrospective cohort study of older adults, we explore the relationship between 
access to non-pharmacologic services (physical therapy and mental health services) and opioid 
prescriptions filled during the first six months of a new episode of persistent musculoskeletal 
pain. We used generalized estimating equations, Medicare claims (2007-2014) and the Area 
Health Resource File to estimate the association between the supply and use of non-
pharmacologic services and filled opioid prescriptions during the first six months of an episode. 
We identified 69,456 beneficiaries 65 and over without an opioid prescription six months before 
a new persistent musculoskeletal pain episode. Greater supply of mental health providers [Odds 
Ratio (OR): 0.97, 95% CI (confidence interval) 0.96-0.98] and physical therapists [OR: 0.98, CI: 
0.96-0.98] were independently associated with lower odds of filling an opioid prescription within 
the first three months of the episode (Phase One). Lower odds of filling an opioid prescription in 
the second three-month period (Phase Two) of an episode were associated with both increases in 
the number of mental health providers [OR: 0.97, CI: (0.96-0.98)] and physical therapy use 
within the first three months of the episode [OR: 2.76, CI: (2.57-2.96)]. The associations 
between the supply and use of non-pharmacologic services with Phase One opioid prescriptions 
differed for metropolitan and rural counties. Decreasing shortages and encouraging early 
                                                          
1 Disclosure of conflict of interest: This research was conducted while Ruchir Karmali was a student at the 
University of North Carolina and a pre-doctoral fellow at the Duke Clinical Research Institute.   
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engagement with non-pharmacologic services may help reduce opioid prescriptions among 
musculoskeletal pain patients.  
Perspective: We found that access to physical therapy and mental health services is 
significantly associated with lower odds of filling opioid prescriptions in the first 6 months of a 
new musculoskeletal pain episode. These results suggest that policies increasing the uptake of 
non-pharmacologic services could help curb future opioid prescriptions for musculoskeletal pain.    
Introduction  
Chronic pain, or pain that continues past three months, significantly impacts the quality 
of life for 20-60% of adults over 65 years old.1,2,46,56,60 Musculoskeletal pain is a common source 
of pain for almost two-thirds of older adults.3 The direct healthcare and indirect cost of 
musculoskeletal pain exceeds $320 billion with older adults accounting for 37% of the cost.3 
Consequences of chronic pain are inactivity, falls, mood disorders, isolation, and disability.46,60  
The biopsychosocial model conceptualizes how physiological, psychological, and social 
factors affect the experience of chronic pain.20 Addressing biopsychosocial factors requires 
multiple strategies to encourage positive self-management behaviors.1,20,21,23,59 Possible 
treatments include opioid and non-opioid medications and non-pharmacologic strategies (e.g. 
physical therapy (PT) or cognitive behavioral therapy).18,55 The benefits of non-pharmacologic 
treatments for older adults include fewer side effects than medications and ability to address 
multiple biopsychosocial factors.25,26,55 For older adults with non-cancer pain, opioids are 
associated with a greater risk of falls, fractures, cardiac events, pneumonia, hospitalizations, and 
death.10,63-66,141 Long-term use and high doses of opioids can exacerbate these risks.15,16,72,73,142 
Clinical guidelines recommend non-pharmacologic treatments over opioids, especially 
for older adults.18,19,55 Patients with chronic pain are at the greatest risk for long-term opioid 
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use.93 Recent trends indicate that older adults use opioids more frequently than non-
pharmacologic treatments.29 One study of adults with low back pain found that primary care 
visits without a PT referral were associated with greater odds of receiving an opioid 
prescription.32 In 2010, 17% of older adults with musculoskeletal pain received an opioid 
prescription.5 Along with rising opioid prescription rates, the incidence of long-term opioid use 
is increasing among older adults.5,62  
Underuse of non-pharmacologic treatments and overuse of opioids may result from 
insufficient capacity of the health care system to deliver non-pharmacologic services.143 For 
example, for workers with acute low back pain, greater supply of physicians including surgeons 
was associated with fewer opioid prescriptions 15 days after the diagnosis.120 Making the 
initiation of opioids even more important, differences in long-term opioid use may depend on the 
type of treatment at the time of a new pain diagnosis; for example, early PT has been shown to 
be associated with reduced opioid use.79,94,95 Conversely, a greater risk of long-term opioid use is 
associated with a higher days’ supply for the first prescription.6,91,93 Little is known about the 
relationship between access to non-pharmacologic treatments and opioid initiation, and 
understanding this relationship could guide policy efforts to reduce opioid prescriptions and 
support chronic pain patients.   
We examine the relationship between access to non-pharmacological services and opioid 
prescriptions during the first six months a new episode of persistent musculoskeletal pain among 
Medicare beneficiaries over 65 without history of recent opioid use. Due to ambiguous 
definitions of chronic pain in the literature and the desire to focus on how pain patients interact 
with the health care system, we refer to the presence of multiple pain diagnoses at least 90 days 
apart as an episode of persistent pain. We measure access as (1) supply of selected non-
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pharmacological providers (PT and mental health) and (2) the beneficiaries’ use of these non-
pharmacological services. We hypothesize: (1) no association between the supply of non-
pharmacologic providers and filling an opioid prescription within 3 months of a new pain 
episode; (2) greater supply of non-pharmacological providers will be associated with lower odds 
of an opioid prescription in the second 3-month period of a new episode; (3)  use of mental 
health services and PT within 3 months of a new episode will be associated with lower odds of 
filling an opioid prescription in the next 3 months; and (4) the associations for opioid 
prescriptions in either period will differ between metropolitan and rural counties. 
Methods 
 We conducted a retrospective cohort study of older adult, Medicare beneficiaries with a 
new episode of what will become persistent musculoskeletal pain. We examine two critical 
periods: Phase One (the first three months after the index pain diagnosis) and Phase Two (the 3 
months after Phase One). The three month cutoff was based on the transition of pain from acute 
to chronic occurring at three months.2 A diagnostic code was used as a proxy measure for pain, 
and only represents a time when a beneficiary sought treatment associated with a pain diagnosis, 
but does not indicate when the pain first began or the severity of pain.  
Data Sources 
 This study utilized Medicare Fee-for-Service (FFS) claims and the Area Health Resource 
File (AHRF) datasets.98 We used a 5% random sample of beneficiaries enrolled in Medicare FFS 
between January 1, 2008 and June 30, 2014. Medicare claims data from 2007 was available for 
the look-back period. The Master Beneficiary Summary file contains information on 
demographics, enrollment, and death. We used claims from Medicare Parts A, B, and D. Part A 
contains inpatient claims and Part B contains outpatient claims including claims from home 
health, hospice, and skilled nursing facilities. Both Part A and B contain information about 
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diagnoses, mental health services, PT visits, and service dates. The Part D Drug Event file 
contains claims for filled prescriptions and includes information about medications dispensed 
and the fill date. Referencing the beneficiaries’ county of residence and their index date from the 
claims data, the AHRF was used to assign county characteristics to beneficiaries including the 
supply of non-pharmacologic providers.98 The AHRF also contains the Rural-Urban Commuting 
Area codes which describe rurality for each county.98,144  
Study Population 
Figure 3.1 depicts how we identified a new episode of what will become persistent 
musculoskeletal pain for the cohort using International Disease Classification Codes, 9th edition 
(ICD-9) (Supplemental Table 3.1).145 Individuals were included if they have two claims with any 
musculoskeletal pain diagnosis greater than 90 days, but fewer than 365, days apart.57 We 
defined a new episode of persistent musculoskeletal pain starting with the first claim with a pain 
diagnosis (index date) after a year without any claims with a pain diagnosis. We did not require 
the same pain diagnosis to define the episode. After the index date, individuals were followed for 
six months or until death, enrollment in Medicare Advantage, or disenrollment from Part D at 
which point they are censored.  
We required individuals to have 12 months of claims before the index date to ensure the 
pain episode was new and that there was no recent history of opioid prescription (within six 
months, consistent with prior research).13 Thus, to be included in the cohort, individuals had to 
be 66 or older and continuously enrolled for one year before the index date. Since the focus of 
this analysis was a new episode of musculoskeletal pain, we excluded individuals with a trauma 
or surgery within the year before the index date using Current Procedural Codes (CPT) and ICD-
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9 codes.145,146 Individuals who used hospice services or long-term care services at any time were 
also excluded because opioid prescription recommendations differ for these individuals.18  
Outcomes 
We created binary measures for receipt of an opioid prescription in Phase One (first 
three-month period) and Phase Two (between three and six months). We included opioids that 
were either in an oral or transdermal formulation with the United States’ Food and Drug 
Administration-approved indication to treat pain. We used the National Drug Codes provided by 
the Centers for Disease Control and Prevention (CDC) to identify opioids.147 
Access Measures 
We measured access to non-pharmacologic therapies in terms of (1) the supply of 
providers and (2) the use of services. As a measure of local availability, the supply of providers 
were defined as the number of mental health providers and PTs per county per year. Mental 
health providers included both psychiatrists and psychologists. We created per capita measures 
using county population from the AHRF multiplied by 10,000.98 For missing data, values were 
interpolated based on existing data (Supplemental Table 3.2). We used binary indicators to 
measure beneficiaries’ use of PT and mental health services in Phase One and/or Phase Two 
using CPT and Healthcare Common Procedural Coding System codes (Supplemental Table 
3.1).28,148,149 
Covariates  
Individual and county characteristics confounding the relationship between access to non-
pharmacologic services and opioid prescription patterns were included based on Donabedian’s 
Quality of Care Model.97 Baseline characteristics were measured based on the year before the 
index date. Individual characteristics included age, race, sex, and Medicaid dual eligibility (a 
proxy for income).150 Comorbidities were measured using the Deyo-Charlson comorbidity score 
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which accounts for 17 unique physical clinical conditions.151 We also identified depression and 
anxiety at baseline using definitions provided by the Centers for Medicare and Medicaid’s 
(CMS) Chronic Conditions Warehouse and the Health Cost and Utilization Project 
(Supplemental Table 3.1).152,153 In the follow-up period, we defined binary indicators of opioid 
prescriptions, trauma, and surgery in either treatment phase.145-147 We defined a categorical 
variable to control for the reasons for incomplete follow-up during Phase Two, such as leaving 
FFS, leaving Part D, or death.  
We also controlled for provider supply and population demographics of a beneficiary’s 
county. Provider supply measures followed the same method used for the mental health and PT 
providers described above (Supplemental Table 3.1). We independently measured the number of 
primary care providers, surgeons, pain specialists, midlevel practitioners (nurse practitioners and 
physician assistants), and pharmacists per capita per county.98 County socioeconomic status 
measured as the percent of the county population living under the Federal Poverty Limit. We 
also controlled for the percent of the county population over 65. Rural-Urban Commuting Area 
codes were used to assign metropolitan and rural designations for each county.98,144 
Statistical Analysis 
Descriptive statistics were generated to describe the means and proportions of individual 
and county-level variables. T-tests and chi-square tests were conducted for three group 
comparisons in the cohort: beneficiaries with and without an opioid prescription in Phase One, 
beneficiaries with and without an opioid prescription in Phase Two, and beneficiaries in 
metropolitan and rural counties.  
We used generalized estimating equations to test the hypotheses. This model uses a 
population average interpretation, where estimates apply to the entire study population.154 The 
dependent variables correspond to binary variable for any opioid prescription fill, with two 
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separate models for Phase One and Two. For models with an opioid prescription fill in Phase 
One, we included the independent variables for access (supply of mental health providers and 
supply of physical therapists, use of mental health in Phase One, and use of PT in Phase One), 
individual characteristics (demographics, comorbidities, trauma, and surgery), and county 
characteristics (provider supply as separate measures and demographics). Models for opioid 
prescriptions filled for Phase Two included all of the variables for Phase One, reason for loss to 
follow up and the following variables referencing Phase One: use of non-pharmacologic 
services, receipt of an opioid prescription, trauma, and surgery. All models included year fixed 
effects. We estimated the models using different correlation structures: independent correlation 
with county clustered standard errors, exchangeable correlation with county standard errors, and 
unstructured correlation. We selected the model with the unstructured correlation based on the 
quasi-likelihood under the independence model criterion (QIC) goodness of fit statistic.  
Finally, we conducted subgroup analyses to determine differences between metropolitan 
and rural counties and compared estimates to determine statistical significance using a Type III 
analysis to produce a score statistic.155 In sensitivity analysis, we explored the relationship 
between the supply of non-pharmacologic providers and use of non-pharmacologic services as a 
positive control. We also explored the total association by excluding measures of non-
pharmacologic service use from the models, and only including supply variables as a measure of 
access. Finally, the results of the models were converted into a figure to depict the significant 
associations between the measures of access and opioid prescriptions during the treatment phases 
to identify leverage points for action. The arrows presented in the figure indicate our 
hypothesized relationships based on our results, though further research needs to verify direction 
of relationship/causality. Analyses for this study were conducted in SAS Version 9.4 (SAS 
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Institute, Inc., Cary, NC). This study was approved by the Institutional Review Boards at Duke 
University’s School of Medicine and the University of North Carolina-Chapel Hill. 
Results 
 Figure 3.2 depicts the cohort selection process. We identified 197,827 beneficiaries with 
an episode of persistent musculoskeletal pain lasting at least three months who were not 
prescribed opioids in the six months prior to the index pain diagnosis. We excluded 80,386 
beneficiaries because of surgery and 1,497 because of trauma within the 12 months before the 
index date, and 5,943 because of hospice use. The final cohort included 69,456 beneficiaries.   
 Table 3.1 presents the characteristics of the entire cohort, comparing those who filled an 
opioid prescription in Phase One/Two to those without a prescription in the corresponding phase. 
Just under 30% of the cohort was between 66 and 69 years old, 65.7% were female, 84.8% were 
white, 19.7% were dually eligible, and 81.4% resided in a metropolitan county. About 46% of 
the cohort had a Deyo-Charlson Comorbidity score of zero, and 14% had a score >3. Only 2.1% 
of the cohort had anxiety and 5.9% had depression. The most prevalent musculoskeletal pain 
conditions included arthritis (98.2%), back pain (65.7%), and fibromyalgia (68.3%). The mean 
supply of providers was four mental health providers and six physical therapists per 10,000 
people per county. Beneficiaries with at least one opioid prescription in either phase were more 
likely to be younger and female and were more likely to have a diagnosis of back pain or 
fibromyalgia compared to beneficiaries without an opioid prescription. Overall, the supply of 
mental health providers and physical therapists per county was significantly lower for 
beneficiaries with an opioid prescription in either phase.   
 About 13% (10%) of beneficiaries filled an opioid prescription in Phase One (Two). 
Nearly13% (10%) of beneficiaries used PT Phase One (Two) (Table 3.1). Fewer than 2% of the 
cohort used mental health services. Beneficiaries used opioid and non-pharmacologic strategies 
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concurrently, and the most common combination was opioid prescriptions and PT. Around 25% 
(21%) of beneficiaries who filled an opioid prescription in Phase One (Two) also used PT in that 
phase. Compared to metropolitan counties, rates of opioid prescriptions were higher and rates of 
PT and mental health services were lower for rural counties.  
Table 3.2 shows the results from multivariable models estimating the associations 
between the supply of non-pharmacologic providers and use of non-pharmacologic services with 
opioid prescriptions in Phase One. After controlling for individual and county characteristics, an 
additional non-pharmacologic provider per 10,000 people per county was significantly 
associated with lower odds of filling an opioid prescription [mental health providers adjusted 
odds ratio [aOR]: 0.97; 95% confidence interval (CI): 0.96-0.98; physical therapists aOR: 0.98; 
95% CI: 0.97-1.00]. The odds of filling an opioid prescription in Phase One did not significantly 
differ by mental health service use in this phase. Beneficiary PT visits in Phase One were 
associated with greater odds of filling an opioid prescription in Phase One [aOR: 2.6; 95% CI: 
2.64-3.36]. Beneficiaries with Medicaid had greater odds of filling an opioid prescription [aOR: 
1.26; 95% CI: 1.19-1.34]. Furthermore, an additional percentage point increase in the county 
poverty rate was associated with greater odds of filling an opioid prescription [aOR: 11.84; 95% 
CI: 1.06-3.21].  
For metropolitan and rural subgroup analysis, the magnitude and significance of 
associations between an opioid prescription in Phase One and access to non-pharmacologic 
providers were similar to the associations for the main analysis. The associations for the 
metropolitan and rural subgroups significantly differed from each other (Score statistic: 36.53, P-
value: 0.019). For both metropolitan and rural counties, dual-eligible status is associated with 
greater odds of filling an opioid prescription. In rural counties, a percentage-point increase in the 
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county poverty rate was associated with greater odds of filling opioid prescriptions in Phase One 
[aOR: 11.2; 95% CI: 3.82-32.87].  
Table 3.3 shows the association between access to non-pharmacological services and the 
odds of filling an opioid prescription during Phase Two. The supply of mental health providers 
was significantly associated with greater odds of filling an opioid prescription in Phase Two 
[aOR: 0.98; 95% CI: 0.96-0.98]. Use of PT in Phase One was associated with lower odds of 
filling an opioid in Phase Two [aOR: 0.62; 95% CI: 0.58-0.68]. However, use of mental health 
services [aOR: 1.20; 95% CI: 0.97-1.48] and filling an opioid prescription [aOR: 2.76; 95% CI: 
3.96-4.43] in Phase One were associated with greater odds of filling an opioid prescription in 
Phase Two.  Associations for the metropolitan and rural subgroups were not significantly 
different from each other (Score Statistic: 23.22, p-value: 0.56). While the supply of non-
pharmacologic providers was not significantly associated with an opioid prescription for rural 
counties, both dual-eligible status and the county poverty rate were significantly associated with 
greater odds of filling an opioid prescription in Phase Two. Sensitivity analysis confirmed a 
positive relationship between the supply of non-pharmacologic services and use of non-
pharmacologic services (Supplemental Table 3.4 and 3.5). Furthermore, results were consistent 
for opioid treatment outcomes for models that estimated the total association (Supplemental 
Table 3.6).  
Figure 3.3 illustrates the direct associations found between the supply of mental health 
providers and opioid prescriptions in and across both treatment phases. The supply of mental 
health providers and physical therapists is indirectly associated with reductions in opioid 




 This study examines the initiation rates of pain treatments during the first six months of a 
new episode of persistent musculoskeletal pain among older adults. We found that while 
utilization rates for opioids and PT during either treatment phase were similar (about 10%), the 
majority of beneficiaries only used one strategy. A common combination of treatments used in 
both treatment phases was opioid prescriptions and PT, though the rate of concurrent use of these 
strategies declined from Phase One to Phase Two. These findings demonstrate that beneficiaries 
may be exposed to opioids early in their experience of pain, even when other strategies like PT 
are used. One concerning finding is that only 2% of beneficiaries used mental health services. 
This was consistent with a previous study that found only 2% of older adults used mental health 
services even though 7% needed services.85 The low utilization rate for mental health services 
could indicate that psychosocial factors of pain may not be addressed, which could leave patients 
ill-equipped to self-manage pain.20 
Despite a wide variety of non-opioid treatments available, our findings indicate that the 
structure of the health care system has a role in the initiation of treatment and the decisions to 
select pharmacologic and non-pharmacologic treatments. Contrary to our hypothesis that the 
supply of non-pharmacologic providers would not be associated with filling an opioid 
prescription during Phase One, we found that a greater supply of mental health providers and 
physical therapists was significantly associated with lower odds of filling an opioid prescription. 
However, the association between the supply of non-pharmacologic providers and opioid 
prescription fills differed by treatment phase. The supply of physical therapists was only 
associated with lower odds of an opioid prescription fill in Phase One but not Phase Two. This 
finding indicates that the impact of the structure of the health care system is different at various 
time points in pain care. While PT may be important early during the experience of pain, as the 
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pain episode progresses it may not be considered a viable alternative to opioids, rendering the 
supply of physical therapists not significantly associated with opioid prescriptions in longer-term 
pain care. 
We observed differences in opioid prescription fills in the second phases associated with 
the type of pain management strategy used in the first phase. PT in Phase One was associated 
with a lower odds of filling an opioid prescription in Phase Two. This finding differs from a 
previous study, which found no difference in odds of opioid use for older adults with low back 
pain who started PT one month after the start of a new episode.114 However, several studies on 
younger adults with musculoskeletal pain found results that were similar to ours.79,94,95 One 
possible explanation for the differences between our findings and the findings from Karvelas and 
colleagues could be the presence of heterogeneous treatment effects for populations with acute 
and persistent pain as well as populations with and without recent exposure to opioids.114 We 
also found that opioid prescriptions in Phase I were significantly associated with opioid 
prescriptions in Phase Two; more than a third of those prescribed opioids in Phase One 
continued to have opioid prescriptions filled in Phase Two. This finding is concerning because 
several recent studies demonstrated that the likelihood of long-term opioid use was associated 
with a greater days’ supply for the first prescription.6,93 
 In the subgroup analysis, we found that increases in the supply of non-pharmacologic 
providers was significantly but weakly associated with lower odds of opioid prescriptions in 
Phase One. However, for Phase Two, the supply of non-pharmacological providers in rural 
counties was not associated with an opioid prescription fill. A previous study using national data 
found that living in a rural area was associated with greater odds of an opioid prescription.156 The 
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findings from our study show that limited access to non-pharmacologic providers may be one 
driver of the disparity in care between urban and rural populations.  
In addition to limited access to non-pharmacologic providers, we found that indicators of 
low socioeconomic status were significantly associated with greater odds of an opioid 
prescription in metropolitan and rural counties. At the individual level, having Medicaid 
increased the odds of filling an opioid prescription in either treatment phase for rural and 
metropolitan counties. However, unlike metropolitan counties, a percentage-point increase in the 
county poverty rate in rural counties was associated with greater odds of filling an opioid 
prescription. This finding is consistent with previous literature that found an inverse relationship 
between opioid prescribing rates and county socioeconomic characteristics.36,37 These 
socioeconomic indicators could be a proxy for other patient barriers to accessing care such as 
distance to providers, lack of social support, high costs of treatments, and limited insurance 
coverage for non-pharmacologic treatments.50,51  
Figure 3.3 identifies a key intervention point to reduce opioid prescriptions: the use of PT 
in Phase One. Addressing workforce shortages of non-pharmacologic providers can encourage 
the use of PT in Phase One, and indirectly result in fewer opioid prescriptions in Phase Two. 
Policies that address the barriers to PT use, such as the removal of the caps on the number of PT 
visits for Medicare beneficiaries, may be helpful to reduce opioid prescriptions as well.157 
However, urban and rural counties likely need different policies, and that policies should address 
the financial barriers to accessing non-pharmacologic treatments.  
Our study has several limitations. First, this is an observational study and the associations 
do not necessarily indicate causal relationships. Results may be biased because of unobserved 
variables at the individual (e.g. pain severity, function, and education) and county levels (e.g. 
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supply of substance use providers). Furthermore, we did not explicitly assess temporality of use 
of non-pharmacologic services and opioid prescriptions within each Phase, though we did 
explore the associations between use of services in Phase One and opioid prescriptions in Phase 
Two. Second, we lack data on whether prescribed opioids were taken as indicated. Third, we 
used administrative claims data, which only include services that were paid for by Medicare. 
Therefore, many pain treatments (e.g. over the counter medications, yoga, acupuncture, massage) 
are excluded from this analysis. When this study was conducted, claims with a diagnosis for 
substance use disorder were redacted.158 The redaction could affect our estimation of the 
utilization of mental health services, particularly those tied to substance use diagnoses. Finally, 
our findings may not be generalizable to younger adults and adults with surgery or trauma.  
Conclusion 
We found that Medicare beneficiaries had comparable rates of opioid prescriptions and 
PT use but lower rates of mental health service use during the first six months of a persistent pain 
episode. In adjusted models, both increases in the supply of non-pharmacologic providers and 
use of non-pharmacologic services were associated with reductions in opioid prescriptions. 
However, in addition to non-pharmacologic provider shortages, socioeconomic indicators may 
indicate other barriers to access beyond structural characteristics of the health care system, 
particularly for rural counties. Policies should address both the supply of physical therapists and 
methods to encourage patient engagement with PT early in their care for pain. Future research 
should examine the association between access to non-pharmacologic services and long-term 
opioid use outcomes as well as determine whether these relationships persist in younger 
populations.  
Incorporating non-pharmacologic strategies in chronic pain management minimizes the 
risks associated with opioid use.55 Even when opioids are beneficial, multiple treatment 
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modalities may be necessary to address the biopsychosocial factors associated with pain and 
reduce the risk of adverse events associated with opioids.18,25,59 Following pain management  
guidelines by using non-pharmacologic pain treatment strategies can reduce the use of 
















































No. (%)  
Outcomes 
          
Opioid Prescription 
in Phase One 
9,122 (13.1) — 9,122 (100.0)  6,530 (10.5) 2,592 (34.8) < .001 1,756 (13.6) 7,366 (13.0) 0.09 
Opioid Prescription 
in Phase Two 
7,445 (10.7) 4,853 (8.0) 2,592 (28.4) < .001 — 7,445 (100.0)  1,453 (11.2) 5,992 (10.6) 0.03 
Physical Therapy in 
Phase One 
9,634 (13.9) 7,297 (12.1) 2,337 (25.6) < .001 8,472 (13.7) 1,162 (15.6) < .001 1,467 (11.3) 8,167 (14.4) < .001 
Physical Therapy in 
Phase Two 
7,409 (10.7) 5,490 (9.1) 1,919 (21.0) < .001 5,787 (9.3) 1,622 (21.8) < .001 1,101 (8.5) 6,308 (11.2) < .001 
Mental Health 
Services in Phase 
One 
1,221 (1.8) 1,065 (1.8) 156 (1.7) 0.71 1,061 (1.7) 160 (2.1) 0.007 97 (0.8) 1,124 (2.0) < .001 
Mental Health 
Services in Phase 
Two 
1,105 (1.6) 973 (1.6) 132 (1.4) 0.24 968 (1.6) 137 (1.8) 0.07 88 (0.7) 1,017 (1.8) < .001 
Demographics           
Age, continuous 75.5 (7.7) 75.5 (7.8) 74.9 (7.6) < .001 75.5 (7.7) 75.0 (7.7) < .001 75.3 (7.6) 75.5 (7.8) 0.01 
Age           
66 – 69 years 20,159 (29.0) 17,317 (28.7) 2,842 (31.2) < .001 17,858 (28.8) 2,301 (30.9) < .001 3,738 (28.9) 16,421 (29.0) 0.77 
70 – 74 years 16,425 (23.6) 14,184 (23.5) 2,241 (24.6) 0.03 14,562 (23.5) 1,863 (25.0) 0.003 3,183 (24.6) 13,242 (23.4) 0.004 
































80 – 84 years  9,911 (14.3) 8,712 (14.4) 1,199 (13.1) < .001 8,964 (14.5) 947 (12.7) < .001 1,738 (13.4) 8,173 (14.5) 0.003 
> 85 years 10,366 (14.9) 9,151 (15.2) 1,215 (13.3) < .001 9,335 (15.1) 1,031 (13.8) 0.006 1,818 (14.1) 8,548 (15.1) 0.002 
Sex           
Female 45,625 (65.7) 39,697 (65.8) 5,928 (65.0) 0.13 40,822 (65.8) 4,803 (64.5) 0.02 8,470 (65.5) 37,155 (65.7) 0.67 
Male 23,831 (34.3) 20,637 (34.2) 3,194 (35.0) 0.13 21,189 (34.2) 2,642 (35.5) 0.02 4,456 (34.5) 19,375 (34.3) 0.67 
Race           
White 58,871 (84.8) 51,094 (84.7) 7,777 (85.3) 0.16 52,553 (84.7) 6,318 (84.9) 0.8 
11,851 
(91.7) 
47,020 (83.2) < .001 
Black 4,751 (6.8) 4,093 (6.8) 658 (7.2) 0.13 4,176 (6.7) 575 (7.7) 0.001 727 (5.6) 4,024 (7.1) < .001 
Other Race 5,834 (8.4) 5,147 (8.5) 687 (7.5) 0.001 5,282 (8.5) 552 (7.4) 0.001 348 (2.7) 5,486 (9.7) < .001 
Medicaid dual 
eligible  
13,662 (19.7) 11,690 (19.4) 1,972 (21.6) < .001 11,953 (19.3) 1,709 (23.0) < .001 2,336 (18.1) 11,326 (20.0) < .001 








1.1 (1.4) 1.1 (1.4) 1.1 (1.5) 0.18 1.1 (1.4) 1.1 (1.5) 0.62 0.9 (1.3) 1.1 (1.5) < .001 
0 32,774 (47.2) 28,415 (47.1) 4,359 (47.8) 0.22 29,300 (47.2) 3,474 (46.7) 0.34 6,813 (52.7) 25,961 (45.9) < .001 
1 17,877 (25.7) 15,532 (25.7) 2,345 (25.7) 0.94 15,900 (25.6) 1,977 (26.6) 0.09 3,300 (25.5) 14,577 (25.8) 0.55 
2 9,108 (13.1) 7,925 (13.1) 1,183 (13.0) 0.66 8,145 (13.1) 963 (12.9) 0.63 1,447 (11.2) 7,661 (13.6) < .001 
>3 9,697 (14.0) 8,462 (14.0) 1,235 (13.5) 0.21 8,666 (14.0) 1,031 (13.8) 0.77 1,366 (10.6) 8,331 (14.7) < .001 
































Anxiety 1,475 (2.1) 1,274 (2.1) 201 (2.2) 0.57 1,304 (2.1) 171 (2.3) 0.27 239 (1.8) 1,236 (2.2) 0.02 
Depression 4,069 (5.9) 3,519 (5.8) 550 (6.0) 0.46 3,624 (5.8) 445 (6.0) 0.64 625 (4.8) 3,444 (6.1) < .001 
Schizophrenia 555 (0.8) 508 (0.8) 47 (0.5) 0.00 510 (0.8) 45 (0.6) 0.046 74 (0.6) 481 (0.9) 0.001 
Substance Use 
Disorder 
34 (0.0) 31 (0.1) — 0.46 28 (0.0) — 0.19 — 28 (0.0) 0.89 
Post-traumatic stress 
disorder 
14 (0.0) 14 (0.0) — 0.15 12 (0.0) — 0.67 — 11 (0.0) 0.79 
Trauma in Phase 
One 
1,354 (1.9) 941 (1.6) 413 (4.5) < .001 1,112 (1.8) 242 (3.3) < .001 233 (1.8) 1,121 (2.0) 0.18 
Trauma in Phase 
Two 
1,213 (1.7) 952 (1.6) 261 (2.9) < .001 885 (1.4) 328 (4.4) < .001 217 (1.7) 996 (1.8) 0.52 
Surgery in Phase 
One 
46 (0.1) 32 (0.1) 14 (0.2) < .001 37 (0.1) — 0.05 — 42 (0.1) 0.08 
Surgery in Phase 
Two 
46 (0.1) 42 (0.1) — 0.37 32 (0.1) 14 (0.2) < .001 — 42 (0.1) 0.08 
Pain Type           
Arthritis 68,193 (98.2) 59,259 (98.2) 8,934 (97.9) 0.06 60,866 (98.2) 7,327 (98.4) 0.11 
12,719 
(98.4) 
55,474 (98.1) 0.04 
Back pain 45,664 (65.7) 39,140 (64.9) 6,524 (71.5) < .001 40,196 (64.8) 5,468 (73.4) < .001 8,510 (65.8) 37,154 (65.7) 0.81 
Chronic pain 10,743 (15.5) 8,466 (14.0) 2,277 (25.0) < .001 8,798 (14.2) 1,945 (26.1) < .001 2,076 (16.1) 8,667 (15.3) 0.04 
Neck pain 8,201 (11.8) 6,919 (11.5) 1,282 (14.1) < .001 7,124 (11.5) 1,077 (14.5) < .001 1,326 (10.3) 6,875 (12.2) < .001 
Psychogenic 
pain 
852 (1.2) 731 (1.2) 121 (1.3) 0.35 741 (1.2) 111 (1.5) 0.03 126 (1.0) 726 (1.3) 0.004 




































21,269 (30.6) 17,805 (29.5) 3,464 (38.0) < .001 18,589 (30.0) 2,680 (36.0) < .001 3,812 (29.5) 17,457 (30.9) 0.002 
County Demographics           
Mental Health 
Providers, (Mean, 
IQR) †  
3.3 (1.6, 5.7) 3.3 (1.6, 5.8) 3.0 (1.4, 5.5) < .001 3.3 (1.6, 5.8) 2.9 (1.4, 5.4) < .001 1.0 (0.3, 2.1) 3.9 (2.1, 6.1) < .001 
Physical Therapists, 
(Mean, IQR) † 




6.8 (5.0, 8.9) 6.9 (5.1, 8.9) 6.6 (4.9, 8.5) < .001 6.9 (5.1, 8.9) 6.6 (4.8, 8.5) < .001 5.0 (3.8, 6.6) 7.2 (5.5, 9.3) < .001 
Surgeons, (Mean, 
IQR) † 
5.7 (3.5, 8.0) 5.7 (3.5, 8.1) 5.5 (3.3, 7.9) < .001 5.7 (3.5, 8.1) 5.5 (3.3, 7.9) < .001 2.8 (1.1, 4.5) 6.4 (4.2, 8.3) < .001 
Pain specialist, 
(Mean, IQR) † 
0.3 (0.1, 0.5) 0.3 (0.1, 0.5) 0.2 (0.1, 0.4) < .001 0.3 (0.1, 0.5) 0.2 (0.1, 0.4) < .001 0.0 (0.0, 0.1) 0.3 (0.2, 0.5) < .001 
Pharmacists, (Mean, 
IQR) † 
8.9 (7.2, 11.2) 8.9 (7.2, 11.2) 8.7 (7.2, 11.1) < .001 8.9 (7.2, 11.3) 8.7 (7.1, 11.0) < .001 7.4 (5.7, 9.3) 9.3 (7.5, 11.7) < .001 
Midlevel providers, 
(Mean, IQR) † 
4.9 (3.3, 7.2) 4.9 (3.3, 7.2) 4.9 (3.3, 7.2) 0.03 4.9 (3.3, 7.2) 4.8 (3.3, 7.1) 0.005 4.1 (2.5, 6.1) 5.1 (3.5, 7.5) < .001 
Proportion of 
population over 65 




0.1 (0.1) 0.1 (0.1) 0.1 (0.1) < .001 0.1 (0.1) 0.1 (0.1) < .001 0.2 (0.1) 0.1 (0.0) < .001 






Table 3.2: Association between the access to non-pharmacologic pain treatments and fill of opioid prescriptions in Phase One and 
subgroup analysis for comparing metropolitan and rural counties.  
  Full cohort Metropolitan Counties Rural Counties 
Variable   aOR 95% CI  
 aOR 95% CI  aOR 95% CI  
 
Mental Health Providers†   0.97 (0.96, 0.98)  *** 0.98 (0.96, 0.99) *** 0.96 (0.93, 1.00)  * 
Physical Therapists†   0.98 (0.97, 1.00)  ** 0.98 (0.97, 1.00) * 0.98 (0.95, 1.00)  * 
Metropolitan county  1.06 (0.99, 1.14)  * —   —    
Used Mental Health Services in 
Phase One 
 0.89 (0.75, 1.06)   0.92 (0.77, 1.11)  0.69 (0.36, 1.31)   
Used Physical Therapy in Phase 
One 
 2.60 (2.47, 2.75)  *** 2.50 (2.36, 2.65) *** 3.19 (2.80, 3.64)  *** 
Medicaid dual eligible  1.26 (1.19, 1.34)  *** 1.24 (1.16, 1.33) *** 1.38 (1.20, 1.57)  *** 
Proportion of population in 
poverty 
  1.84 (1.06, 3.21)  ** 1.07 (0.55, 2.07)  11.2 (3.82, 32.87)  *** 
Age Category  70 – 74 years 0.98 (0.92, 1.05)   0.97 (0.91, 1.04)  1.03 (0.90, 1.19)   
  75 – 79 years 0.92 (0.86, 0.99)  ** 0.93 (0.86, 1.00) * 0.88 (0.76, 1.03)   
  80 – 84 years 0.87 (0.81, 0.94)  *** 0.88 (0.81, 0.96) ** 0.83 (0.70, 1.00)  ** 
  ≥ 85 years 0.82 (0.76, 0.89)  *** 0.83 (0.77, 0.91) *** 0.78 (0.65, 0.93)  ** 
  66 – 69 years -Ref    -Ref   -Ref    
Female  1.00 (0.95, 1.05)   1.00 (0.94, 1.05)  1.02 (0.91, 1.13)   
Race Black 1.04 (0.95, 1.14)   1.05 (0.95, 1.16)  0.98 (0.78, 1.23)   
  Other 0.80 (0.72, 0.87)  *** 0.80 (0.72, 0.88) *** 0.91 (0.65, 1.28)   
  Unknown 1.19 (0.85, 1.67)   0.97 (0.67, 1.42)  5.25 (2.15, 12.84)  *** 
  White -Ref    -Ref   -Ref    
Deyo-Charlson Comorbidity 
Score 






  Full cohort Metropolitan Counties Rural Counties 
Variable   aOR 95% CI  
 aOR 95% CI  aOR 95% CI  
 
Depression  1.02 (0.92, 1.12)   0.99 (0.89, 1.10)  1.16 (0.92, 1.46)   
Anxiety  1.03 (0.88, 1.21)   1.03 (0.87, 1.22)  1.06 (0.72, 1.55)   
Trauma in Phase One  2.98 (2.64, 3.36)  *** 2.83 (2.48, 3.24) *** 3.66 (2.76, 4.84)  *** 
Surgery in Phase One  2.93 (1.54, 5.56)  ** 2.36 (1.17, 4.76) * 20.73 (2.13, 201.37)  ** 
Year 2009 1.00 (0.94, 1.06)   0.99 (0.93, 1.06)  1.00 (0.87, 1.14)   
  2010 0.98 (0.91, 1.05)   0.95 (0.88, 1.04)  1.09 (0.92, 1.28)   
  2011 1.07 (0.99, 1.17)   1.04 (0.95, 1.15)  1.22 (1.01, 1.47)  * 
  2012 0.99 (0.90, 1.09)   1.00 (0.90, 1.11)  0.94 (0.75, 1.17)   
  2013 0.96 (0.87, 1.06)   0.98 (0.88, 1.09)  0.83 (0.66, 1.06)   
  2014 1.13 (0.99, 1.28)  * 1.11 (0.96, 1.28)  1.22 (0.90, 1.65)   
  2008 -Ref    -Ref   -Ref    
Primary care providers †   0.98 (0.97, 1.00)  * 0.98 (0.96, 0.99) ** 1.00 (0.98, 1.03)   
Surgeons †   1.02 (1.00, 1.03)  * 1.02 (1.00, 1.03) ** 1.03 (1.00, 1.06)  * 
Pain specialist†   0.82 (0.71, 0.94)  ** 0.82 (0.70, 0.95) ** 0.89 (0.64, 1.25)   
Pharmacists†   1.01 (1.00, 1.02)  * 1.00 (0.99, 1.01)  1.01 (0.99, 1.03)   
Midlevel providers†   1.00 (0.99, 1.01)   1.01 (1.00, 1.02) * 0.98 (0.96, 1.00)  * 
Proportion of population over 65   0.60 (0.33, 1.11)   0.44 (0.22, 0.85) ** 3.57 (0.74, 17.16)   
Intercept   0.14 (0.12, 0.17)  *** 0.18 (0.15, 0.22) *** 0.07 (0.05, 0.10)  *** 
Scale   2.72 (2.72, 2.72)   2.72 (2.72, 2.72)  2.72 (2.72, 2.72)   
***P <0.01, **P <0.05, *P<0.1 
†Providers per 10,000 people 
aOR: adjusted Odds ratio 
95% CI: 95% confidence interval 






Table 3.3: Association between the access to non-pharmacologic pain treatments and opioid prescription fill in Phase Two of a pain 








Variable  aOR 95% CI   aOR 95% CI   aOR 95% CI   
Mental Health Providers†  0.97 (0.96, 0.98)  *** 0.96 (0.95, 0.98)  *** 1.01 (0.97, 1.04)    
Physical Therapists†  1.00 (0.98, 1.01)   0.99 (0.97, 1.01)   1.00 (0.97, 1.03)    
Metropolitan county  1.02 (0.94, 1.10)   —    —    
Used Mental Health Services in 
Phase One 
 1.20 (0.97, 1.48)  * 1.19 (0.95, 1.49)   1.32 (0.68, 2.57)    
Used Physical Therapy in Phase 
One 
 0.62 (0.58, 0.67)  *** 0.62 (0.57, 0.68)  *** 0.63 (0.52, 0.76)  *** 
Opioid Prescription in Phase One  4.18 (3.95, 4.43)  *** 4.18 (3.93, 4.45)  *** 4.19 (3.68, 4.77)  *** 
Used Mental Health Services in 
Phase Two 
 1.00 (0.79, 1.25)   0.99 (0.78, 1.27)   1.16 (0.58, 2.31)    
Used Physical Therapy in Phase 
Two 
 2.75 (2.56, 2.96)  *** 2.67 (2.47, 2.89)  *** 3.17 (2.67, 3.76)  *** 
Medicaid dual eligible Buy-in  1.28 (1.20, 1.37)  *** 1.27 (1.18, 1.37)  *** 1.35 (1.16, 1.56)  *** 
Proportion of population in poverty  2.75 (2.56, 2.96)  *** 2.67 (2.47, 2.89)  *** 3.17 (2.67, 3.76)  *** 
Age Category 70 – 74 years 0.98 (0.91, 1.05)   0.99 (0.91, 1.06)   0.96 (0.82, 1.12)   
 75 – 79 years 0.89 (0.82, 0.96)  *** 0.86 (0.79, 0.94)  *** 0.99 (0.84, 1.18)   
 80 – 84 years 0.82 (0.76, 0.90)  *** 0.81 (0.74, 0.89)  *** 0.89 (0.73, 1.08)   
 ≥ 85 years 0.85 (0.78, 0.92)  *** 0.84 (0.76, 0.92)  *** 0.89 (0.73, 1.08)   













Variable  aOR 95% CI   aOR 95% CI   aOR 95% CI   
Female Female 0.96 (0.91, 1.01)   0.98 (0.92, 1.04)   0.88 (0.78, 1.00)  ** 
Race Black 1.05 (0.95, 1.16)   1.05 (0.94, 1.17)   1.01 (0.79, 1.29)    
 Other 0.82 (0.73, 0.91)  *** 0.82 (0.74, 0.92)  *** 0.81 (0.55, 1.19)    
 Unknown 0.81 (0.53, 1.24)   0.77 (0.49, 1.23)   1.16 (0.38, 3.54)    
 White -Ref    -Ref    -Ref    
Deyo-Charlson Comorbidity Score  1.01 (0.99, 1.02)   1.01 (0.99, 1.03)   0.99 (0.95, 1.04)    
Depression  0.95 (0.86, 1.07)   0.93 (0.83, 1.06)   1.04 (0.81, 1.36)    
Anxiety  1.06 (0.89, 1.26)   1.01 (0.83, 1.22)   1.29 (0.87, 1.91)    
Year 2009 0.99 (0.93, 1.06)   1.01 (0.94, 1.09)   0.93 (0.80, 1.08)   
 2010 0.89 (0.82, 0.97)  *** 0.89 (0.81, 0.98)  ** 0.92 (0.77, 1.11)   
 2011 0.89 (0.81, 0.98)  ** 0.89 (0.79, 0.99)  ** 0.95 (0.77, 1.18)   
 2012 0.91 (0.82, 1.01)  * 0.91 (0.81, 1.02)   0.95 (0.75, 1.22)   
 2013 0.88 (0.79, 0.98)  ** 0.9 (0.80, 1.01)  * 0.82 (0.62, 1.06)   
 2014 0.89 (0.77, 1.04)   0.89 (0.76, 1.06)   0.93 (0.65, 1.32)   
 2008 -Ref    -Ref    -Ref    
Trauma or surgery,  Phase One  1.01 (0.87, 1.18)   1.04 (0.88, 1.23)   0.86 (0.59, 1.25)    
Trauma or surgery,  Phase Two  2.78 (2.42, 3.19)  *** 2.66 (2.28, 3.11)  *** 3.37 (2.44, 4.66)  *** 
Censored Full follow up 0.36 (0.27, 0.46)  *** 0.33 (0.25, 0.44)  *** 0.49 (0.25, 0.97)  ** 













Variable  aOR 95% CI   aOR 95% CI   aOR 95% CI   
 Died -Ref    -Ref    -Ref    
Primary care providers†  0.98 (0.96, 1.00)  ** 0.98 (0.96, 1.00)   0.98 (0.95, 1.01)    
Surgeons†  1.02 (1.00, 1.03)  ** 1.02 (1.01, 1.04)  *** 0.99 (0.96, 1.03)    
Pain specialists†  0.97 (0.84, 1.12)   0.92 (0.78, 1.08)   1.19 (0.84, 1.67)    
Pharmacists†  1.00 (0.99, 1.01)   1.00 (0.99, 1.01)   1.00 (0.98, 1.02)    
Midlevel providers†  1.00 (0.99, 1.01)   1.00 (0.99, 1.02)   0.99 (0.97, 1.01)    
Proportion of population over 65  0.56 (0.29, 1.11)  * 0.69 (0.33, 1.46)   0.23 (0.04, 1.36)    
Intercept  0.30 (0.22, 0.42)  *** 0.35 (0.24, 0.49)  *** 0.21 (0.10, 0.48)   
Scale  2.72 (2.72,2.72)   2.72 (2.72,2.72)   2.72 (2.72,2.72)   
***P <0.01, **P <0.05, *P<0.1 
†Providers per 10,000 people 
aOR: adjusted Odds ratio 
95% CI: 95% confidence interval 














Table 3.4: Association between the access to non-pharmacologic pain treatments and physical therapy use during the Phase One and 
Two after a pain diagnosis. 
  Phase One Phase Two 
Variable  aOR 95% CI   aOR 95% CI   
Mental Health Providers†  1.02 (1.01, 1.03)  *** 1.02 (1.01, 1.03)  ** 
Physical Therapists †  1.02 (1.01, 1.04)  *** 1.02 (1.00, 1.03)  * 
Metropolitan county  1.13 (1.06, 1.21)  *** 1.07 (0.98, 1.16)   
Used Mental Health Services in 
Phase One 
 2.59 (2.45, 2.73)  *** 1.22 (0.98, 1.52)   
Opioid Prescription in Phase One  1.21 (1.03, 1.42)  * 1.64 (1.54, 1.76)  *** 




   9.3 (8.80, 9.83)  *** 
Opioid Prescription in Phase Two  —    2.77 (2.58, 2.97)  *** 




   1.55 (1.25, 1.93)  *** 
Age Category 70 – 74 years 0.87 (0.82, 0.93)  *** 0.96 (0.90, 1.03)   
 75 – 79 years 0.83 (0.78, 0.88)  *** 0.89 (0.82, 0.96)  ** 
 80 – 84 years 0.72 (0.67, 0.78)  *** 0.82 (0.75, 0.90)  *** 
 ≥ 85 years 0.70 (0.65, 0.76)  *** 0.74 (0.67, 0.81)  *** 
 66 – 69 years -Ref    -Ref    






  Phase One Phase Two 
Variable  aOR 95% CI   aOR 95% CI   
Race Black 0.52 (0.46, 0.59)  *** 0.76 (0.66, 0.86)  *** 
 Other 0.98 (0.90, 1.08)   0.97 (0.86, 1.08)   
 Unknown 0.92 (0.67, 1.26)   1.07 (0.72, 1.57)   
 White -Ref    -Ref    
Medicaid dual eligible  0.67 (0.62, 0.72)  *** 0.79 (0.73, 0.86)  *** 
Deyo-Charlson Comorbidity Score  0.95 (0.93, 0.96)  *** 0.99 (0.97, 1.01)   
Depression  1.02 (0.93, 1.13)   1.05 (0.94, 1.18)   
Anxiety  0.98 (0.84, 1.14)   0.94 (0.78, 1.14)   
Trauma in Phase One  1.13 (0.97, 1.31)   1.35 (1.14, 1.59)  *** 
Surgery in Phase One  0.23 (0.06, 0.96)  * 0.71 (0.21, 2.35)   
Trauma in Phase Two  —    1.52 (1.27, 1.81)  *** 
Surgery in Phase Two  —    0.19 (0.02, 1.38)   
Year 2009 1.05 (0.99, 1.11)   1.05 (0.98, 1.13)   
 2010 1.12 (1.05, 1.21)  ** 1.08 (0.98, 1.18)   
 2011 1.15 (1.06, 1.25)  *** 1.12 (1.01, 1.24)  * 
 2012 1.22 (1.11, 1.33)  *** 1.29 (1.16, 1.44)  *** 






  Phase One Phase Two 
Variable  aOR 95% CI   aOR 95% CI   
 2014 1.58 (1.42, 1.76)  *** 1.66 (1.44, 1.91)  *** 
 2008 -Ref    -Ref    
Censored Full follow up —    2.04 (1.27, 3.27)  ** 
 Left FFS —    2.01 (1.17, 3.45)  * 
 Died —    -Ref    
Primary care providers†  1.02 (1.00, 1.03)  ** 1.03 (1.01, 1.04)  ** 
Surgeons†  1.01 (1.00, 1.02)  * 0.99 (0.98, 1.01)   
Pain specialist†  0.89 (0.79, 0.99)  * 1.05 (0.92, 1.21)   
Pharmacists†  0.99 (0.98, 1.00)  ** 0.98 (0.98, 0.99)  ** 
Midlevel providers†  1.00 (0.99, 1.01)   0.99 (0.98, 1.00)  * 
Proportion of population over 65  0.80 (0.44, 1.44)   0.26 (0.12, 0.53)  *** 
Proportion of population in poverty  0.20 (0.11, 0.36)  *** 0.25 (0.13, 0.51)  *** 
Intercept  0.15 (0.13, 0.18)  *** 0.03 (0.02, 0.05)  *** 
Scale  2.72 (2.72, 2.72)  *** 2.72 (2.72, 2.72)  *** 
***P <0.01, **P <0.05, *P<0.1 
†Providers per 10,000 people 
aOR: adjusted Odds ratio 






Table 3.5: Association between the access to non-pharmacologic pain treatments and mental health service use during the Phase One 
and Two of new episode of persistent musculoskeletal pain. 
  Phase One Phase Two 
Variable  aOR 95% CI P-value  aOR 95% CI P-value  
Mental Health Providers per 10k people  1.05 (1.02, 1.07) <.0001 *** 0.97 (0.94, 1.00) 0.0438 ** 
Physical Therapists per 10k people  1.06 (1.02, 1.10) 0.0024 ** 0.99 (0.94, 1.03) 0.5793  
Metropolitan county  2.04 (1.62, 2.57) <.0001 *** 0.59 (0.45, 0.78) 0.0002 *** 
Used Mental Health Services in Phase One  —    0.01 (0.01, 0.01) <.0001 *** 
Used Physical Therapy in Phase One  1.21 (1.04, 1.43) 0.0172 ** 0.82 (0.66, 1.01) 0.0678 * 
Opioid Prescription in Phase One  0.91 (0.77, 1.09) 0.3169  1.18 (0.94, 1.49) 0.1542  
Opioid Prescription in Phase Two  —    0.95 (0.75, 1.21) 0.7006  
Used Mental Health Services in Phase Two  —    0.66 (0.53, 0.82) 0.0002 *** 
Age Category 70 – 74 years 0.88 (0.74, 1.04) 0.126  1.06 (0.85, 1.31) 0.621  
 75 – 79 years 0.84 (0.70, 1.01) 0.0621 * 1.12 (0.89, 1.42) 0.344  
 80 – 84 years 0.87 (0.71, 1.05) 0.153  1.06 (0.83, 1.36) 0.6367  
 ≥ 85 years 1.06 (0.88, 1.27) 0.553  0.87 (0.69, 1.10) 0.247  
 66 – 69 years -Ref    -Ref    
Female  1.11 (0.97, 1.27) 0.1174  1.12 (0.95, 1.33) 0.1682  
Race Black 1.16 (0.93, 1.44) 0.1973  0.96 (0.72, 1.28) 0.7599  
 Other 0.50 (0.38, 0.65) <.0001 *** 1.79 (1.27, 2.52) 0.0009 *** 






  Phase One Phase Two 
Variable  aOR 95% CI P-value  aOR 95% CI P-value  
 White -Ref    -Ref    
Medicaid dual eligible   1.67 (1.45, 1.92) <.0001 *** 0.63 (0.52, 0.75) <.0001 *** 
Deyo-Charlson Comorbidity Score  1.1 (1.07, 1.14) <.0001 *** 0.94 (0.90, 0.98) 0.0073 ** 
Depression  9.64 (8.48, 10.95) <.0001 *** 0.24 (0.20, 0.29) <.0001 *** 
Anxiety  3.46 (2.87, 4.19) <.0001 *** 0.4 (0.30, 0.52) <.0001 *** 
Year 2009 1.00 (0.86, 1.18) 0.9639  0.9 (0.74, 1.10) 0.3061  
 2010 1.04 (0.85, 1.28) 0.6834  1.18 (0.91, 1.54) 0.2168  
 2011 1.14 (0.90, 1.43) 0.2743  1.08 (0.80, 1.46) 0.6078  
 2012 1.16 (0.90, 1.50) 0.2445  1.01 (0.73, 1.38) 0.9632  
 2013 1.61 (1.28, 2.04) <.0001 *** 1.23 (0.89, 1.69) 0.2044  
 2014 1.53 (1.13, 2.06) 0.0059 ** 0.88 (0.58, 1.32) 0.524  
 2008 -Ref    -Ref    
Trauma in Phase One  2.99 (2.29, 3.91) <.0001 *** 0.88 (0.60, 1.30) 0.5319  
Surgery in Phase One  2.65 (0.76, 9.22) 0.1248  0.51 (0.09, 2.73) 0.4283  
Trauma in Phase Two  —    0.37 (0.25, 0.54) <.0001 *** 
Surgery in Phase Two  —    0.22 (0.05, 1.03) 0.0551  
Censored Full follow up —    0.52 (0.23, 1.20) 0.1273  
 Left FFS —    1.14 (0.34, 3.82) 0.8377  






  Phase One Phase Two 
Variable  aOR 95% CI P-value  aOR 95% CI P-value  
Primary care providers†  0.97 (0.93, 1.01) 0.1839  1.06 (1.01, 1.12) 0.0288 * 
Surgeons†  1.01 (0.98, 1.05) 0.4457  0.98 (0.94, 1.02) 0.3061  
Pain specialist†  1.33 (0.98, 1.80) 0.0638 * 0.97 (0.66, 1.45) 0.8996  
Pharmacists†  0.99 (0.97, 1.01) 0.3434  1.01 (0.98, 1.04) 0.463  
Midlevel providers†  0.95 (0.93, 0.97) <.0001 *** 0.98 (0.95, 1.01) 0.18  
Proportion of population over 65  1.20 (0.23, 6.15) 0.8304  0.32 (0.04, 2.45) 0.2728  
Proportion of population in poverty  3.32 (0.70, 15.81) 0.1312  2.83 (0.38, 21.15) 0.3112  
Intercept  0 (0.00, 0.00) <.0001 *** 626.17 (215.24, 1821.67) <.0001 *** 
Scale  2.72 (2.72, 2.72) _ *** 2.72 (2.72, 2.72) _ *** 
***P <0.001, **P <0.01, *P<0.05 
†Providers per 10,000 people 
aOR: adjusted Odds ratio 









Table 3.6: Association between supply of non-pharmacologic providers and opioid prescriptions fills in Phase One and Phase Two 
(Total Association). 
  Phase One Phase Two 
Variable  aOR 95% CI P-value  aOR 95% CI P-value  
Mental Health Providers per 10k people  0.98 (0.97, 0.99) <.0001 *** 0.97 (0.96, 0.98) <.0001 *** 
Physical Therapists per 10k people  0.99 (0.97, 1.00) 0.0491 ** 0.99 (0.98, 1.01) 0.4843   
Metropolitan county  1.08 (1.01, 1.15) 0.0324 ** 1.04 (0.97, 1.12) 0.318   
Age Category 70 – 74 years 0.96 (0.91, 1.02) 0.2403   0.97 (0.91, 1.04) 0.3524   
 75 – 79 years 0.90 (0.84, 0.96) 0.0018 *** 0.86 (0.80, 0.92) <.0001 *** 
 80 – 84 years 0.84 (0.78, 0.90) <.0001 *** 0.78 (0.72, 0.85) <.0001 *** 
 ≥ 85 years 0.79 (0.73, 0.85) <.0001 *** 0.78 (0.72, 0.85) <.0001 *** 
 66 – 69 years -Ref        -Ref 
Female  1.00 (0.95, 1.05) 0.9591   0.97 (0.92, 1.02) 0.2529   
Race Black 0.98 (0.89, 1.07) 0.6147   1.02 (0.93, 1.13) 0.6261   
 Other 0.79 (0.72, 0.87) <.0001 *** 0.77 (0.70, 0.86) <.0001 *** 
 Unknown 1.20 (0.86, 1.67) 0.2811   0.86 (0.57, 1.30) 0.4856   
 White -Ref     -Ref     
Medicaid dual eligible   1.20 (1.13, 1.27) <.0001 *** 1.30 (1.22, 1.39) <.0001 *** 
Deyo-Charlson Comorbidity Score  1.00 (0.98, 1.02) 0.9726   1.00 (0.99, 1.02) 0.6275   
Depression  1.01 (0.92, 1.11) 0.8354   0.98 (0.88, 1.09) 0.7375   






  Phase One Phase Two 
Variable  aOR 95% CI P-value  aOR 95% CI P-value  
Year 2009 1.00 (0.94, 1.06) 0.9814  1.00 (0.94, 1.07) 0.982   
 2010 0.99 (0.92, 1.07) 0.8381  0.9 (0.83, 0.98) 0.0144 ** 
 2011 1.09 (1.00, 1.19) 0.0412 ** 0.93 (0.84, 1.02) 0.1062   
 2012 1.02 (0.93, 1.12) 0.676  0.95 (0.86, 1.05) 0.2901   
 2013 1.00 (0.91, 1.10) 0.9375  0.91 (0.82, 1.01) 0.074 * 
 2014 1.19 (1.05, 1.35) 0.0077 *** 1.00 (0.86, 1.15) 0.9849   
 2008 -Ref    -Ref    
Trauma in Phase One  3.03 (2.69, 3.41) <.0001 *** —    
Surgery in Phase One  2.57 (1.35, 4.87) 0.0039 *** —    
Trauma in Phase One or Two  —    1.41 (1.22, 1.63) <.0001 *** 
Surgery in Phase One or Two  —     2.96 (2.60, 3.38) <.0001 *** 
Censored Full follow up —    0.35 (0.27, 0.45) <.0001 *** 
 Left FFS —    0.46 (0.33, 0.64) <.0001 *** 
 Died —    -Ref    
Primary care providers†  0.98 (0.97, 1.00) 0.0395 ** 0.98 (0.96, 1.00) 0.0126 ** 
Surgeons†  1.02 (1.00, 1.03) 0.0072 *** 1.02 (1.01, 1.04) 0.0046 *** 
Pain specialist†  0.81 (0.70, 0.92) 0.0018 *** 0.93 (0.81, 1.08) 0.342   
Pharmacists†  1.01 (1.00, 1.01) 0.1909   1.00 (0.99, 1.01) 0.6824   






  Phase One Phase Two 
Variable  aOR 95% CI P-value  aOR 95% CI P-value  
Proportion of population over 65  0.58 (0.32, 1.06) 0.0778 * 0.45 (0.23, 0.88) 0.0196 ** 
Proportion of population in poverty  1.50 (0.87, 2.60) 0.1479   1.30 (0.72, 2.37) 0.3863   
Intercept  0.18 (0.15, 0.21) <.0001 *** 0.47 (0.34, 0.65) <.0001 *** 
Scale  2.72 (2.72, 2.72)   2.72 (2.72, 2.72)   
***P <0.001, **P <0.01, *P<0.05 
†Providers per 10,000 people 
aOR: adjusted Odds ratio 



















Figure 3.3: Significant associations between supply and use of non-pharmacologic services and 




Supplemental Table 3.1: ICD-9/Current Procedural Codes/ Healthcare Common Procedure 
Coding System. 
Measure ICD-9/CPT/HCPCS 
Musculoskeletal Pain145 3078, 30789, 338, 3382, 3384, 7100, 7103, 7104, 7105, 7109, 712, 
713, 714, 715, 716, 717, 718, 719, 7200, 7201, 7202, 7208, 7209, 
7210, 7211, 7212, 7213, 7214, 7219, 722, 7230, 7231, 7239, 7240, 
7241, 7242, 7243, 7244, 7245, 7246,7247, 725, 726, 72700, 7273, 
7276, 7279, 7289, 729, 7291, 7292, 7294, 7295, 7298, 7328, 7329, 
7371, 7373, 7382, 7383, 7384, 7385, 7386, 7398, 7399, 78096, 8052, 
8054, 8056, 8058, 8080, 8082, 8084, 80841, 80842, 80843, 80844, 
80849, 8088, 8090, 8100, 8110, 8120, 8122, 8124 , 8130, 8132, 8134, 
8138, 8140, 8150, 8160, 8170, 8180, 8190, 8200, 8202, 8208, 8210, 
8212, 8220, 8230, 8232, 8238, 8240, 8242, 8244, 8246, 8248, 8250, 
82520, 82521, 82522, 82523, 82524, 82525, 82529, 8260, 8270, 
8290, 8310, 8320, 8330, 8340, 8350, 83600, 8361, 8362, 8363, 8365, 
8366, 8370, 8380, 8390, 8392, 8394, 8396, 8398, 840, 8409, 841, 
842, 843, 844, 845, 846, 847, 848, 959, 7391, 7392, 7393, 7394, 
7395, 7396, 7397, 72703, 72704, 72705, 72706, 72709 
Trauma145 875, 876, 877, 879, 880, 881, 882, 883, 884, 885, 886, 887, 890, 891, 
892, 893, 894, 895, 896, 897, 926, 927, 928, 929, 996  
Physical Therapy148 97110, 97350, 97535, 97112 ,97150, 97035, 97010, 97032, 97012, 
97140, 97001, 97002, 97124, 99070, 97750, 97113, 97116 
Mental Health Services28,149 90832, 90833, 90834, 90836, 90837, 90838, 90791, 90792, 90804, 
90805, 90806, 90807, 90808, 90809, 90810, 90811, 90812, 90813, 
90814, 90815, 90816, 90817, 90818, 90819, 90820, 90821, 90822, 
90823, 90824, 90825, 90826, 90827, 90828, 90829, 90845, 90847, 
90849, 90853, 90857, 90865, 90870, G0409, G0410, G0411, 90839, 
99354, 90840 
Depression152   
(one inpatient or one 
outpatient diagnosis) 
29620, 29621, 29622, 29623, 29624, 29625, 29626, 29630, 29631,  
29632, 29633, 29634, 29635, 29636, 29650, 29651, 29652, 29653, 
29654, 29655, 29656, 29660, 29661, 29662, 29663, 29664, 29665, 
29666, 29689, 2980, 3004, 3091, 311 
Anxiety153 
(one inpatient or two 
outpatient diagnoses)  
29384, 30000, 30001, 30002, 30009, 30010, 30020, 30021, 30022, 
30023, 30029, 3003, 3005, 30089, 3009, 3080, 3081, 3082, 3083, 




Supplemental Table 3.2: Construction of variables from the Area Health Resource File.98 
Variable in 
Model 









Carry Forward, Backward 
Physical 
Therapists 






with MD or DO 
training in office based 
settings, hospital staff, 
hospital residents, and 






Surgeons  General and “other” 
surgery with MD or DO 
training in Office based 
settings, hospital staff, 
hospital residents, and 





Pain specialist  Physical 
Medicine/Rehabilitation 
MD or DO training in 
Office based settings, 
hospital staff, hospital 
residents, and clinical 





Pharmacists   2009 Carry Forward, Backward 
Midlevel 
providers 








CHAPTER 4: THE ASSOCIATION BETWEEN ACCESS TO NON-PHARMACOLOGIC 
PAIN MANAGEMENT TREATMENTS AND HIGH-RISK OPIOID PRESCRIPTION 
PATTERNS FOR MEDICARE BENEFICIARIES WITH PERSISTENT 
MUSCULOSKELETAL PAIN2.    
Overview 
Background 
 Contrary to clinical guidelines, recent trends in pain management indicate that opioids are 
prescribed more frequently than non-pharmacologic treatments. Significant geographic variation 
in opioid use persists, and high-risk opioid use – both high-dose and long-term use – are 
prevalent. Understanding how access to non-pharmacologic treatment affects these high-risk 
prescription patterns could inform policies to prevent them.  
Objectives 
 We present temporal and geographic trends in high-risk opioid prescription patterns 
among Medicare beneficiaries with persistent musculoskeletal pain and estimate the association 
between access to two key non-pharmacologic services (Physical Therapy (PT) and mental 
health services) and high-risk opioid prescription patterns.  
Subjects  
 Using claims from Medicare beneficiaries over age 65 enrolled in fee-for-service and Part 
D between 2007 and 2013, we constructed a cohort of beneficiaries with a new persistent 
musculoskeletal pain episode and no opioid prescription within the prior six months.   
                                                          
2 Disclosure of conflict of interest: This research was conducted while Ruchir Karmali was a student at the 
University of North Carolina and a pre-doctoral fellow at the Duke Clinical Research Institute.   
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Measures and Research Design 
 We used four measures of access to non-pharmacologic services: supply of PT and 
mental health providers per 10,000 people per county and any use of PT and mental health 
services during the first three months of a new episode of pain (early use). Outcomes include 
long-term prescription (≥90 days’ supply within a year) and high-dose prescription (any 
prescription ≥50 Milligrams Morphine Equivalent). For the outcomes, annual incidence rates and 
hospital referral region prevalence rates were calculated. Using multinomial regression and 
generalized estimating equations, we estimated the association between access to non-
pharmacologic services and high-risk prescription patterns, controlling for individual and county 
characteristics.  
Results 
 Geographic variation in high-risk opioid prescription patterns was substantial. Across 
models, greater supply of mental health providers and pain specialists was associated with lower 
odds of high-risk prescriptions. Evidence on early non-pharmacologic services use was mixed, 
but an early opioid prescriptions was associated with greater odds of high-risk prescriptions. 
Conclusion 
 Improving access to mental health services can help providers follow clinical 
recommendations, and is likely to decrease high-risk prescriptions. 
Introduction 
Chronic pain, or pain that continues past three months, significantly impacts the quality 
of life for adults over age 65.1,2,46,56,60 One common chronic pain condition is musculoskeletal 
pain, which affects almost 60% of older adults.3 The direct healthcare and indirect cost of 
musculoskeletal pain exceeds $320 billion with older adults accounting for 37% of the cost.3 
Consequences of chronic pain include inactivity, falls, mood disorders, isolation, and 
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disability.2,46,60 For long-term treatment, clinical guidelines recommend non-pharmacologic (e.g. 
mental health services or physical therapy (PT)) and/or multimodal treatments for chronic pain, 
even when opioids are appropriate.18,19,55 Both mental health services (e.g. cognitive behavioral 
therapy) and PT improve pain symptoms, functioning, and opioid use, especially among older 
adults.26,79,80,94,95,112,113  
Opioids may be effective for acute pain, but limited evidence exists to support long-term 
opioid use and high-dose prescriptions.9,17 Compared acute pain diagnoses (e.g. surgery, trauma), 
patients with a chronic pain diagnosis have the greatest risk of long-term opioid use.93 From 
2007 to 2012, the rate of prescriptions with >90 days’ supply almost doubled from 4% to 7% 
among older adults.62 Approximately 16% of Medicare beneficiaries are prescribed daily doses 
greater than 100 milligrams morphine equivalent (MME) -- more than twice the maximum dose 
recommended by the Centers for Disease Control and Prevention (CDC).18,74 Long-term opioid 
use, which could be necessary for chronic pain, can lead to opioid tolerance and need for 
increasingly high doses.18 About 25% of Medicare beneficiaries have >90 consecutive days of 
opioid prescriptions and daily doses greater than 100 MME.74 Both long-term and high-dose 
opioid use increase the risk of overdose and mortality.10-13,15,16,69 Furthermore, opioid use in older 
adults is associated with a greater risk of adverse events (e.g. falls, fractures, and respiratory 
illness).10,63-66,141 The combination of long-term and high-dose opioid use also increases the risk 
of adverse events.73 
Among older adults, opioids are used more frequently than non-pharmacologic services.29 
Underuse of non-pharmacologic treatments and overuse of opioids may result from insufficient 
capacity of the health care system to deliver non-pharmacologic services.143 Previous studies 
demonstrate a positive relationship between the supply of providers, such as primary care and 
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surgeons, and opioid prescription rates in adult populations.34,35,37 Little is known about the 
relationship between access to non-pharmacologic services and these high-risk prescription 
patterns among older adults with chronic pain. Understanding the drivers of high-risk 
prescription patterns can help inform efforts to prevent these patterns.  
In this study, we sought to (1) examine the temporal and geographic trends in high-risk 
opioid prescription among older-adult Medicare beneficiaries with a new episode of persistent 
musculoskeletal pain and (2) estimate the association between access to non-pharmacologic 
services and high risk prescribing. Due to ambiguous definitions of chronic pain in the literature 
and the desire to focus on how pain patients interact with the health care system, we refer to the 
presence of multiple pain diagnoses at least 90 days apart as an episode of persistent pain. We 
measure access to non-pharmacologic services using four independent variables: per capita: 
county supply of mental health providers and physical therapists and any individual use of 
mental health services and PT during the first three months after the index pain diagnosis (early 
use after new claims indicating pain). Outcomes include two high-risk prescription patterns: 
receiving long-term and high-dose prescriptions. We hypothesize that (1) greater supply of non-
pharmacologic providers is associated with lower odds of high-risk opioid prescribing, and (2) 
early use of non-pharmacologic services is associated with lower odds of high-risk prescribing.  
Methods  
This retrospective cohort study examined the relationship between access to non-
pharmacological services and high-risk opioid prescription patterns for older adult, Medicare 
beneficiaries with what will become a new episode of persistent musculoskeletal pain. A 
diagnostic code was used as a proxy measure for pain; we acknowledge it represents a time when 




 This study utilized Medicare Fee-for-Service (FFS) claims and the Area Health Resource 
File (AHRF) datasets.98 We used a 5% sample of beneficiaries enrolled in Medicare FFS during 
January 1, 2008 and December 31, 2013. Medicare claims data from 2007 was available for the 
look-back period. The Master Beneficiary Summary file contains information on demographics, 
enrollment, and death. We used claims from Medicare Parts A, B, and D. Part A contains 
inpatient claims and Part B contains outpatient claims, including home health, hospice, and 
skilled nursing facilities. Both Medicare Part A and B contained information about diagnoses, 
mental health services and PT visits, and dates of service. The Part D Drug Event file contains 
claims for filled prescriptions which include information about the amount of medication 
dispensed, the days’ supply, and the fill date. Referencing the beneficiaries’ county of residence 
and index date from the claims data, the AHRF was used to assign county characteristics to 
beneficiaries including the supply of non-pharmacologic providers in their county of residence.98 
The AHRF also contains the Rural-Urban Commuting Area codes which describe rurality for 
each county.98,144 
Study Population 
Supplemental Figure 4.1 depicts how we identified a new episode of what will become 
persistent musculoskeletal pain for the cohort using International Disease Classification Codes, 
9th edition (ICD-9) (Supplemental Table 4.1).145 Individuals were included if they have two 
claims with diagnoses of musculoskeletal pain that are greater than 90, but fewer than 365 days 
apart.57 We defined an episode of persistent musculoskeletal pain using the first claim with a 
pain diagnosis (index date) after a year without any claims with a pain diagnosis. Pain diagnoses 
did not have to be the same to identify an episode. After the index date, individuals were 
 
82 
followed for one year or death, enrollment in Medicare Advantage, or disenrollment from Part D, 
at which point they were censored.  
We required individuals to have 12 months of claims before the index date, to ensure the 
pain episode was new and that there was no recent history of opioid prescription (within six 
months, consistent with prior research).13 Thus, to be in the cohort, individuals were 66 or older 
and continuously enrolled in Medicare FFS for one year before the index date. Since the focus of 
this analysis was a new episode of persistent musculoskeletal pain, we excluded individuals with 
a trauma diagnosis or surgery in the year before the index date (defined by Current Procedural 
Codes (CPT) and ICD-9 codes).145,146 Individuals with hospice or long term care services at any 
time were excluded because opioid prescription guidelines differ for these individuals.18 
Outcomes 
We identified long-term and high-dose prescriptions during the year after the index date 
using Medicare Part D claims. Both oral or transdermal formulations of opioids were included to 
reflect the United States’ Food and Drug Administration-approved indication to treat pain. 
Opioids were identified by the National Drug Codes provided by the CDC.147 
Beneficiaries were coded with a long-term prescription if their total days’ supply 
exceeded 90 during the one-year follow-up period (less if censored).62 The total days’ supply is 
the sum of days for each prescription filled during follow-up. To identify high-dose 
prescriptions, we calculated the average daily MME for each prescription by multiplying the 
quantity prescribed, the drug strength, and the morphine equivalent conversion factor and 
dividing this by the days’ supplied.147,159 Beneficiaries had a high dose prescription if the dose of 
any prescription filled during the follow-up period was >50 MME.18 We created a five-category, 
beneficiary level outcome for high-risk prescription fills: no opioid prescriptions, >1 opioid 
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prescription but no long-term or high dose prescriptions, long-term prescription only, high-dose 
prescription only, and both long-term and high-dose prescription.   
Access Measures 
We operationalized access to non-pharmacologic services in terms of the supply of 
providers in individuals’ county of residence and individuals’ early use of mental health and PT 
services. As a measure of local availability, the supply of providers were defined as the number 
of mental health providers and PT per county per year. Mental health providers includes both 
psychiatrists and psychologists. We created per capita measures using county population from 
the AHRF multiplied by 10,000.98 When annual county supply variables were missing, we 
interpolated values based on existing data (Supplemental Table 4.2). Beneficiaries’ early use of 
pain management services was a binary indicator for any opioid prescriptions, mental health 
services, and PT visits within three months of the index pain diagnosis using the CPT and 
Healthcare Common Procedural Coding System (Supplemental Table 4.1).28,148,149 
Covariates  
Individual and county characteristics confounding the relationship between access to non-
pharmacologic services and opioid prescription patterns were included based on Donabedian’s 
Quality of Care Model.97 Individual characteristics, measured at baseline and one year before the 
index date, included age, race, sex, and Medicaid dual eligibility (proxy for income).150 
Comorbidities were measured using the Deyo-Charlson comorbidity score.151 We also identified 
depression and anxiety at baseline using the ICD-9 codes identified by the Centers for Medicare 
and Medicaid’s (CMS) Chronic Conditions Warehouse and the Health Cost and Utilization 
Project.145,152,153 In the follow up period, we controlled for trauma diagnosis and surgery.145,146 
To account for loss to follow up, models included binary indicators for death and leaving FFS 
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Medicare during the year after the index date. Counts of the total number of prescribers and 
pharmacies seen by the individual during the follow up period were also included.3 
For county characteristics, we independently controlled for the supply of primary care 
providers, surgeons, pain specialists, midlevel practitioners (nurse practitioners and physician 
assistants), and  pharmacists.98 Provider supply per capita measures followed the same method 
used for non-pharmacologic provider supply described above (Supplemental Table 4.1). We 
controlled for the county socioeconomic status (percent of the population below the Federal 
Poverty Limit) and percent of the county population over 65. Rural-Urban Commuting Area 
codes were used to assign counties to metropolitan and rural designations.98 
Statistical Analysis 
We describe the trends in opioid prescription patterns over time and geographically. The 
annual opioid prescription rate from 2008 to 2014 was calculated by dividing the number of 
beneficiaries with the outcome at the end of each year by the total number of beneficiaries who 
completed follow up in that year. We describe the unadjusted, geographic rates in any opioid 
prescriptions, long-term prescription, or high-dose prescriptions. Because many counties had < 
ten beneficiaries, we calculated the rates by hospital referral regions (HRR). Beneficiaries were 
assigned to HRR based on their zip code of residence. We calculated the rate of opioid 
prescribing patterns by HRR which reflect market for healthcare in an area.160 HRRs with fewer 
than 10 beneficiaries overall or fewer than 10 beneficiaries with an opioid prescription pattern 
were censored.  
                                                          
3 The Centers for Medicare and Medicaid changed the encryption method to identified unique prescribers and 
pharmacies in 2014. To obtain the total number of prescribers for beneficiaries with a 2013 index date, we counted 
each prescriber or pharmacy as unique, which may lead to double counting. However, time trends in the model 
should adjust for this difference. 
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We calculated means and proportions for individual and county-level variables. T-tests 
and chi-square tests were used to compare individual and county characteristics of beneficiaries 
with an opioid prescription, long-term prescriptions, and high-dose prescriptions to those 
without those outcomes, separately.  
We used a multinomial logistic regression to test hypotheses using data from the entire 
cohort. The outcome was the five-category high-risk prescribing pattern measure, with the 
reference category as any opioid prescription during the follow-up period to allow for 
comparisons with subsequent subgroup analyses. The model included measures of access 
(supply of mental health providers and supply of physical therapists, early use of mental health 
services, and early use of physical therapy), individual characteristics (demographics, 
comorbidities, trauma, and surgery), and county characteristics (provider supply and 
demographics). 
Subgroup analyses of beneficiaries with an opioid prescription in the follow-up period 
were conducted to address potential selection bias issues by controlling for opioid prescription 
characteristics. We used generalized estimating equations and selected the model with the 
unstructured correlation based on the quasi-likelihood under the independence model criterion 
(QIC) goodness of fit statistic (unstructured). The dependent variables were long-term 
prescriptions and high-dose prescriptions. The independent variables from the multinomial 
model were included along with an indicator for an early opioid prescription, the number of 
prescribers, and the number of pharmacies visited. For both models, we used the definition for 
high dose prescriptions as 90 MME in sensitivity analysis. Since the association between the 
supply of non-pharmacologic providers and opioid prescribing outcomes is mediated by use, we 
also examined the “total association” between the supply and the outcomes in another sensitivity 
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analysis. The subgroup analyses using different definitions for long-term and high-dose 
prescriptions were replicated. Analyses were conducted in SAS Version 9.4 (SAS Institute, Inc., 
Cary, NC) and Stata version 15.1 (StataCorp). The Institutional Review Boards at Duke 
University School of Medicine and the University of North Carolina-Chapel Hill approved this 
study.  
Results 
 We identified 197,827 beneficiaries with a new episode of persistent musculoskeletal 
pain without an opioid prescription within six months of the index date. After excluding 80,386 
beneficiaries because of surgery, 1,497 because of a trauma diagnosis before the index date, and 
5,943 because of hospice use, the final cohort included 67,183 beneficiaries (Figure 4.1).   
Descriptive Statistics  
 One third of the cohort filled an opioid prescription during the one year follow-up period 
(Table 4.1). Overall, 12% had high-dose prescriptions, and 2.4% had long-term prescriptions. 
About 28% of the cohort was 66 to 69 years old, 66% was female, 84.8% was White, 19.9% 
were dually eligible, and 81.3% resided in a metropolitan county. The mean Charlson 
Comorbidity Score was 1.1. Only 2.1% of the cohort had anxiety and 5.8% had depression at 
baseline. The most prevalent musculoskeletal pain conditions include arthritis (98.4%), back pain 
(66.5%), and fibromyalgia (69.1%). On average, there were four mental health providers and six 
physical therapists per 10,000 people per county.  
Compared to beneficiaries without an opioid prescription after the index date, 
beneficiaries with an opioid prescription were more likely to be younger, have Medicaid, live in 
rural counties, and have depression at baseline (Table 4.1). The average daily dose was 43.7 
MME/day and average days’ supply was 28.2 days. During the first three months of the 
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persistent pain episode, 17.3% used PT, 1.7% used mental health services, and 41.9% filled an 
opioid prescription. Beneficiaries has an average of 1.4 prescribers and 1.2 pharmacies.  
Long-Term and High-Dose Prescriptions  
 Among beneficiaries with an opioid prescription during the follow up period, 7.6% had a 
long-term prescription, 38.3% had a high-dose prescription, and 3% had both long-term and high 
dose prescriptions (Table 4.2). The average daily dose for beneficiaries with a long-term 
prescription was a significantly lower than average daily dose for beneficiaries without a long-
term prescription. (32.7 MME/day vs 44.6 MME/day, p≤0.001). About 44% of beneficiaries with 
long-term prescription had a prescription dose >50 MME. Beneficiaries with long-term 
prescriptions were more likely to be female, Black, have Medicaid, have depression and anxiety 
at baseline, have more prescribers and pharmacies, and use mental health services early than 
those without long-term prescriptions. Beneficiaries with high-dose prescriptions were more 
likely to be younger, male, White, live in a rural county, and use PT but less likely to have 
Medicaid early compared to beneficiaries without high-dose prescriptions. Early opioid 
prescriptions were significantly more likely among beneficiaries with long-term (65.5%) or high-
dose prescriptions (46.8%). The median supply of providers for beneficiaries with long-term 
prescriptions and high-doses was lower compared to beneficiaries without a long-term 
prescription or high-doses, respectively. 
Temporal and Geographic Variation 
 While the opioid prescription and the long-term prescription rates for the entire cohort 
were stable over the study period, the high-dose prescriptions rate decreased by 35% (Figure 
4.2). The opioid prescription rate by HRR ranged from 12% to 52% (Figure 4.3). The rate of 
long-term prescriptions by HRR ranged from 0% to 8%, and the rate of high-dose prescriptions 
by HRR ranged from 2% to 35%. 
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Access to Non-Pharmacologic Services and High-Risk Prescription Patterns 
 Compared to beneficiaries with an opioid prescription during follow-up, an additional 
non-pharmacologic provider was associated with greater odds of not filling an opioid 
prescription [mental health providers: adjusted odds ratio (aOR): 1.01, 95% Confidence interval 
(CI): 1.00-1.02, PT aOR: 1.02, 95% CI: 1.01-1.03] (Table 4.3). A greater supply of mental health 
providers and pain specialists were associated with lower odds of long-term and high-dose 
prescriptions. An additional physical therapists was significantly associated with greater odds of 
long-term prescriptions [aOR: 1.04, 95% CI: 1.00-1.09]. The supply of physical therapists was 
not significantly associated with high-dose or concurrent high-dose and long-term prescriptions. 
Relative to beneficiaries with an opioid prescription, early use of mental health services was 
associated with greater odds of long-term prescriptions [aOR: 1.94, 95% CI: 1.32-2.86. Early use 
of PT was associated with greater odds of high-dose [aOR: 1.28, 95% CI: 1.19-1.38] and 
concurrent long-term and high-dose prescriptions [aOR: 1.19, CI: 0.97-1.46].   
Among beneficiaries with an opioid prescription during the follow-up year (Table 4.4 and 
Table 4.5), greater supply of mental health providers and pain specialists was significantly 
associated with lower odds of a long-term prescription and high-dose prescriptions. The supply 
of physical therapists was not significantly associated with the odds of long-term prescriptions or 
high-dose prescriptions. An early opioid prescription was associated with greater odds of long-
term prescriptions and high-dose prescriptions. An additional prescriber or pharmacy was 
associated with greater odds of long-term and high-dose prescriptions.  
Sensitivity analyses which examined the total association between the supply of non-
pharmacologic providers and opioid prescription patterns were consistent with the main analysis 




This study examined high-risk opioid prescription patterns for Medicare beneficiaries 
over 65 with a new episode of persistent musculoskeletal pain. We found that a third of the 
cohort filled an opioid prescription during the one year follow-up period, and almost half of 
those prescriptions occurred three months into a new episode. The average daily dose for 
beneficiaries with long-term prescriptions was lower than estimates reported from a recent study 
of all Medicare beneficiaries with long-term prescriptions.74 A concerning finding is that about 
3% of this cohort had long-term and high-dose prescriptions concurrently. Furthermore, almost 
40% of beneficiaries with a long-term prescription had a prescription > 50 MME. These results 
suggest that while many beneficiaries with long-term prescriptions have relatively low average 
doses of opioids, the doses of individual prescriptions may exceed the CDC thresholds, which 
could represent an increase in pain and expose beneficiaries to adverse events.18,62,161 Long-term, 
high-dose opioids may be appropriate for certain patients, but require careful monitoring and 
clear understanding of associated risks.18 
We found patterns of high-risk opioid prescriptions for older adults with persistent 
musculoskeletal pain were distinct from populations that have previously been studied. For 
example, unlike previous studies which found rising rates of long-term prescriptions among 
Medicare beneficiaries, the rate of long-term prescriptions was stable in this cohort.62,74 
However, the rate of high-dose prescriptions fell by about 35% from 2008 to 2014, which is 
slower than the rate of change observed for all Medicare beneficiaries.74 Comparable to previous 
studies with different populations, the rates of high-risk patterns varied across the country.33,35-37 
The greatest concentration of high-dose prescriptions was the South and the West, while the 
long-term prescription rate was highest in the Midwest. This substantial geographic variation 
may indicate variations in care for patients with musculoskeletal pain, differences in available 
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resources, and policy differences, especially for preventing and addressing high-risk prescribing 
patterns.33,35,37 
The supply of mental health providers and pain specialists were both strongly associated 
with lower odds of high-risk prescription patterns across models while the supply of physical 
therapists was not significantly associated. This finding could reflect the differences in needs of 
beneficiaries when pain persists. For example, compared to physical therapists, pain specialists 
may be better equipped to manage long-term pain episodes and manage long-term opioid 
treatments.1 Furthermore, mental health providers can address the mental health needs that may 
develop during a pain episode.1 We found mixed evidence for early use of non-pharmacologic 
services and high-risk prescribing patterns. Without information about duration and dose of non-
pharmacologic services use as well as the patient’s pain severity, function, and psychosocial 
characteristics, it is difficult to conclude whether early use of non-pharmacologic services 
increases high-risk prescribing patterns or if associations indicate a greater need for pain 
treatments.  
This study extends previous literature which found that the characteristics of initial opioid 
prescriptions such as dose and duration are associated with long-term opioid prescriptions.6,93 
We found that opioid prescriptions filled within three months of a new pain episode is associated 
with greater odds of high-risk prescription patterns. Based on this finding, timing of the opioid 
prescription with respect to the onset of a new episode of pain may be an important consideration 
to prevent high-risk patterns.  
Recent policy approaches which target prescribing behaviors or limit access to narcotics 
have limited evidence demonstrating reductions in opioid prescriptions.62,90,162 These policies 
take a myopic approach to the opioid epidemic by doing little to increase access to alternative 
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pain management strategies. We found preliminary evidence supporting policies that address 
shortages for mental health professionals and pain specialists. The independent association of the 
supply of providers, after controlling for use of these services, suggests that these providers are 
valuable resources to the health care system. For example, integrating mental health providers 
and pain specialists in primary care settings may provide additional organizational and practice 
level support for primary care providers who care for chronic pain patients.163-165  
Our study has several limitations. First, this is an observational study and the associations 
are not causal. Results may be biased because of unobserved variables (e.g. pain severity, 
function, education, and supply of substance use providers). Second, we lack data on whether 
prescribed opioids were taken as indicated. Third, we used administrative claims data which only 
include services that were paid for by Medicare. Therefore, many pain treatments (e.g. over the 
counter medications, yoga, acupuncture, massage) are excluded from this analysis. When this 
study was conducted, claims with a diagnosis for substance use disorder were redacted.158 The 
redaction could affect our estimation of the utilization of mental health services, particularly 
those tied to substance use diagnoses. Finally, our findings may not be generalizable to younger 
adults and adults with surgery or trauma.  
Conclusion 
Clinical guidelines recommend non-pharmacologic services over opioids for patients 
with chronic pain.18,19 We examined access to two common non-pharmacologic services, PT and 
mental health services, and found that only the supply of mental health providers was 
significantly associated with lower odds of high-risk patterns. Early opioid prescriptions was 
associated with greater odds of high-risk patterns. Future research should examine how the   
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timing, dose, and duration of non-pharmacologic services may impact high-risk prescriptions. 
Improving access to mental health services, particularly to communities with the greatest rates of 





Table 4.1: Characteristics of Medicare beneficiaries with a new episode of persistent 























    
Opioid prescription during follow up 20,962 (31.2) — 20,962 (100.0)  
Prescription dose ≥ 50 MME 8,024 (11.9) — 8,024 (38.3)  
Prescription Dose ≥ 90 MME 3,953 (5.9) — 3,953 (18.9)  
Average Dose ≥ 50 MME, as prescribed• 5,868 (8.7) — 5,868 (28.0)  
Average Dose ≥ 50 MME• 4,055 (6.0) — 4,055 (19.3)  
Days’ supply ≥ 90 days 1,597 (2.4) — 1,597 (7.6)  
Days’ supply ≥ 90, accounting for overlap• 1,409 (2.1) — 1,409 (6.7)  
Chronic long-term opioid prescription• 707 (1.1) — 707 (3.4)  
Opioid prescription characteristics  —   
Early Opioid Prescription  8,776 (13.1) — 8,776 (41.9)  
Average daily MME 13.6 (29.0) — 43.7 (37.2)  
Total days’ supply 8.8 (31.0) — 28.2 (50.2)  
Total opioid days covered 8.2 (27.2) — 26.1 (43.5)  
Demographics     
Age (categories)     
66 – 69 years 18,850 (28.1) 12,603 (27.3) 6,247 (29.8) < .001 
70 – 74 years 16,006 (23.8) 10,793 (23.4) 5,213 (24.9) < .001 
75 – 79 years 12,355 (18.4) 8,531 (18.5) 3,824 (18.2) 0.51 
80 – 84 years 9,752 (14.5) 6,935 (15.0) 2,817 (13.4) < .001 
> 85 years 10,220 (15.2) 7,359 (15.9) 2,861 (13.6) < .001 
Age, continuous  75.6 (7.7) 75.8 (7.8) 75.1 (7.6) < .001 
Sex     
















Male 22,857 (34.0) 15,517 (33.6) 7,340 (35.0) < .001 
Race     
White 56,959 (84.8) 39,042 (84.5) 17,917 (85.5) < .001 
Black 4,602 (6.8) 3,132 (6.8) 1,470 (7.0) 0.26 
Other Race 5,622 (8.4) 4,047 (8.8) 1,575 (7.5) < .001 
Medicaid dual eligible 13,371 (19.9) 8,994 (19.5) 4,377 (20.9) < .001 
Metropolitan county 54,636 (81.3) 37,773 (81.7) 16,863 (80.4) < .001 
Comorbidities     
Deyo-Charlson Comorbidity Score (mean) 1.1 (1.4) 1.1 (1.4) 1.1 (1.5) 0.49 
0 31,533 (46.9) 21,675 (46.9) 9,858 (47.0) 0.75 
1 17,302 (25.8) 11,860 (25.7) 5,442 (26.0) 0.41 
2 8,886 (13.2) 6,118 (13.2) 2,768 (13.2) 0.91 
>3 9,462 (14.1) 6,568 (14.2) 2,894 (13.8) 0.16 
Anxiety 1,408 (2.1) 967 (2.1) 441 (2.1) 0.92 
Depression 3,909 (5.8) 2,653 (5.7) 1,256 (6.0) 0.2 
Trauma during follow up 4,248 (6.3) 2,339 (5.1) 1,909 (9.1) < .001 
Surgery during follow up 17,122 (25.5) 9,541 (20.6) 7,581 (36.2) < .001 
Pain type     
Arthritis 66,076 (98.4) 45,459 (98.4) 20,617 (98.4) 0.98 
Back pain 44,659 (66.5) 29,408 (63.6) 15,251 (72.8) < .001 
Chronic pain 10,571 (15.7) 5,596 (12.1) 4,975 (23.7) < .001 
Neck pain 8,087 (12.0) 5,076 (11.0) 3,011 (14.4) < .001 
Psychogenic pain 844 (1.3) 550 (1.2) 294 (1.4) 0.02 
Sprain or strain 19,430 (28.9) 12,435 (26.9) 6,995 (33.4) < .001 
Fibromyalgia 46,441 (69.1) 31,434 (68.0) 15,007 (71.6) < .001 
Other pain type 20,955 (31.2) 13,241 (28.6) 7,714 (36.8) < .001 
















Utilization during follow up 
Use Mental Health Services  2,181 (3.2) 1,453 (3.1) 728 (3.5) 0.03 
Used Physical Therapy 17,708 (26.4) 10,076 (21.8) 7,632 (36.4) < .001 
Number of pharmacists 0.4 (0.6) — 1.2 (0.4)  
Number of prescribers 0.4 (0.8) — 1.4 (0.8)  
Early use of Physical Therapy  9,201 (13.7) 5,565 (12.0) 3,636 (17.3) < .001 
Early use of Mental Health Services  1,165 (1.7) 802 (1.7) 363 (1.7) 0.97 
County Characteristics (Median, Interquartile 
Range) 
    
Mental Health Providers †  3.3 (1.6, 5.7) 3.4 (1.7, 6.0) 3.0 (1.4, 5.5) < .001 
Physical Therapists † 5.9 (4.0, 7.6) 6.0 (4.1, 7.7) 5.7 (3.8, 7.4) < .001 
Primary care providers † 6.8 (5.0, 8.9) 6.9 (5.1, 9.0) 6.6 (4.9, 8.6) < .001 
Surgeons † 5.7 (3.5, 8.0) 5.8 (3.6, 8.1) 5.5 (3.3, 7.9) < .001 
Pain specialist † 0.3 (0.1, 0.4) 0.3 (0.1, 0.5) 0.2 (0.1, 0.4) < .001 
Pharmacists †  8.9 (7.2, 11.2) 8.9 (7.2, 11.3) 8.8 (7.2, 11.1) < .001 
Midlevel providers † 4.8 (3.3, 7.1) 4.8 (3.3, 7.2) 4.8 (3.2, 7.1) < .001 
Proportion of population over 65 0.1 (0.1, 0.2) 0.1 (0.1, 0.2) 0.1 (0.1, 0.2) < .001 
Proportion of population in poverty 0.1 (0.1, 0.2) 0.1 (0.1, 0.2) 0.1 (0.1, 0.2) < .001 
† per 10,000 people 
• Average daily dose as prescribed: total MME/total days’ supply 
Average daily dose: total MME/ total days’ supply accounting for overlapping prescriptions 
Days’ supply ≥ 90, accounting for overlap: ≥ 90 total days’ supply accounting for any overlapping prescription 







Table 4.2: Characteristics of Medicare beneficiaries with a new episode of persistent 
musculoskeletal pain with high-risk opioid prescription patterns. 
  Long-term opioid prescriptions High-dose prescriptions 
  
















Outcomes             
Dose ≥ 50 MME 7,316 (37.8) 708 (44.3) < .001 — 8,024 (100.0)  
Average Dose ≥ 50 
MME, as prescribed 
5,581 (28.8) 287 (18.0) < .001 
— 
5,868 (73.1)  
Average Dose  ≥ 50 
MME 
4,040 (20.9) 15 (0.9) < .001 
— 
4,055 (50.5)  
Days’ supply ≥ 90 days — 1,597 100.0)  889 (6.9) 708 (8.8) < .001 
Days’ supply ≥ 90, 
accounting for overlap 
— 




707 (44.3)  383 (3.0) 324 (4.0) < .001 
Opioid prescription 
characteristics 
      
Average daily MME 44.6 (37.6) 32.7 (30.0) < .001 25.3 (10.6) 73.2 (45.0) < .001 
Total days’ supply 16.5 (17.2) 171.0 (86.3) < .001 26.2 (45.9) 31.5 (56.3) < .001 
Total opioid days 
covered 
15.8 (16.3) 151.0 (69.3) < .001 25.1 (42.6) 27.8 (44.9) < .001 
Demographics             
Age (categories)             
66 – 69 years 5,822 (30.1) 425 (26.6) 0.004 3,768 (29.1) 2,479 (30.9) 0.006 
70 – 74 years 4,879 (25.2) 334 (20.9) < .001 3,114 (24.1) 2,099 (26.2) < .001 
75 – 79 years 3,516 (18.2) 308 (19.3) 0.26 2,385 (18.4) 1,439 (17.9) 0.36 
80 – 84 years 2,578 (13.3) 239 (15.0) 0.06 1,804 (13.9) 1,013 (12.6) 0.007 
> 85 years 2,570 (13.3) 291 (18.2) < .001 1,867 (14.4) 994 (12.4) < .001 
Age, continuous 75.0 (7.5) 76.3 (8.0) < .001 75.3 (7.7) 74.8 (7.4) < .001 
Sex             
Female 12,561 (64.9) 1,061 (66.4) 0.21 8,488 (65.6) 5,134 (64.0) 0.02 
Male 6,804 (35.1) 536 (33.6) 0.21 4,450 (34.4) 2,890 (36.0) 0.02 
Race             
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White 16,605 (85.7) 1,312 (82.2) < .001 10,763 (83.2) 7,154 (89.2) < .001 
Black 1,321 (6.8) 149 (9.3) < .001 994 (7.7) 476 (5.9) < .001 
Other Race 1,439 (7.4) 136 (8.5) 0.11 1,181 (9.1) 394 (4.9) < .001 
Medicaid dual eligible 3,821 (19.7) 556 (34.8) < .001 3,046 (23.5) 1,331 (16.6) < .001 
Metropolitan county 15,604 (80.6) 1,259 (78.8) 0.09 10,460 (80.8) 6,403 (79.8) 0.06 




1.1 (1.5) 1.2 (1.6) 0.002 1.1 (1.5) 1.0 (1.5) < .001 
0 9,170 (47.4) 688 (43.1) 0.001 5,930 (45.8) 3,928 (49.0) < .001 
1 4,993 (25.8) 449 (28.1) 0.04 3,435 (26.5) 2,007 (25.0) 0.01 
2 2,551 (13.2) 217 (13.6) 0.64 1,738 (13.4) 1,030 (12.8) 0.21 
>3 2,651 (13.7) 243 (15.2) 0.09 1,835 (14.2) 1,059 (13.2) 0.04 
Alcohol Disorder 53 (0.3) 17 (1.1) < .001 36 (0.3) 34 (0.4) 0.08 
Anxiety 393 (2.0) 48 (3.0) 0.009 289 (2.2) 152 (1.9) 0.1 
Depression 1,128 (5.8) 128 (8.0) < .001 774 (6.0) 482 (6.0) 0.94 
Trauma in year after 
index date 
1,734 (9.0) 175 (11.0) 0.007 1,045 (8.1) 864 (10.8) < .001 
Surgery in year after 
index date 
6,778 (35.0) 803 (50.3) < .001 4,333 (33.5) 3,248 (40.5) < .001 
Pain type             
Arthritis 19,045 (98.3) 1,572 (98.4) 0.79 12,685 (98.0) 7,932 (98.9) < .001 
Back pain 13,963 (72.1) 1,288 (80.7) < .001 9,470 (73.2) 5,781 (72.0) 0.07 
Chronic pain 4,364 (22.5) 611 (38.3) < .001 2,654 (20.5) 2,321 (28.9) < .001 
Neck pain 2,744 (14.2) 267 (16.7) 0.005 1,802 (13.9) 1,209 (15.1) 0.02 
Psychogenic pain 273 (1.4) 21 (1.3) 0.76 176 (1.4) 118 (1.5) 0.51 
Sprain or strain 6,531 (33.7) 464 (29.1) < .001 4,134 (32.0) 2,861 (35.7) < .001 
Fibromyalgia 13,793 (71.2) 1,214 (76.0) < .001 9,155 (70.8) 5,852 (72.9) < .001 
Other pain type 7,090 (36.6) 624 (39.1) 0.05 4,577 (35.4) 3,137 (39.1) < .001 
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Utilization during follow up 
Any Use of Mental 
Health Services  
627 (3.2) 101 (6.3) < .001 460 (3.6) 268 (3.3) 0.41 
Any Use of Physical 
Therapy 
7,080 (36.6) 552 (34.6) 0.11 4,185 (32.3) 3,447 (43.0) < .001 
Number of pharmacists 1.1 (0.4) 1.5 (0.8) < .001 1.1 (0.4) 1.2 (0.5) < .001 
Number of prescribers 1.4 (0.7) 2.3 (1.5) < .001 1.3 (0.6) 1.7 (1.0) < .001 
Early use of Physical 
Therapy  
3,387 (17.5) 249 (15.6) 0.05 2,054 (15.9) 1,582 (19.7) < .001 
Early use of Mental 
Health Services  
307 (1.6) 56 (3.5) < .001 229 (1.8) 134 (1.7) 0.59 
Early Opioid 
Prescription  
7,729 (39.9) 1,047 (65.6) < .001 5,022 (38.8) 3,754 (46.8) < .001 
County Characteristics             
Mental Health Providers †  3.0 (1.4, 5.5) 2.7 (1.2, 4.9) < .001 3.1 (1.4, 5.5) 2.9 (1.3, 5.2) < .001 
Physical Therapists † 5.7 (3.9, 7.5) 5.3 (3.5, 7.3) < .001 5.7 (3.8, 7.4) 5.7 (3.9, 7.6) 0.04 
Primary care providers † 6.6 (4.9, 8.6) 6.4 (4.7, 8.4) 0.002 6.6 (4.9, 8.6) 6.6 (4.8, 8.5) 0.03 
Surgeons † 5.5 (3.4, 7.9) 5.2 (3.1, 7.7) 0.003 5.5 (3.3, 7.9) 5.5 (3.3, 7.9) 0.99 
Pain specialist † 0.2 (0.1, 0.4) 0.2 (0.0, 0.4) 0.001 0.2 (0.1, 0.4) 0.2 (0.1, 0.4) < .001 
Pharmacists †  8.8 (7.2, 11.1) 8.5 (6.8, 10.9) < .001 8.7 (7.1, 11.0) 8.9 (7.2, 11.2) < .001 
Midlevel providers † 4.8 (3.2, 7.1) 4.6 (3.2, 6.9) 0.12 4.7 (3.2, 7.1) 4.8 (3.2, 7.0) 0.43 
Proportion of population 
over 65 
0.1 (0.1, 0.2) 0.1 (0.1, 0.2) 0.94 0.1 (0.1, 0.2) 0.1 (0.1, 0.2) 0.17 
Proportion of population 
in poverty 
0.1 (0.1, 0.2) 0.1 (0.1, 0.2) < .001 0.1 (0.1, 0.2) 0.1 (0.1, 0.2) < .001 
† per 10,000 people 
• Average daily dose as prescribed: total MME/total days’ supply 
Average daily dose: total MME/ total days’ supply accounting for overlapping prescriptions 
Days’ supply ≥ 90, accounting for overlap: ≥ 90 total days’ supply accounting for any overlapping prescription 






Table 4.3: Association between access to non-pharmacologic pain treatments and opioid prescribing patterns compared to Medicare 
beneficiaries without opioid prescriptions. 
  No opioids • Long term prescription • High-dose prescription• Long term and high dose • 
    aOR P-value  aOR P-value  aOR P-value  aOR P-value  
Mental Health Providers  †   1.01 0.01 *** 0.96 0.02 ** 0.97 0.00 *** 0.97 0.12  
Physical Therapists  †   1.02 0.00 *** 1.04 0.07 * 1.01 0.25  1.00 0.97  
Early Use of Mental Health Services  1.22 0.02 ** 1.94 0.00 *** 0.94 0.59  1.45 0.11  
Early Use of Physical Therapy  0.70 <.0001 *** 0.95 0.61  1.28 <.0001 *** 1.19 0.09 * 
Metropolitan County   1.03 0.32  0.90 0.29  0.97 0.52  1.09 0.45  
Age Category 70 – 74 years 1.02 0.44  0.87 0.20  0.95 0.22  0.87 0.22  
  75 – 79 years 1.11 0.00 *** 1.10 0.38  0.83 <.0001 *** 0.87 0.24  
  80 – 84 years 1.23 <.0001 *** 1.21 0.09 * 0.76 <.0001 *** 0.73 0.02 ** 
  ≥ 85 years 1.37 <.0001 *** 1.21 0.09 * 0.65 <.0001 *** 0.82 0.11  
  66 – 69 years -Ref  -Ref  -Ref  -Ref  
Female Female 0.95 0.04 ** 1.11 0.20  0.97 0.40  0.94 0.45  
Race Unknown 0.89 0.52  0.59 0.47  0.64 0.15  0.42 0.40  
  Other 1.03 0.55  0.84 0.18  0.62 <.0001 *** 0.69 0.03 ** 
  Black 0.96 0.28  1.13 0.33  0.85 0.01 ** 0.84 0.27  
  White -Ref  -Ref  -Ref  -Ref  
Medicaid dual eligible  0.87 <.0001 *** 2.08 <.0001 *** 0.72 <.0001 *** 1.42 0.00 *** 
Deyo-Charlson Comorbidity Score   0.99 0.03 ** 1.00 0.96  0.97 0.02 ** 1.03 0.28  
Depression  1.03 0.50  1.22 0.14  1.02 0.78  1.04 0.83  
Anxiety  0.94 0.41  1.30 0.20  0.89 0.27  1.13 0.62  
Year 2012 0.97 0.48  0.93 0.67  1.02 0.83  1.25 0.33  
  2008 0.85 0.00 ** 0.90 0.52  0.86 0.05 * 0.93 0.76  
 2011 1.02 0.67  0.82 0.24  1.30 0.00 *** 1.54 0.04 ** 
 2009 1.06 0.19  1.03 0.86  1.85 <.0001 *** 2.32 <.0001 *** 
 2010 1.04 0.40  0.96 0.78  1.71 <.0001 *** 2.23 <.0001 *** 







  No opioids • Long term prescription • High-dose prescription• Long term and high dose • 
    aOR P-value  aOR P-value  aOR P-value  aOR P-value  
Trauma after index date  0.68 <.0001 *** 0.85 0.23  1.29 <.0001 *** 1.40 0.00 *** 
Surgery after index date  1.88 <.0001 *** 0.72 <.0001 *** 0.75 <.0001 *** 0.36 <.0001 *** 
Censor 1 year Follow up 0.97 0.76  1.88 0.09 * 0.68 0.00 ** 0.43 0.00 *** 
 Left FFS or Part D 1.05 0.67  1.83 0.13  0.74 0.04 ** 0.85 0.51  
 Died -Ref  -Ref  -Ref  -Ref  
Primary care providers †   1.01 0.10 * 0.99 0.74  0.97 0.00 ** 0.99 0.81  
Surgeons †   0.99 0.31  1.03 0.23  1.04 <.0001 *** 1.01 0.69  
Pain specialist †   1.08 0.20  0.65 0.07 * 0.76 0.00 ** 0.90 0.65  
Pharmacists †    1.00 0.79  0.98 0.19  1.02 0.01 ** 1.00 0.78  
Midlevel providers †   1.00 0.41  1.00 0.93  1.01 0.45  1.02 0.28  
Proportion of population over 65   2.40 0.00 ** 2.22 0.41  2.01 0.08 * 1.86 0.56  
Proportion of population in poverty   0.65 0.10 * 3.20 0.16  0.79 0.54  1.64 0.60  
† per 10,000 people 
• Reference group is any opioid prescription during follow up 
P < 0.01***; P < 0.05 **; P < 0.1 * 
aOR: adjusted Odds ratio 
Ref: Reference 
 







Table 4.4: Association between access to non-pharmacologic pain treatments and long-term prescriptions. 
  Days’ Supply ≥ 90 days 
Chronic Opioid prescribing  
(≥ 90 days, <7 day gap) 
Long term, as prescribed, ≥ 90 
days 
  aOR P-value  aOR P-value  aOR   
Mental Health Providers †   0.97 0.0555 * 0.99 0.6965   0.98 0.1371   
Physical Therapists  †   1.03 0.1011   1.05 0.0594 * 1.04 0.0498 ** 
Metropolitan County   0.97 0.6952   0.86  0.1963   0.92 0.3653   
Age Category 70 – 74 years 0.93 0.3999   0.86 0.2323   0.9 0.2485   
  75 – 79 years 1.18 0.0529 * 1.07 0.5754   1.14 0.1365   
 
80 – 84 years 1.33 0.0024 *** 1.57 0.0005 *** 1.27 0.0152 ** 
  ≥ 85 years 1.63 <.0001 *** 2.17 <.0001 *** 1.61 <.0001 *** 
 66 – 69 years -Ref   -Ref   -Ref   
Female Female 0.99 0.9242   0.94 0.4888   1.02 0.7443   
Race Black 1.04 0.7391   0.92 0.6039   1.06 0.5876   
  Other 0.93 0.4968   0.91 0.5443   0.84 0.1498   
  Unknown 0.53 0.3275   0.42 0.4006   0.60 0.4282   
 White -Ref   -Ref   -Ref   
Medicaid dual eligible  1.89 <.0001 *** 1.87 <.0001 *** 1.94 <.0001 *** 
Deyo-Charlson Comorbidity Score  1.03 0.1362   1.04 0.1431   1.03 0.1188   
Depression  1.21 0.0798 * 1.29 0.0852 * 1.11 0.3688   







  Days’ Supply ≥ 90 days 
Chronic Opioid prescribing  
(≥ 90 days, <7 day gap) 
Long term, as prescribed, ≥ 90 
days 
  aOR P-value  aOR P-value  aOR   
Early Opioid Prescription  2.08 <.0001 *** 1.83 <.0001 *** 2.33 <.0001 *** 
Early Use of Mental Health Services  1.78 0.0006 *** 2.16 0.0002 *** 1.82 0.0007 *** 
Early Use of Physical Therapy  0.76 0.0005 *** 0.84 0.1271  0.74 0.0003 *** 
Year 2009 0.92 0.2279   1.08 0.4309   0.92 0.2855   
  2010 0.81 0.0273 ** 0.96 0.7738   0.80 0.0261 ** 
  2011 0.80 0.0395 ** 1.02 0.9001   0.81 0.0673 * 
  2012 0.81 0.0772 * 1.06 0.7032   0.80 0.0772 * 
  2013 0.64 0.0007 *** 0.87 0.4229   0.67 0.0029 *** 
 2008 -Ref   -Ref   -Ref    
Trauma after index date  0.79 0.0142 ** 0.94 0.5956   0.77 0.0088 *** 
Surgery after index date  1.22 0.0007 *** 1.51 <.0001 *** 1.19 0.0056 *** 
Number of pharmacies   1.79 <.0001 *** 1.76 <.0001 *** 1.78 <.0001 *** 
Number of prescribers   1.91 <.0001 *** 1.58 <.0001 *** 1.79 <.0001 *** 
Censor 1 year Follow up 0.81 0.0631 * 0.65 0.0028 *** 0.93 0.5313   
  Left Part D or FFS 0.93 0.7405   0.9 0.7055   0.60 0.0655 * 
 Died -Ref   -Ref   -Ref   
Primary care providers †   1.00 0.9562   1.05 0.0791 * 0.99 0.458   







  Days’ Supply ≥ 90 days 
Chronic Opioid prescribing  
(≥ 90 days, <7 day gap) 
Long term, as prescribed, ≥ 90 
days 
  aOR P-value  aOR P-value  aOR   
Pain specialist †   0.73 0.0637 * 0.85 0.4848   0.74 0.0897 * 
Pharmacists per †   0.98 0.0845 * 0.98 0.1156   0.98 0.0984 * 
Midlevel providers †   0.99 0.446   0.99 0.6337   0.99 0.6734   
Proportion of population over 65   1.32 0.7129   0.92 0.9353   1.06 0.9385   
Proportion of population in poverty   3.97 0.0468 ** 1.76 0.5709   4.82 0.0302 ** 
Intercept   0.01 <.0001 *** 0 <.0001 *** 0.01 <.0001 *** 
Scale   2.72   2.72   2.72   
† per 10,000 people 
unstructured correlation 
P < 0.01***; P < 0.05 **; P < 0.1 * 
aOR: adjusted Odds ratio 
Ref: Reference 









Table 4.5: Association between access to non-pharmacologic pain treatments and high-dose prescriptions. 
  
High Dose Prescriptions 
 ≥ 50 MME 
Average dose as prescribed,  
≥ 50 MME 
Average dose, 
≥ 50 MME 
  aOR P-value  aOR P-value  aOR   
Mental Health Providers †   0.98 0.001 *** 0.98 0.004 *** 0.98 0.03 ** 
Physical Therapists  †   1.01 0.45   1.02 0.02 ** 1.02 0.04 ** 
Metropolitan County   0.97 0.49   1.00 0.98   1.07 0.22   
Age Category 70 – 74 years 0.96 0.28   0.93 0.09 * 0.97 0.47   
  75 – 79 years 0.82 <.0001 *** 0.82 <.0001 *** 0.86 0.01 *** 
  80 – 84 years 0.76 <.0001 *** 0.78 <.0001 *** 0.85 0.01 *** 
  ≥ 85 years 0.71 <.0001 *** 0.72 <.0001 *** 0.74 <.0001 *** 
 66 – 69 years -Ref   -Ref   -Ref   
Female Female 0.94 0.07 * 0.96 0.26   0.98 0.69   
Race Black 0.82 0.00 *** 0.83 0.01 *** 0.84 0.03 ** 
  Other 0.65 <.0001 *** 0.65 <.0001 *** 0.72 0.00 *** 
  Unknown 0.64 0.16   0.79 0.48   1.24 0.55   
 White -Ref   -Ref   -Ref   
Medicaid dual eligible  0.67 <.0001 *** 0.69 <.0001 *** 0.62 <.0001 *** 
Deyo-Charlson Comorbidity 
Score  0.98 0.02 ** 0.96 0.00 *** 0.96 0.01 *** 
Depression  1.00 0.96   0.96 0.54   1.02 0.76   
Anxiety  0.91 0.41   0.83 0.12   0.95 0.68   








High Dose Prescriptions 
 ≥ 50 MME 
Average dose as prescribed,  
≥ 50 MME 
Average dose, 
≥ 50 MME 
  aOR P-value  aOR P-value  aOR   
Early Use of Mental Health 
Services  0.89 0.35   0.85 0.22   0.97 0.83   
Early Use of Physical Therapy  1.20 <.0001 *** 1.15 0.00 *** 1.12 0.02 ** 
Year 2009 0.91 0.01 ** 0.88 0.00 *** 0.89 0.01 *** 
  2010 0.69 <.0001 *** 0.67 <.0001 *** 0.68 <.0001 *** 
  2011 0.43 <.0001 *** 0.42 <.0001 *** 0.43 <.0001 *** 
  2012 0.51 <.0001 *** 0.46 <.0001 *** 0.50 <.0001 *** 
  2013 0.46 <.0001 *** 0.45 <.0001 *** 0.55 <.0001 *** 
 2008 -Ref   -Ref   -Ref   
Trauma after index date  1.22 0.00 *** 1.09 0.10 * 1.17 0.01 ** 
Surgery after index date  1.20 <.0001 *** 1.15 <.0001 *** 1.05 0.26   
Number of pharmacies   1.15 0.0003 *** 1.03 0.54   0.66 <.0001 *** 
Number of prescribers   1.88 <.0001 *** 0.98 0.45   0.36 <.0001 *** 
Censor 1 year Follow up 0.86 0.02 ** 1.04 0.63   0.95 0.52   
  Left Part D or FFS 1.54 0.00 *** 1.68 0.00 *** 1.54 0.01 ** 
 Died -Ref   -Ref   -Ref   
Primary care providers †   0.97 0.001 *** 0.96 0.00 *** 0.95 <.0001 *** 
Surgeons †   1.04 <.0001 *** 1.04 0.00 *** 1.04 0.00 *** 
Pain specialist †   0.73 0.00 *** 0.78 0.01 *** 0.78 0.03 ** 
Pharmacists per †   1.02 0.00 *** 1.01 0.01 *** 1.02 0.00 *** 








High Dose Prescriptions 
 ≥ 50 MME 
Average dose as prescribed,  
≥ 50 MME 
Average dose, 
≥ 50 MME 
  aOR P-value  aOR P-value  aOR   
Proportion of population over 
65   2.01 0.08 * 2.21 0.05 * 2.37 0.06 * 
Proportion of population in 
poverty   0.54 0.11   1.38 0.42   2.18 0.10 * 
Intercept   0.35 <.0001 *** 0.48 <.0001 *** 1.66 0.01 *** 
Scale   2.72 _ *** 2.72 _ *** 2.72 _ *** 
† per 10,000 people 
unstructured correlation  
P < 0.01***; P < 0.05 **; P < 0.1 * 











Table 4.6: Association between supply of non-pharmacologic providers and opioid prescribing patterns compared to Medicare 
beneficiaries without opioid prescriptions (Total Association). 
  No opioids • Long term prescription • High-dose prescription• Long term and high dose • 
    aOR P-value  aOR P-value  aOR P-value  aOR P-value  
Mental Health Providers  †   1.01 0.02 ** 0.96 0.02 ** 0.98 0.00 *** 0.97 0.12  
Physical Therapists  †   1.02 0.00 *** 1.04 0.07 * 1.01 0.21  1.00 1.00  
Metropolitan county   1.04 0.28  0.89 0.27  0.97 0.47  1.08 0.48  
Age Category 70 – 74 years 1.03 0.34  0.87 0.19  0.95 0.18  0.87 0.21  
  75 – 79 years 1.11 0.00 *** 1.10 0.39  0.82 <.0001 *** 0.87 0.23  
  80 – 84 years 1.25 <.0001 *** 1.21 0.09 * 0.75 <.0001 *** 0.73 0.02 ** 
  ≥ 85 years 1.38 <.0001 *** 1.21 0.09 * 0.65 <.0001 *** 0.81 0.10  
  66 – 69 years -Ref  -Ref  -Ref  -Ref  
Female Female 0.95 0.03 ** 1.11 0.19  0.97 0.42  0.94 0.47  
Race Unknown 0.90 0.53   0.58 0.46  0.64 0.15   0.41 0.39   
  Other 1.02 0.56   0.83 0.16  0.62 <.0001 *** 0.69 0.03 ** 
  Black 0.98 0.55   1.13 0.31  0.83 0.00 *** 0.84 0.24   
  White -Ref  -Ref  -Ref  -Ref  
Medicaid dual eligible  0.88 <.0001 *** 2.11 <.0001 *** 0.71 <.0001 *** 1.42 0.00 *** 
Deyo-Charlson Comorbidity Score   0.99 0.07 * 1.00 0.95  0.97 0.01 *** 1.03 0.27  
Depression  1.05 0.29   1.32 0.04 ** 1.01 0.86   1.08 0.62   
Anxiety  0.96 0.53   1.36 0.13   0.89 0.27   1.17 0.54   
Year 2012 0.97 0.51   0.92 0.63   1.02 0.83   1.25 0.34   
  2008 1.07 0.11   1.02 0.90   1.83 <.0001 *** 2.29 <.0001 *** 
 2011 0.86 0.00 *** 0.89 0.49   0.86 0.05 ** 0.93 0.74   
 2009 1.05 0.29   0.95 0.74   1.70 <.0001 *** 2.21 <.0001 *** 
 2010 1.03 0.58   0.82 0.22   1.29 0.00 *** 1.53 0.04 ** 
  2013 -Ref  -Ref  -Ref  -Ref  
Trauma after index date  0.68 <.0001 *** 0.86 0.26   1.29 <.0001 *** 1.40 0.00 *** 







  No opioids • Long term prescription • High-dose prescription• Long term and high dose • 
    aOR P-value  aOR P-value  aOR P-value  aOR P-value  
Censor 1 year Follow up 0.96 0.70   1.83 0.10  0.69 0.00 *** 0.43 <.0001 *** 
 Left FFS or Part D 1.04 0.70   1.79 0.14  0.75 0.04 ** 0.84 0.47   
 Died -Ref  -Ref  -Ref  -Ref   
Primary care providers †   1.01 0.12  0.99 0.74   0.97 0.00 *** 1.00 0.84   
Surgeons †   0.99 0.29   1.02 0.24   1.04 <.0001 *** 1.01 0.67   
Pain specialist †   1.08 0.18   0.66 0.07 *  0.75 0.00 *** 0.89 0.63   
Pharmacists †    1.00 0.71   0.98 0.18   1.01 0.01 *** 1.00 0.81   
Midlevel providers †   1.00 0.40   1.00 0.89   1.00 0.47   1.02 0.29   
Proportion of population over 65   2.43 0.00 *** 2.24 0.40   1.99 0.09 * 1.88 0.55   
Proportion of population in poverty   0.69 0.15   3.27 0.15   0.75 0.44   1.57 0.63   
† per 10,000 people 
• Reference group is any opioid prescription during follow up 
P < 0.01***; P < 0.05 **; P < 0.1 * 









Table 4.7: Association between supply of non-pharmacologic providers and high-risk opioid prescriptions (Total Association). 
  
High Dose Prescriptions 
 ≥ 50 MME 
Long-Term Prescription  
(≥ 90 Days’ Supply) 
  aOR P-value  aOR P-value  
Mental Health Providers †   0.98 0.0012 *** 0.97 0.0592 * 
Physical Therapists  †   1.01 0.4493   1.03 0.0982 * 
Metro   0.97 0.479   0.98 0.7798  
Age Category 70 – 74 years 0.95 0.2561   0.93 0.4035   
  75 – 79 years 0.82 <.0001 *** 1.18 0.0553 * 
  80 – 84 years 0.76 <.0001 *** 1.33 0.0019 *** 
  ≥ 85 years 0.71 <.0001 *** 1.65 <.0001 *** 
 66 – 69 years -Ref   -Ref   
Female 
 
0.94 0.0657 * 1.00 0.977  
Race Black 0.81 0.0013 *** 1.05 0.6228  
  Other 0.66 <.0001 *** 0.91 0.4161  
  Unknown 0.63 0.1496   0.53 0.3286  
 White -Ref   -Ref   
Medicaid dual eligible  0.66 <.0001 *** 1.94 <.0001 *** 
Deyo-Charlson Comorbidity Score  0.98 0.0156 ** 1.03 0.09 * 
Depression  0.98 0.8096   1.28 0.0207 ** 
Anxiety  0.91 0.3777   1.44 0.0348 ** 








High Dose Prescriptions 
 ≥ 50 MME 
Long-Term Prescription  
(≥ 90 Days’ Supply) 
  aOR P-value  aOR P-value  
Year 2009 0.91 0.0137 ** 0.91 0.1944   
  2010 0.69 <.0001 *** 0.81 0.0249 ** 
  2011 0.44 <.0001 *** 0.8 0.0387 ** 
  2012 0.52 <.0001 *** 0.81 0.0725 * 
  2013 0.46 <.0001 *** 0.65 0.0008 *** 
 2008 -Ref   -Ref   
Trauma after index date  1.22 0.0001 *** 0.8 0.0184 ** 
Surgery after index date  1.2 <.0001 *** 1.23 0.0004 *** 
Number of pharmacies   1.15 0.0004 *** 1.79 <.0001 *** 
Number of prescribers   1.88 <.0001 *** 1.91 <.0001 *** 
Censor 1 year Follow up 0.86 0.0291 ** 0.8 0.0483 ** 
  Left Part D or FFS 1.53 0.0027 *** 0.94 0.7937   
 Died -Ref   -Ref   
Primary care providers †   0.97 0.0015 *** 1.00 0.8882   
Surgeons †   1.04 <.0001 *** 1.02 0.1691   
Pain specialist †   0.73 0.0005 *** 0.74 0.0763 * 
Pharmacists per †   1.02 0.0042 *** 0.98 0.0954 * 
Midlevel providers †   1.00 0.6887   0.99 0.3951   








High Dose Prescriptions 
 ≥ 50 MME 
Long-Term Prescription  
(≥ 90 Days’ Supply) 
  aOR P-value  aOR P-value  
Proportion of population in poverty   0.51 0.0807 * 4.27 0.036 ** 
Intercept   0.36 <.0001 *** 0.01 <.0001 *** 
Scale   2.72   2.72   
† per 10,000 people 
unstructured correlation        
P ≤ 0.01***;  ≤ 0.05 **; P ≤ 0.1 * 
















Table 4.8: Association between access to non-pharmacologic pain treatments and high-dose prescriptions ≥ 90 MME. 
  
High Dose Prescriptions 
 ≥ 90 MME 
  aOR P-value  
Intercept   0.17 <.0001 *** 
Mental Health Providers †   0.96 <.0001 *** 
Physical Therapists  †   1.03 0.0066 *** 
Metropolitan County   0.97 0.6368   
Age Category 70 – 74 years 1.00 0.9397  
  75 – 79 years 0.91 0.1018  
  80 – 84 years 0.95 0.444  
  ≥ 85 years 1.00 0.9388  
 66 – 69 years -Ref   
Female Female 1.14 0.001 *** 
 Male -Ref   
Race Black 0.96 0.5816   
  Other 0.69 <.0001 *** 
  Unknown 1.05 0.9001   
 White -Ref   
Medicaid dual eligible  0.75 <.0001 *** 
Deyo-Charlson Comorbidity Score  0.99 0.296  








High Dose Prescriptions 
 ≥ 90 MME 
  aOR P-value  
Anxiety  1.03 0.861  
Early Opioid Prescription  1.12 0.0029 *** 
Early Use of Mental Health Services  0.91 0.526  
Early Use of Physical Therapy  1.12 0.0167 ** 
Year 2009 0.84 <.0001 *** 
  2010 0.52 <.0001 *** 
  2011 0.22 <.0001 *** 
  2012 0.27 <.0001 *** 
  2013 0.22 <.0001 *** 
 2008 -Ref   
Trauma after index date  1.07 0.31  
Surgery after index date  1.10 0.022 *** 
Number of pharmacies   1.19 <.0001 *** 
Number of prescribers   1.63 <.0001 *** 
Censor 1 year Follow up 0.49 <.0001 *** 
  Left Part D or FFS 0.59 0.0009 *** 
 Died -Ref   
Primary care providers †   0.97 0.0156 ** 








High Dose Prescriptions 
 ≥ 90 MME 
  aOR P-value  
Pain specialist †   0.8 0.0459 ** 
Pharmacists per †   1.02 0.0068 *** 
Midlevel providers †   0.99 0.3355   
Proportion of population over 65   2.58 0.0476 ** 
Proportion of population in poverty   4.09 0.0029 *** 
Scale   2.72 _ *** 
† per 10,000 people 
unstructured correlation        
P ≤ 0.01***; P ≤ 0.05 **; P ≤ 0.1 * 















Panel A: Annual Rate for the entire cohort 
Panel B: Annual Rate for only beneficiaries with >1 opioid prescription during follow up.  
N= 68,949 
Figure 4.4: Trends of opioid prescribing patterns for Medicare beneficiaries with a new episode 
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A. Rate of opioid prescriptions. 
B. Rate of high-dose prescriptions. 
C. Rate of long-term prescriptions. 
N= 68,949 
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Supplemental Table 4.1: ICD-9/Current Procedural Codes/ Healthcare Common Procedure 
Coding System. 
Measure ICD-9/CPT/HCPCS 
Musculoskeletal Pain145 3078, 30789, 338, 3382, 3384, 7100, 7103, 7104, 7105, 7109, 712, 
713, 714, 715, 716, 717, 718, 719, 7200, 7201, 7202, 7208, 7209, 
7210, 7211, 7212, 7213, 7214, 7219, 722, 7230, 7231, 7239, 7240, 
7241, 7242, 7243, 7244, 7245, 7246,7247, 725, 726, 72700, 7273, 
7276, 7279, 7289, 729, 7291, 7292, 7294, 7295, 7298, 7328, 7329, 
7371, 7373, 7382, 7383, 7384, 7385, 7386, 7398, 7399, 78096, 8052, 
8054, 8056, 8058, 8080, 8082, 8084, 80841, 80842, 80843, 80844, 
80849, 8088, 8090, 8100, 8110, 8120, 8122, 8124 , 8130, 8132, 8134, 
8138, 8140, 8150, 8160, 8170, 8180, 8190, 8200, 8202, 8208, 8210, 
8212, 8220, 8230, 8232, 8238, 8240, 8242, 8244, 8246, 8248, 8250, 
82520, 82521, 82522, 82523, 82524, 82525, 82529, 8260, 8270, 
8290, 8310, 8320, 8330, 8340, 8350, 83600, 8361, 8362, 8363, 8365, 
8366, 8370, 8380, 8390, 8392, 8394, 8396, 8398, 840, 8409, 841, 
842, 843, 844, 845, 846, 847, 848, 959, 7391, 7392, 7393, 7394, 
7395, 7396, 7397, 72703, 72704, 72705, 72706, 72709 
Trauma145 875, 876, 877, 879, 880, 881, 882, 883, 884, 885, 886, 887, 890, 891, 
892, 893, 894, 895, 896, 897, 926, 927, 928, 929, 996  
Physical Therapy148 97110, 97350, 97535, 97112 ,97150, 97035, 97010, 97032, 97012, 
97140, 97001, 97002, 97124, 99070, 97750, 97113, 97116 
Mental Health Services28,149 90832, 90833, 90834, 90836, 90837, 90838, 90791, 90792, 90804, 
90805, 90806, 90807, 90808, 90809, 90810, 90811, 90812, 90813, 
90814, 90815, 90816, 90817, 90818, 90819, 90820, 90821, 90822, 
90823, 90824, 90825, 90826, 90827, 90828, 90829, 90845, 90847, 
90849, 90853, 90857, 90865, 90870, G0409, G0410, G0411, 90839, 
99354, 90840 
Depression152   
(one inpatient or one 
outpatient diagnosis) 
29620, 29621, 29622, 29623, 29624, 29625, 29626, 29630, 29631,  
29632, 29633, 29634, 29635, 29636, 29650, 29651, 29652, 29653, 
29654, 29655, 29656, 29660, 29661, 29662, 29663, 29664, 29665, 
29666, 29689, 2980, 3004, 3091, 311 
Anxiety153 
(one inpatient or two 
outpatient diagnoses)  
29384, 30000, 30001, 30002, 30009, 30010, 30020, 30021, 30022, 
30023, 30029, 3003, 3005, 30089, 3009, 3080, 3081, 3082, 3083, 




Supplemental Table 4.2: Construction of variables from the Area Health Resource File.98 
Variable in 
Model 









Carry Forward, Backward 
Physical 
Therapists 






with MD or DO 
training in office based 
settings, hospital staff, 
hospital residents, and 






Surgeons  General and “other” 
surgery with MD or DO 
training in Office based 
settings, hospital staff, 
hospital residents, and 





Pain specialist  Physical 
Medicine/Rehabilitation 
MD or DO training in 
Office based settings, 
hospital staff, hospital 
residents, and clinical 





Pharmacists   2009 Carry Forward, Backward 
Midlevel 
providers 









CHAPTER 5: UNDERSTANDING HOW PRIMARY CARE PROVIDERS FROM 
DIVERSE PRACTICE SETTINGS APPROACH CHRONIC PAIN IN OLDER ADULTS: 
A SYSTEMS SCIENCE STUDY 4 
Overview 
 Caring for older adults with chronic musculoskeletal pain is a complex and difficult task 
for primary care providers. We interviewed 16 primary care providers across North Carolina to 
understand how they approach this, and how well supported they are in doing so. Using a 
structured systems thinking approach called System Support Mapping, we asked providers to 
operationalize their approach to caring for chronic pain patients in terms of discrete 
responsibilities and the key needs, supports, barriers, and priorities for change associated with 
each responsibility. Providers struggled to avoid prescribing opioids and prioritize 
recommending non-pharmacologic treatments and discussing the relationship between pain and 
mental health. Common needs included an engaged patient, alternatives to opioids, and being 
able to set expectations about pain. Common supports to meet their needs included published 
literature, conversations with the patient about their pain, allied health professionals, electronic 
health records, and policies and guidelines. Key barriers included poor insurance coverage and 
limited time to address pain. Priorities to improve chronic pain care were: better patient 
education materials and more mental health professionals. This study illuminates the need for 
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comprehensive policy approaches that go beyond opioid prescription regulations for addressing 
the opioid epidemic.  
Introduction 
Among older adults, the health and economic impact of chronic pain is significant.1,46,56,60 
The estimated percent of older adults suffering from chronic pain ranges from 20 to 60% .1 
Chronic pain management is complex for older adults because they may have multiple pain sites, 
comorbidities and medications, physiologic changes, cognitive impairments, and fragmented 
care.42-47,56,124A web of biological (e.g. physical symptoms), psychological (e.g. anxiety, 
depression, anger), and social factors (e.g. work history, social support, insurance) affect pain 
and multiple treatments are needed to address these factors.1,20,25,58,59 Without a biopsychosocial 
approach to pain treatment, pain may be undertreated in older adults which leads to inactivity, 
isolation, mood disorders, and disability.60  
Clinical guidelines for chronic pain management rely on three principles for chronic pain 
treatment: non-pharmacologic strategies (e.g. physical therapy or cognitive behavioral therapy) 
and non-opioid medications (e.g. acetaminophen) should be used before opioids; 2. Opioids 
should only be used if the benefits of pain relief override the risks; 3.Use of multi-modal 
strategies (e.g. opioids with non-pharmacologic treatments) for older adults.18,19,55 Selecting 
appropriate treatments for older adults is difficult because opioid and non-opioid medications are 
associated with an increased risk of adverse events.18 Despite the fact that non-pharmacologic 
services can be appropriate and effective for older adults,26,59 older adults report that their 
providers do not discuss or recommend non-pharmacologic strategies.50 Non-pharmacologic 
treatments are critical for chronic pain management because they can minimize the risk of side 
effects from medications, reduce the use of ineffective long-term treatments, such as opioids, and 
improve pain outcomes.75-78 
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Primary care providers (PCPs) deliver the majority of pain management services, which 
include recommendations for self-management practices, prescription medication, and referral to 
specialty care (e.g. physical therapy, mental health, orthopedics, and pain specialists).1,124 More 
than half of all opioid prescriptions for Medicare beneficiaries are dispensed by PCPs.74 While 
providers often report that opioids are only prescribed when alternative strategies are 
unsuccessful as recommended by the guidelines,48,130 previous studies suggest that PCPs may 
rely on opioids for pain management if they perceive that opioids can improve functions and if 
opioids have relieved pain before.51,134 Recent trends in chronic pain management show that 
opioids are used more frequently than non-pharmacologic treatment, especially among older 
adults.29,31,85 One study showed that having Medicare insurance is associated with a lower odds 
of a physical therapy referral.32  
Encouraging adherence to the clinical guidelines requires an understanding of how PCPs 
approach caring for patients with pain and what factors affect their approach. Previous studies 
have focused on the role of patient characteristics regarding provider’s decisions to prescribe 
opioids48,52,54,131,132,134 or non-pharmacologic treatments.51,54,137 In addition to patient 
characteristics, access to non-pharmacologic treatments, time, and resources, may influence 
PCPs’ recommendations.51,131,134 However, these studies do not capture the full range of pain 
management activities performed by PCPs. Little is known about what factors contribute to the 
difference between what PCPs intend to do and what is actually done, and how/whether these 
differences depend on the incentives and constraints innate in different practice settings and 
geographic locations. Therefore, we sought to 1. To document how PCPs approach caring for 
older adults with chronic musculoskeletal pain in terms of discrete responsibilities or tasks they 
engage in; 2. Determine the supports and barriers associated with these responsibilities, linking 
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each to specific responsibilities and core needs to complete it; 3. Identify priorities for being 
better supported in caring for these older adults, with “wishes” for how change linked to specific 
responsibilities, needs, supports/barriers; and, 4. Illuminate key differences across rural and 
urban settings.  
Methods 
 We used a structured systems thinking method called System Support Mapping (SSM) 
developed by the senior author (KHL) to document how PCPs approach delivery of pain care to 
older adult patients and how well supported they are in this work.99  
Study Population 
 In the spring of 2018, we recruited PCPs across North Carolina (NC) using internet 
searches, professional organizations, and personal referrals. To be included in the study, 
providers had to be licensed in NC and provide care for patients over 65 years old. Physicians 
(both MD and DOs), nurse practitioners, and physician assistants were eligible to participate. 
Both purposive and snowball sampling were used to select PCPs in rural and urban counties. We 
sampled providers until concept saturation was achieved for the overall sample.166 This study 
was approved by the Institutional Review Board at the University of North Carolina-Chapel Hill.  
Data Collection 
Data collection occurred in two phases. First, interested providers completed a ten minute 
survey that collected information on their patient population (Appendix 1), their professional 
background, their level of comfort in caring for patients with chronic musculoskeletal pain, and 
years of practice. We also asked providers about their practice setting (e.g. safety net or private 
practice). Safety net settings were defined as Federally Qualified Health Centers (FQHCs), 
FQHC look-alikes, rural health centers, free clinics, and academic resident clinics. Private 
practice was defined as physician-owned practices and academically-affiliated, community-
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based primary care clinics. For the purpose of subgroup analysis, rural and urban designations 
were based on the Rural-Urban Continuum Codes for counties in NC.167 The survey collected 
information about the providers’ patient population, including insurance status, percent non-
White minorities, and percent “vulnerable” defined as low health literacy, low income, and users 
of social safety net programs such as Temporary Assistant for Needy Families (TANF), 
Supplemental Security Income(SSI), and Women Infants and Children (WIC). The survey also 
asked about the burden of chronic musculoskeletal pain for their patient population (overall and 
older adults only).  
Based on this survey, we purposively invited providers to participate in a one-on-one, 
semi-structured interview. The interview guide was adapted from a systems science methodology 
called System Support Mapping described in detail below.99 This method seeks to 
diagrammatically describe a participant’s experience in a bounded system, in this case providing 
care to older adult patients with chronic musculoskeletal pain. The guide asks participants to 
clarify their role in general terms (the context in which they provide pain care), how they 
conceptualize this work in discrete responsibilities or tasks, what they need to complete each 
responsibility, resources that support them, barriers, and wishes. This method has been used in a 
variety of system strengthening projects, to support public health workforce capacity building, 
and as the foundation for patient-centered health behavior research.99 SSMs were developed 
during interviews, conducted both in person and over the phone. For phone interviews, web-
conferencing was used so interviewees could see how their responses were being documented in 
the SSM during the course of the interview. 
To set the boundary for the system, participants were prompted to consider their 
experiences caring for patients older than 65 with chronic musculoskeletal pain, defined as pain 
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like backaches or knee pain that lasts longer than three months. We instructed participants to 
describe their approach in general practice, and not to base their approach on any specific patient 
or any extreme cases.  
  Participants were shown a blank map with four concentric rings; the content to be placed 
in each ring throughout the course of the interview was described as follows (starting with the 
inner most ring):  
1. Role:  The role is defined by the participant’s specialty, practice setting, and patient 
population. We used information from the survey to define the participant’s role, and 
asked them to clarify their role for the in-person interview. To further define the 
participant’s role, we asked providers to describe their philosophy on caring for patients 
with musculoskeletal pain.  
2. Responsibilities: Responsibilities are the discrete activities that participants do to care for 
patients with chronic musculoskeletal pain. To elicit a comprehensive list of activities, we 
asked participants what they did to support their patients over time. Among those listed, 
participants then selected the two responsibilities they found to be the most difficult and 
the one they found the easiest. We completed the rest of the mapping exercise based on 
these difficult and easy responsibilities.  
3. Needs:  For each selected responsibility, providers were asked about the conditions or 
inputs necessary to fulfill each responsibility. Needs are defined as both internal needs 
(e.g. patience, energy, or understanding) as well as external needs (e.g. information, 
professional network, or education).  
4. Supports and Barriers: For each need, participants were then asked to identify the past and 
current resources they have used to meet each need. In general, supports were described as 
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resources that help providers in their practice. Barriers were identified when resources 
were missing and when providers described something that prevented them from fulfilling 
their responsibilities.   
5. Wishes: Lastly, participants were asked what would better support them to successfully 
completing their responsibilities and meet their needs. Wishes could be anything from 
physical improvements, social changes, or immediate or long-term changes.  
To illustrate the connections between responsibilities, needs, supports, barriers, and wishes 
arrows are drawn from the responsibility to the needs each generates, from the resources to the 
needs they address, and from the wishes to the needs the address. The interviewer (RNK) created 
three maps with each participant, two maps documenting needs, resources, and wishes associated 
with difficult responsibilities, and one map documenting needs, resources, and wishes associated 
with an easy responsibility. When possible, a note taker was present to help the interviewer 
create the maps during the interview. All interviews were recorded and transcribed. 
Validation 
Several steps were taken to validate the data collected during the mapping exercise. After 
each map was created, the interviewer asked the participant to verify the completeness and 
accuracy of information. Next, the interviewer compared the maps to the interview transcripts to 
ensure that the maps accurately reflected what was said and made clarifications as necessary. 
Finally, a sample of the maps (N=4) were reviewed by another researcher (MR), who compared 
the maps to the transcripts and made notes on any discrepancies. Discrepancies were resolved 
using a consensus process.  
Analysis 
Once the maps were verified, the maps were treated as “raw” data. First, an aggregated 
list of responses by ring was created. We used qualitative content analysis to develop codes 
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describing distinct constructs identified by participants.168 The list of responses were sorted by 
ring into distinct codes. To retain the richness of the data, responses were only combined into a 
single code based on similarity and to reduce redundancy. Codes were named using “in vivo” 
coding to make sure the code retained the original meaning of the data.169 Two researchers (RNK 
and DB) used an iterative coding process to examine the codes with and without responses and 
ensure that the codes stood on their own without the maps or transcripts.  
The sorted lists were used to generate two datasets: a dataset describing the frequency a 
code appeared in a map (up to three maps per participant) and a dataset describing the frequency 
of connections between the codes. Descriptive statistics were calculated based off of the dataset 
with the code frequencies. Percentages were calculated as the total number of times the code 
appeared across the maps divided by the total number of codes in the ring for the needs, 
resources, and wishes ring. For this analysis, we present the aggregated results for all 
responsibilities (difficult and easy), and by “difficult” responsibilities for urban and rural 
providers. No statistical comparisons were made between the subgroups because of small sample 
size. 
For the urban and rural providers, we generated aggregated System Support Maps for the  
responsibilities that related to “avoiding or minimizing opioids” and recommend non-
pharmacologic treatments using Kumu, an online visualization software.170 The maps were 
generated based off of data describing the frequency of connections between codes, and the 
frequency of codes across the maps. To simplify the maps, we retained pairs of codes with two 
or more connections for the urban providers for all rings and two connections for the rural 




 We interviewed 16 primary care providers across NC, including 10 providers from an 
urban setting, 5 providers from a rural setting, and 1 provider who practiced in both. Two 
interviews were completed in-person, and 14 interviews were completed over the phone with 
web conferencing for ten of those providers.  
Most providers were MDs (N=14), and practiced in diverse practice settings including 
safety net (N=10) and private practice (N=5). The majority of providers in rural counties 
practiced in a safety net setting (N=5). On average, providers practiced for 13 years (standard 
deviation (SD): 11.6 years), and urban providers practiced longer than rural ones (urban: 15.0 vs 
rural: 9.5). On a scale of one to ten, with one being the least comfortable, PCPs in urban counties 
were more comfortable treating pain than those in rural counties (urban: 6.9 vs rural: 5.7).  
The providers served diverse clinic populations. Two-thirds of providers had populations 
where the majority were vulnerable (e.g. low health literacy, low income, or users of social 
safety net programs). About 40% of providers served populations where 26-50% had Medicaid, 
and 56.3% of providers served populations where 26-50% had Medicare. More than half of the 
providers reported that less than 25% of their clinic population had private insurance or were 
uninsured. Compared to the majority of clinic populations of urban providers, the majority of 
clinic populations for rural providers were “vulnerable” or had Medicaid. Two-thirds of 
providers reported that chronic musculoskeletal pain occurred in 26-50% of their clinic 
population, but more than half said that fewer than 25% of their populations over 65 and have 
chronic musculoskeletal pain. The burden of chronic musculoskeletal pain in the clinical 
population was similar for urban and rural providers.  
 
130 
System Support Map 
 The aggregate SSM maps are shown for urban providers (Figure 5.1) and rural providers 
(Figure 5.2) to illustrate the relationship between opioid prescriptions and non-pharmacologic 
treatment recommendations (e.g. engaging patients in alternatives to opioids such as non-
pharmacologic treatments and behavior change). For the urban PCPs, there were none of the 
needs overlapped and each need had distinct resources. However, there were several barriers that 
were common to needs across activities. For example, providers had limited time to talk to 
patients when they needed to educate patients about behavior change and pain treatment options. 
Another overlapping barrier was poor insurance coverage for treatment options which linked to 
needs such as geographic access and having options available. 
 Most of their wishes concerned having more options for alternatives to opioids.  
For rural PCPs, needs and resources for avoiding opioids and recommending non-
pharmacologic treatments overlapped significantly. Similar to urban PCPs, rural PCPs needed 
affordable and available alternatives to avoid opioids and recommend non-pharmacologic 
treatments. Other needs reported by rural providers for these responsibilities included patient 
education, understanding the patient’s background (e.g their history, resources, “red flags”).  
Furthermore, resources were used to meet multiple needs and often relied on other people to help 
support the patients (e.g. health professionals, patient’s family). Overlapping barriers included 
lack of transportation, poor insurance coverage, and the perception that patients want quick fixes. 
As a result, their wishes related to improving access to treatments and community resources. 
Responsibilities 
 Table 5.2 shows the ten most common responsibility codes out of the 38 codes described. 
Common responsibilities include: “Get patients to use physical therapy” (75.0%), “Avoid or 
minimize opioid treatments” (present in 75.0% of maps), “Recommend non-pharmacologic and 
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multimodal therapies” (75.0%), “Recommend and encourage patients to lose weight or exercise” 
(56.3%), “Prescribe both opioids and non-opioid medications” (56.3%), “Get patient history with 
pain treatments” (56.3%), and “Create treatment plan” (56.3%). Responsibilities were similar 
across urban and rural providers, though more urban providers referred patients to physical 
therapy, recommended behaviors changes for weight loss and exercise, perform diagnostic 
evaluations, and ensure follow up visits.  
The 16 providers completed 33 maps for difficult responsibilities, and 13 maps for easy 
activities. Table 5.2 describes the most frequently identified “difficult” and ‘easy” 
responsibilities in urban and rural settings. Providers in urban and rural settings struggled with 
getting patients to use physical therapy: 
It's a big time commitment for them [patients] to go to all of these visits and it typically 
tends to be fairly expensive. It's not an immediate payoff. Medications immediately makes 
them feel better, whereas physical therapy, might take six weeks to help. - Provider in 
Urban Setting  
 
Both urban and rural providers found it difficult to “avoid or minimize opioids for long-
term pain management.” Providers said they may feel pressured to prescribe opioids when 
patients see them as the only valid treatment and because patients’ expectations about pain may 
be unrealistic.  
If I don't feel that they should be on opiates, I'm not gonna prescribe them, and I will 
have that tough discussion. What I think you don't wanna do or does not work well is try 
to have the patient agree with you. The patient certainly might not agree with you, 
particularly, if addiction or diversion is the issue. But being honest, transparent but 
empathic, and know what you are willing to do based on your assessment of the medical 
situation. If it's a back and forth with the patient, that often goes nowhere good.  Because 
the patient will be arguing for why they want opiates and then you're trying to justify why 
they shouldn't have opiates and that my 20 years of experience of doing it is a no-win 




 Unlike urban providers, rural providers thought it was difficult to “recommend non-
pharmacologic and multi-model approaches” because patients may not be receptive to 
alternatives to opioids:  
It's very difficult if a patient has come to me with something that they want from me. So if 
they've come to me with the purpose of getting opioids, it's really difficult to sell an 
alternative treatment plan…Because I think a lot of those patients have tried it, but 
maybe not in the proper treatment management -Provider in Rural Setting 
 
 “Assessing and educating patients about the relationship between pain and mental 
health” was also difficult. One PCP said,  
A lot of patients don't attribute their pain to a mental health cause or they don't 
understand that the chronic pain is being exacerbated by their mental health condition. 
So establishing that link with them can be very, very difficult. I worked with a bunch of 
patients that making that link takes multiple visits, and years, sometimes, to get them to 
understand that link. - Provider in Urban Setting  
 
Providers also struggled with “setting expectations and creating treatment goals” because 
older adults often expect to be pain free or to be able to do the same things they could when they 
were younger. Patients’ resistance to change made it difficult for providers to taper opioid doses. 
Another difficult responsibility for urban providers was “recommending and encouraging 
patients to exercise and lose weight.” Rural providers struggled with “monitoring opioid 
treatment” which often includes pain contracts, follow up visits, monitoring refills, and 
performing drug screens. Both urban and rural providers reported that “prescribing medications” 
was an easy responsibility, but this could be challenging in an older adult population because of 
comorbidities or interactions with other medications.  
Needs 
 Table 5.3 shows the ten most frequently described needs among urban and rural providers 
for the “difficult” responsibilities. About 6% of the need codes for urban providers and 4.5% of 
the codes for rural providers described “an engaged patient”. Other needs included “availability 
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of other options to use instead of opioids” (Urban: 5.5%; Rural: 6.0%), “set expectations about 
pain” (Urban: 5.5%; Rural: 4.5%), “evidence about different pain management treatments” 
(Urban: 4.4%; Rural: 4.5%), and “knowledge of patient resources” (Urban: 4.4%; Rural: 4.5%).  
 Providers in urban settings reported that they needed to talk to patients about their goals 
(6.8%) and about pain and treatments (6.8%). Institutional support (5.5%) was another common 
need, which one provider described it as “I'm not standing alone. I have someone behind [me].” 
Other needs included “access to treatments” (4.4%), “knowledge of the patient’s history” (4.4%), 
and “a patient who wants to change behaviors” (6.6%).  
Rural providers reported that they needed to “educate patients about pain and mental 
health” (4.5%). Providers also needed a “good relationship with the patient” (6.0%). “Tolerance 
for conflict” was also reported (4.5%), and described as  
I need a stronger spine at times for changing perception of pain management, and how 
do you balance patients who were started on pain medication under this concept, does it 
fit vital sign, with now a greater understanding of the consequences of opiate 
medications. And how do you deal with your own internal guilt about the fact that you're 
probably one of the people who has been prescribing the pain medicine to this patient for 
five, 10 years, and now you're saying, ‘I'm taking it away.’  
 
Other needs for rural providers include “affordable pain treatments” (10.4%) and 
“identification of red flags” (6.0%).  Providers looked for red flags like “doctor shopping” and 
willingness to comply with the rule of treatments.  
Providers reported that they also needed to educate patients about opioids, the 
relationship between pain and mental health, and pain and obesity. Many needs also centered on 
the interaction with the patient which includes establishing a partnership, developing a good 
relationship with the patient, and having good communication. Providers also discussed needs 
that the patient might have, including money to pay for treatment, time to do treatments, 
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transportation to treatments, and available providers (e.g. mental health or pain specialist) 
(Supplemental Table 5.2). 
Resources: Supports and Barriers 
 Table 5.3 describes the 10 most frequent supports and barriers that providers in urban and 
rural settings reported met their needs. Both urban and rural providers reported that they used 
published literature in two ways (Urban: 1.6%; Rural: 1.8%): to learn about the evidence on pain 
treatments and opioids and to educate evidence on treatments, particularly opioids, to patients.  
 Primary care providers in urban settings used a variety of supports for their practice 
(Table 5.3; Supplemental Table 5.3). The primary supports used by providers included 
conversations about the risk of opioids (2.2%), goals (1.8%), and setting expectations with pain 
and treatment (1.4%). Many providers used Motivational Interviewing to talk to patients (1.4%) 
as well as family caregivers (1.4). Providers spoke with other colleagues to review cases and 
discuss treatment strategies (1.8%). They often referred patients to specialty services (1.6%). For 
opioid treatments, providers used the NC Controlled Substances Database (1.4%) and opioid 
treatment agreements (1.4%). Providers used previous patient records and outside records to 
learn about the patient’s history with pain and previous treatments (1.4%).  
The most frequent supports in rural settings differed from the most frequent supports in 
urban settings. Providers in rural settings often worked with allied health professionals to 
facilitate patient care. For example, care managers facilitated the pain contracts and connected 
patients to non-pharmacologic services and other community resources. Providers referred 
patients to behavioral health specialists (2.2%) to teach patients about coping strategies or get 
referrals for other health services. Pharmacists (1.8%) helped providers monitor opioid 
prescriptions. Point of care references (1.8%) and prescribing guidelines (2.2%) were also useful 
to support provider’s knowledge about pain treatments. Providers also use multiple visits (2.2%) 
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to monitor treatments and build relationships. Providers educated patients about pain and 
treatments through stories about other patients (2.2%). 
Providers also mentioned that many of their supports involved talking to the patient about 
the patient’s treatment goals, exercise, long term benefits, physical therapy, mental health, and 
obesity. Forms of patient education included online sources, classes, videos, and handouts. 
Though sometimes, the patient education materials were not helpful because patients may have 
difficulty understanding them or because patients did not use them. They frequently worked with 
and referred patients to other providers such as social workers, behavioral health specialists, 
clinic staff, home health nurses, pharmacists, physical therapists, psychologists, as well as pain 
specialists. Electronic health records (EHR) were used in a variety of ways including as a way to 
note the patient’s medical history, history with treatments, to track longitudinal progress, 
referrals, and to access patient education materials. However, the EHR also had some downsides 
including taking time away from the patient and incomplete patient histories. Providers used a 
variety of resources to support their knowledge about pain treatments including medical school 
and residency training, conferences, continuing medical education, and supplemental trainings. 
Providers generally felt that clinic and state policies, in addition to the clinical guidelines on 
prescribing limits, helped them say no to patients who demanded opioids. Some providers even 
had a pain committee in the clinic to help them make decisions about pain treatments.  
The barriers reported by providers in urban and rural settings also differed. For example, 
among urban PCPs, patients’ resistance to changes (1.6%) and poor insurance coverage for 
alternatives to opioids (1.6) were also common barriers. One of the most common barriers for 
these providers was that there was not enough time to talk about pain when there are other health 
concerns (1.6%).  According to one provider,  
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[With] 20 minutes, and especially when you're meeting someone, [pain] is like the 
fifth issue of the visit. So it's like, diabetes, hypertension, high cholesterol, history 
of cancer, and pain. So by the time you get to pain, you don't have any time to 
think about to even do all the [treatments and education]. 
 
There were two barriers that rural providers reported: transportation (3.7%) and 
difficulties doing the urine drug screen (1.8%). Other barriers could be categorized as 
barriers that providers faced and barriers that patients faced. Some of the barriers 
providers faced included a lack of training on pain and addiction, limited time with the 
patient, patient satisfaction scores, and poor patient education materials. The culture of 
medicine was also a barrier because it was perceived to promote a pill based approach to 
pain. Providers reported that patients often faced barriers to accessing treatments and had 
poor insurance coverage. Furthermore, providers thought that patients’ limited time for 
treatment may encourage patients to seek out “quick fixes” for pain such as medications.  
Wishes  
 The top 10 most frequently reported wishes are described in Table 5.4. Both urban and 
rural providers wished for better patient education materials about pain and treatments (Urban 
7.9%; Rural 9.5%) and more mental health providers (Urban 6.6%, Rural 7.1%). Primary care 
providers in urban settings wished for more time to talk about pain (7.9%), improved access to 
pain treatments (e.g pain psychiatry, orthopedics, physical therapy, and addiction medicine 
providers) (9.2%), better access to interventions for obesity (6.6%), and better medications for 
pain (6.6%). In rural settings, providers wished for more allied health professionals (e.g. social 
workers, nutritionists, and pharmacists) to address the concerns of pain (9.5%), more training on 
pain diagnosis and treatments (7.1%), use more non-pharmacologic options for pain (7.1%), and 




 This study extends previous work54,131 examining pain management practices in primary 
care by exploring the process of pain care as a whole rather than isolating specific strategies and 
examining how practices vary by setting.  
 A primary finding was that PCPs undertake diverse responsibilities to care for patients 
with chronic musculoskeletal pain, many of which were similar in urban and rural settings. Many 
responsibilities corresponded to the content present in clinical guidelines.18,19,55,171 Both urban 
and rural primary care providers struggled with several of the same responsibilities which were 
rooted in making recommendations about different pain treatments. Treatment recommendations 
went beyond prescribing medications, and encompassed non-pharmacologic approaches (e.g. 
physical therapy, mental health treatments, and acupuncture) and behavior changes (e.g. exercise 
and weight loss). Difficulties in these responsibilities may result from the fact that they require 
more time from the patient and provider and entails the patient to learn and practice self-
management strategies.51,54 Non-pharmacologic strategies often involve other providers (e.g. 
physical therapists or behavioral health specialists) which can be challenging to coordinate.51,54  
 Comparable to a previous study examining opioid prescribing for older adults, most 
providers in this study reported that they prescribe opioids only after trying other approaches.48 
While many providers reported that prescribing medications was easy for them to do, it was 
more difficult to avoid or minimize opioid prescriptions. Providers often mentioned avoiding 
opioids along with difficulties providers found in engaging patients with non-pharmacologic 
approaches to pain. This indicates that the two responsibilities are related, and if providers try to 
avoid opioids, then they also have to offer other treatments.54   
 Providers reported their own needs and what they need from their patients. For example, 
providers need knowledge of the patient’s history and resources, evidence of pain treatments, 
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and knowledge about pain the appropriate treatments. They also need patients to be engaged in 
care, ready to change behaviors, as well as have the means to follow recommendations (e.g. time 
and money). Similar to other studies, these two categories of needs illustrate that providers are 
somewhat limited in their ability to fulfill their most difficult responsibilities since many needs 
depend on the patient.50,54,134 Providers reported that a good patient-provider relationship, trust, 
and empathy are frequent needs to meet many responsibilities. While the decision to prescribe 
opioids can strain the patient-provider relationship, aspects of the patient-provider relationship 
that foster shared decision-making and patient-centered care, such as empathy, trust, 
understanding, and communication support many of the PCP’s needs.25,54,132,133,136,138 
  The availability and affordability of alternatives to opioids was frequently described as a 
major need and barrier to meet multiple responsibilities including avoiding or minimizing 
opioids, recommending non-pharmacologic modalities for treatment, and encouraging behavior 
changes. Because these needs overlap over these responsibilities, policies or interventions that 
address these needs could change the way that multiple responsibilities are completed. Though 
availability and affordability of alternatives to opioids has been frequently viewed as a patient-
level barrier,50,51 this finding reveals that patient-level barriers also impact how providers 
practice which is consistent with findings from a previous study of PCPs who manage chronic 
pain.131 While providers may attempt to follow clinical guidelines by recommending alternatives 
to opioids for pain management, absence of patient resources may hinder providers’ abilities to 
implement the guidelines and ultimately affect the number of options that are available to 
patients to treat pain.18,19,54,55,131 Beyond patient characteristics such as potential for side-effects, 
addiction, or “red flag” behaviors (e.g., diversion), this study confirms findings from previous 
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studies which show that presence of patient resources frequently impacts opioid prescribing 
decisions.48,52,54 
Providers discussed clinical guidelines, legislation, and clinic policies as resources that 
helped providers shift practices away from opioids. However, these policies have failed to 
address a barrier NC providers face whiling caring for patients with chronic pain: lack of access 
to non-pharmacologic treatments. For example, in NC, policies such as the Strengthen Opioid 
Misuse and Prevention Act (STOP ACT) and the Medicaid-Lock In Program have largely 
focused on opioids prescribing limits.81,172 Though the trend in opioid prescriptions is decreasing 
in NC, there has been little action to strengthen the delivery of pain care by improving access to 
evidence based treatment modalities such as physical therapy and mental health services.173 This 
directly links to priorities identified by providers to strengthen the health system such as having 
more mental health providers and allied health professionals as well as improving access to 
alternative pain treatments. 
We found that some codes overlapped across the rings, which could indicate the 
participants view these codes as interconnected and related. For example, some providers viewed 
“setting expectations for pain and treatment” as a responsibility but other described it as a need 
to meet other responsibilities such as “avoiding or minimizing opioids” and “recommending non-
pharmacologic and multimodal treatment strategies” This demonstrates that in order to avoid or 
minimize opioid use, there are potentially several additional responsibilities that providers have. 
Similarly, providers often discussed having conversations about different topics in pain care (e.g. 
“conversations about goals”) as both a need and a resource. The overlap between needs and 
resources could indicate that the lack of formal resources or that providers use their own 
professional experience to support themselves. Furthermore, it could imply that providers may 
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need more training or support from allied health professionals such as social workers, to assist 
providers in engaging patients in care.   
 There are several limitations to this study. We recruited enough PCPs to reach theme 
saturation for the study sample; however, it is difficult to conclude whether saturation was 
reached for the urban and rural subgroups. Second, while we employed recruitment strategies to 
invite providers from across NC to participate in this study, we had limited representation of 
providers from the Western and Eastern parts of the state, where the opioid epidemic has hit the 
hardest.173 Furthermore, selection bias in the study sample could indicate that the providers who 
participated were likely to be the most eager and interested in pain management practices. 
Finally, we did not explicitly instruct providers to consider clinical guidelines during the 
interview so that we could capture the lived experience of providers. However, this could result 
in social desirability bias and providers may not describe their true pain management practices. 
Conclusion 
 The findings from this study it illustrate the scope of pain practices for PCPs in urban and 
rural settings. Comprehensive policy approaches are necessary to address the opioid epidemic 
because pain practices are interrelated. Future research should investigate what patients suffering 
from chronic musculoskeletal pain do to manage their pain and how the system supports their 
health. Without addressing the significant systemic barriers to the delivery of alternatives for 
pain care, it will be difficult to sustain policies that restrict opioids, and both patients may not 








Figure shows only connections between codes that were mentioned more than once, with exception of wishes. Node size indicates 
prevalence of code. 
Online access: https://kumu.io/rkarmali/primary-care-urban-hard-jul10#map-ySXo3cPh  









Figure shows all code for the responsibilities and wishes, and only needs, supports and barriers that were mentioned more than once. 
Node size indicates prevalence of code. 
Online access: https://kumu.io/rkarmali/primary-care-rural-hard-jul-10th#map-TVusPgRS  




Table 5.1: Sample characteristics of North Carolina Primary Care Providers Who Care for 
Chronic Pain Patients. 





Provider demographics N (%)       
Sample Size* 16  11 68.8% 6 37.5% 
Provider type       
MD or DO 14 87.5% 10 90.9% 5 83.3% 
Nurse practitioner 2 12.5% 1 9.1% 1 16.7% 
Setting**       
Safety Net 10 62.5% 6 54.5% 5 83.3% 
Private Practice 5 31.3% 4 36.4% 1 16.7% 
Other 1 6.3% 1 9.1% 0 0.0% 
Average number of years of experience 
(mean, standard deviation) 13.31 11.6 15.05 10.51 9.5 11.07 
Level of comfort with treating pain 
(mean, standard deviation) 6.5 1.71 6.91 1.76 5.67 1.21 
Clinic Population Characteristics       
Percent vulnerable***       
Less than 25% 3 18.8% 3 27.3% 0 0.0% 
26-50% 4 25.0% 2 18.2% 2 33.3% 
51-75% 4 25.0% 3 27.3% 1 16.7% 
Greater than 76% 6 37.5% 3 27.3% 3 50.0% 
Percent with Medicaid       
Less than 25% 6 37.5% 5 45.5% 1 16.7% 
26-50% 7 43.8% 4 36.4% 4 66.7% 
51-75% 2 12.5% 2 18.2% 0 0.0% 
Greater than 76% 0 0.0% 0 0.0% 0 0.0% 
Unsure 1 6.3% 0 0.0% 1 16.7% 
Percent with Medicare       
Less than 25% 3 18.8% 3 27.3% 1 16.7% 
26-50% 9 56.3% 6 54.5% 3 50.0% 
51-75% 3 18.8% 2 18.2% 1 16.7% 
Greater than 76% 0 0.0% 0 0.0% 0 0.0% 
Unsure 1 6.3% 0 0.0% 1 16.7% 
Percent with Private Insurance       
Less than 25% 9 56.3% 5 45.5% 5 83.3% 
26-50% 3 18.8% 3 27.3%  0.0% 
51-75% 4 25.0% 3 27.3% 1 16.7% 
Greater than 76% 0 0.0% 0 0.0%  0.0% 
Unsure 0 0.0% 0 0.0%  0.0% 
Percent Uninsured       
Less than 25% 10 62.5% 8 72.7% 2 33.3% 
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26-50% 4 25.0% 3 27.3% 2 33.3% 
51-75% 2 12.5% 0 0.0% 2 33.3% 
Greater than 76% 0 0.0% 0 0.0% 0 0.0% 
Unsure 0 0.0% 0 0.0% 0 0.0% 
Percent Non-White Minorities       
Less than 25% 2 12.5% 1 9.1% 1 16.7% 
26-50% 6 37.5% 5 45.5% 2 33.3% 
51-75% 5 31.3% 4 36.4% 1 16.7% 
Greater than 76% 2 12.5% 0 0.0% 2 33.3% 
Unsure 1 6.3% 1 9.1% 0 0.0% 
Percent with chronic musculoskeletal 
pain       
Less than 25% 4 25.0% 3 27.3% 2 33.3% 
26-50% 10 62.5% 7 63.6% 3 50.0% 
51-75% 2 12.5% 1 9.1% 1 16.7% 
Greater than 76% 0 0.0% 0 0.0% 0 0.0% 
Unsure 0 0.0% 0 0.0% 0 0.0% 
Characteristics of clinic population with chronic 
musculoskeletal pain     
Percent over 65 years       
Less than 25% 9 56.3% 6 54.5% 4 66.7% 
26-50% 4 25.0% 2 18.2% 2 33.3% 
51-75% 3 18.8% 3 27.3% 0 0.0% 
Greater than 76% 0 0.0% 0 0.0% 0 0.0% 
Unsure 0 0.0% 0 0.0% 0 0.0% 
Percent seen monthly       
Less than 25% 12 75.0% 8 72.7% 4 66.7% 
26-50% 3 18.8% 2 18.2% 2 33.3% 
51-75% 1 6.3% 1 9.1% 1 16.7% 
Greater than 76% 0 0.0% 0 0.0% 0 0.0% 
Unsure 0 0.0% 0 0.0% 0 0.0% 
* One provider worked in both rural and urbans settings and was counted in both totals 
**Safety Net:  FQHC, FQHC look alikes, rural health centers, free clinics, and academic resident 
clinics. 
Private practice: physician owned practices and academically-affiliated, community based, primary 
care clinics 
















Get patients to use physical therapy 75.0% 81.8% D 50.0% D 
Recommend non-pharmacological and multimodal 
approaches 75.0% 72.7%E 83.3% D, E 
Avoid or minimize opioids for long term pain 
management 75.0% 63.6%D 100.0%D 
Recommend and encourage patients to change 
behaviors to exercise and lose weight 56.3% 63.6% D 33.3% 
Get patient history with pain treatments 56.3% 63.6% 33.3% 
Create treatment plan 56.3% 45.5% D, E 83.3% 
Prescribing medications (opioid and non-opioid) 56.3% 45.5% E 66.7% E 
Set goals for pain treatment 50.0% 63.6% 33.3% 
Physical exam 43.8% 54.5% D,E 16.7% 
Set expectations about pain and treatments 43.8% 45.5% D 50.0% D 
Diagnostic evaluation 43.8% 45.5% D 33.3% 
Get patient history (comorbidities and 
medications) 43.8% 45.5% 33.3% 
Assess and educate patients about the relationship 
between pain and mental health 43.8% 36.4% D 66.7% D, E 
Ensure follow-up visit 37.5% 45.5% D 16.7% 
Understand how pain affects daily life 37.5% 45.5% 16.7% 
Identify root cause of pain and history with pain 37.5% 36.4% 50.0% 
Partner with the patient 37.5% 36.4% E 33.3% 
Monitor opioid treatment 31.3% 27.3%D 33.3%D 
Refer to specialists 31.3% 27.3% 33.3% 
Taper opioid use 31.3% 18.2% D 50.0% D 
Change Medication treatments 6.3% 9.1%D 0.0% 
Educate patients about opioids 12.5% 18.2%D 0.0% 
Get patient to sign pain contract 18.2% 9.1% 16.7%E 
Education patients about naloxone 6.3% 0.0% 17.7E 
Grayed percentages indicate that it was not a top ten responsibility.  
Proportions are calculated by dividing the number of providers who reported the responsibility by the total 
number in that group. 






Table 5.3: Top 10 needs, barriers, and supports for difficult responsibilities for primary care 
providers in urban and rural settings.  
 Needs for Difficult Responsibilities 
  Urban Rural 
Total Number of Codes 129 67 
Engaged patient 6.6% 4.5% 
Availability of other options to use instead of opioids 5.5% 6.0% 
Set expectations about pain 5.5% 4.5% 
Knowledge of patient resources 4.4% 4.5% 
Evidence about different pain management treatments 4.4% 4.5% 
Patient medical history (comorbidities including, medications) 4.4% 1.5% 
Conversation about patient goals 6.6% 1.5% 
Knowledge of patient history with pain treatments 4.4% 3.0% 
Educate patients about pain treatments 6.6% 3.0% 
Patient who wants to change behaviors 6.6% 0.0% 
Institutional support 5.5% 3.0% 
Patient trust 5.5% 0.0% 
Geographic access to pain treatments and specialists 4.4% 0.0% 
Affordable pain treatments 2.2% 10.4% 
Good patient provider relationship 2.2% 6.0% 
Identify red flags 0.0% 6.0% 
Tolerate conflicts with opioid prescriptions 2.2% 4.5% 
Educate patients about pain and mental health 1.1% 4.5% 
 
Supports and Barriers for Difficult 
Responsibilities 
  Urban Rural 
Total Number of Codes 
504 272 
Published literature 1.6% 1.8% 
Conversations with colleagues 1.8% 1.5% 
Patient education about opioids 2.2% 0.4% 
Previous patient records and outside records 1.4% 0.7% 
Conversation about goals 1.8% 0.7% 
Barrier: poor insurance coverage for alternatives to opioids 1.6% 1.5% 
NC controlled substance database 1.4% 1.5% 
Social worker 1.4% 0.4% 
Family caregivers 1.4% 1.1% 
Opioid treatment agreements 1.4% 0.7% 
Specialty referral 1.6% 0.7% 
Barrier: not enough time to talk about pain when there are other 
health concerns 
1.6% 0.7% 
Motivational interviewing 1.4% 0.7% 
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Barrier: patients don't want changes 1.6% 0.0% 
Setting expectations with pain and treatments 1.4% 0.0% 
Patient stories 1.2% 2.2% 
Barrier: transportation 0.8% 3.7% 
Behavioral health 1.0% 2.2% 
Use multiple visits to explore pain (follow up) 1.2% 2.2% 
Care manager 0.0% 3.3% 
Point of care references 1.2% 1.8% 
Prescribing guidelines to inform safe opioid prescribing 1.0% 2.2% 
Pharmacists 0.0% 1.8% 
Barrier: hard to get and interpret urine drug screen 0.0% 1.8% 
Percent calculated by dividing the total number of times the code appears in a map by the total number of codes for 
the provider category. 




Table 5.4: Wishes for easy and difficult responsibilities for primary care providers in urban and 
rural settings.  
  Total Urban Rural  
Total codes 100 76 42 
Better patient education materials about pain and treatments 6.0% 7.9% 9.5% 
More mental health providers 6.0% 6.6% 7.1% 
More time to talk about pain 8.0% 7.9% 4.8% 
Improve access to pain treatments 7.0% 9.2% 4.8% 
More allied health professionals to address all concerns with 
pain 8.0% 5.3% 9.5% 
Better medication for pain 5.0% 6.6% 4.8% 
Better access to interventions for obesity 5.0% 6.6% 0.0% 
More training on pain diagnosis and treatment 5.0% 5.3% 7.1% 
Use more non-pharmacologic options for pain 5.0% 5.3% 7.1% 
Better insurance coverage 4.0% 1.3% 7.1% 
More community resources 4.0% 0.0% 9.5% 
Percent calculated by dividing the total number of times the code appears in a map by the total number of codes 
for the provider category. 






Table 5.5: Illustrative quotes for the top 5 responsibilities and wishes for urban and rural 
providers. 
Responsibility Illustrative Quote 
Avoid or minimize 
opioids for long term 
pain management 
I'm responsible for what I prescribe, so if I don't feel that they should be on opiates, 
I'm not gonna prescribe them, and I will have that tough discussion. What I think you 
don't wanna do or does not work well is try to have the patient agree with you. The 
patient certainly might not agree with you, particularly, obviously if addiction or 
diversion is the issue. But being honest, transparent but empathic, and knowing what 
you are willing to do based on your assessment of the medical situation. If it's a back 
and forth with the patient, that often goes nowhere good.  Because the patient will be 
arguing for why they want opiates and then you're trying to justify why they shouldn't 
have opiates and that my 20 years of experience of doing it is a no-win situation. - 





A lot of times it's very difficult if a patient has come to me with something that they 
want from me. So if they've come to me with the purpose of getting opioids, it's really 
difficult to sell an alternative treatment plan… And so, trying to convince a patient to 
try that before we would move to an opioid is challenging. Because I think a lot of 
those patients have tried it, but maybe not in the proper treatment management -
Provider in Rural Setting 
 
Assess and educate 
patients about the 
relationship between 
pain and mental health 
The hardest thing is mental health, in the sense that, a lot of patients don't attribute 
their pain to a mental health cause or that they don't understand that the chronic pain 
is being exacerbated by their mental health condition. So establishing that link with 
them can be very, very difficult. I worked with a bunch of patients that making that 
link takes multiple visits, and years, sometimes, to get them to understand that link. 
But, it's also just access to mental health resources. Most of these patients with 
chronic pain would benefit from cognitive behavioral therapy, or biofeedback 
therapy, but it is really difficult financially. - Provider in Urban Setting 
Recommend and 
encourage patients to 
change behaviors to 
exercise and lose weight 
I think always making lifestyle modifications can be very difficult, especially for 
older patients that have really developed severe deconditioning and severe weight 
issues. Getting them to even do minimal movement can be very difficult for them... 
You can beg them, plead them, tell them how at risk they are, it's just really hard to 
move them off that set point that they've established over decades. - Provider in 
Urban Setting 
Set expectations and 
create treatment goals 
It's a hard thing to do to say to somebody, "I know you want to be pain-free, and I 
don't know if that's gonna be possible.": How do you have that conversation? How do 
you frame it in a productive way, and not just a, "It's not gonna be possible. Stop 
asking." - Provider in Urban and Rural Setting 
Get patients to use 
physical therapy 
I would also say physical therapy is actually one of my most difficult things. It's a big 
time commitment for them [patients] to go to all of these visits and it typically tends 
to be fairly expensive. It's kind of not a immediate payoff. Medications immediately 
makes them feel better, whereas physical therapy, might take six weeks to help. - 
Provider in Urban Setting 
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Tapering opioid use I struggle to take them off of their pain medications, to decrease that dose. I've been 
here 12 years, and so some of my patients have gone from being 60 and still fixing 
their own cars, and bringing in their firewood, to 72 and approaching the need for 
hospice care. And so to start talking about, "Well, you weigh 20% less than you did 
10 years ago when we first started this, how do we taper it down?" Because I then get 
the granddaughter calling and saying, "Grandpa hurts so much. He won't sleep in bed 
anymore." That multi-generational family stuff is challenging to work with because 
rarely do I see these patients in isolation. I see several generations of the family. -
Provider in Rural Setting 
Monitor opioid 
treatment (rural) 
Oftentimes the drug screens are more difficult than I want them to be. And that 
sometimes is a red flag to me. But a lot of times they'll be like, "Oh, I just peed." Or 
lab error, my lab technician accidentally throws it out, or my medical assistant doesn't 
give them the urine cup. But a lot of times, that is difficult in those first steps. -
Provider in Rural Setting 
Wish Illustrative Quote 
More allied health 
professionals to address 
all concerns with pain 
I think again, when you have more continuity with staff, whether it's medical staff, 
nursing staff, whatever, patients develop more trust, that they trust people that they've 
been coming to see for a long time. -Provider in Rural Setting 
More time to talk about 
pain 
So dedicated visit for pain, in my mind, would be like a pain clinic within a primary 
care setting. So we have a smoking cessation clinic, we have... It's sort of these ideas 
like within primary care you offer these smaller areas that are specialized to help 
people out. -Provider in Urban Setting 
Improve access to pain 
treatments 
I think that there are models where the cardiologist will come one Saturday a month 
out to somewhere rural. I think that having a similar model for orthopedics, or maybe 
this is a gold star, orthopedics, or pain, or psychiatry to travel to rural places, not 
every day, but on a regular basis, on a scheduled basis to see patients, would be 
awesome.  - Provider in Urban and Rural Setting 
Better patient education 
materials about pain and 
treatments 
I would love to have more educational options for patients about how chronic pain 
works, why it perpetuates itself, how different therapies work, not just opiates, but 
how many adjunct therapies work, how it interplays with their mental health... that's a 
video you can show. -Provider in Urban and Rural Setting 
More mental health 
providers 
More mental health support on the day of the visit. So a pain psychologist, we don't 
really have one of those at our clinic, and they take forever to get into, for other 
clinics. It can be really challenging. And I think we're very capable to do that. I'm not 
saying that I know more or I'm more capable than a pain psychologist, but to just ask 
like, "So, tell me about your pain. How is it going?" or like, "What are your goals? 
Where are you? Where would you like to be? From a one to a 10? Where are you? 
Oh, you're a nine. Why are you a nine?" It's like, we can do that, we just don't have 
time. - Provider in Urban Setting 
Better access to 
interventions for obesity 
I mean, the obesity thing is gigantic societal changes [chuckle] would make that a lot 
easier. The government subsidizes healthy food, instead of unhealthy corn products, 
and our society moving away from kind of a workaholic culture into people having 
more of a work/life balance, where they have time for exercise, and schools including 
more exercise time in their curriculum, rather than less, and kids getting better 
education in schools about nutrition. - Provider in Urban Setting 
Better medication for 
pain 
There are new drugs coming out they're talking about that target pain receptors 
without giving...the sense of euphoria that is so addictive. And so I think, in the 
future, when we talk about effective treatments, alternatives that aren't as 




More training on pain 
diagnosis and treatment 
I wish I had gotten better training during residency [on pain management] to be 
honest. I think that would give me a better foundation to go out and practice. -




I wish there was a better system for universal healthcare that would let our patients 
seek alternative treatments more easily, such as therapy and specialist consultation 
and physical therapy and whatnot 'cause I think that that would really reinforce that 
these alternative treatment plans actually work by allowing patients to actually do 
them and complete them.  -Provider in Rural Setting 
Better insurance 
coverage 
Medicaid expansion in NC. We had a legislature who cared for the half million 
people or more who could benefit from Medicaid expansion. It would help our 
patients, it would help us. It would probably help us not have the tremendous turnover 
that we've had.  -Provider in Rural Setting 
More community 
resources 
It's harder with older people, I think, 'cause they're not as probably connected on the 
internet as younger people are, but some sort of way to put people in touch with other 
similar, or people in similar situations where they can have support groups, or... Not 
necessarily like a guided support group, but just build them on their own. Just 
someone to walk with, even, so you can't use an excuse of, "I don't wanna walk by 










Percent of Urban 
Providers 
(N=11) 
Percent of Rural 
Providers 
(N=6) 
Avoid or minimize opioids for long term 
pain management 75.0% 63.6% 100.0% 
Recommend non-pharmacological and 
multimodal approaches 75.0% 72.7% 83.3% 
Get patient history with pain treatments 56.3% 63.6% 33.3% 
Get patients to use physical therapy 75.0% 81.8% 50.0% 
Recommend and encourage patients to 
change behaviors to exercise and lose 
weight 56.3% 63.6% 33.3% 
Create treatment plan 56.3% 45.5% 83.3% 
Prescribing medications (opioid and non-
opioid) 56.3% 45.5% 66.7% 
Set goals for pain treatment 50.0% 63.6% 33.3% 
Assess and educate patients about the 
relationship between pain and mental 
health 43.8% 45.5% 33.3% 
Add flag for chronic pain in electronic 
health record 43.8% 45.5% 33.3% 
Avoid asking patients about pain 43.8% 45.5% 50.0% 
Be curious with the patient 43.8% 54.5% 16.7% 
Change medication treatments 43.8% 36.4% 66.7% 
Determine whether patient's need for 
treatment is legitimate (e.g. no doctor 
shopping or inappropriate medication use) 37.5% 45.5% 16.7% 
Diagnostic evaluation 37.5% 45.5% 16.7% 
Educate patients about naloxone 37.5% 36.4% 50.0% 
Educate patients about opioids 31.3% 27.3% 33.3% 
Educate patients about treatment options 37.5% 36.4% 33.3% 
Ensure follow-up visit 31.3% 27.3% 33.3% 
Follow opioid prescribing guidelines 31.3% 18.2% 50.0% 
Get patient history (comorbidities and 
medications) 6.3% 0.0% 16.7% 
Get patient to sign pain contract 6.3% 0.0% 16.7% 
Get urine drug test 6.3% 9.1% 0.0% 
Identify "red flags" for opioid behaviors 6.3% 9.1% 0.0% 
Identify patient resources 6.3% 9.1% 0.0% 
Identify root cause of pain and history with 
pain 6.3% 0.0% 16.7% 
Minimize or avoid non-opioid medications 12.5% 18.2% 0.0% 
Monitor opioid treatment 6.3% 9.1% 0.0% 






Percent of Urban 
Providers 
(N=11) 
Percent of Rural 
Providers 
(N=6) 
Physical exam 12.5% 9.1% 16.7% 
Prepare for potential conflicts with pain 
management 12.5% 9.1% 16.7% 
Reduce all medication use 18.8% 18.2% 16.7% 
Refer to specialists 12.5% 18.2% 0.0% 
Set expectations about pain and treatments 12.5% 9.1% 16.7% 
Taper opioid use 6.3% 9.1% 0.0% 
Teach coping strategies 12.5% 18.2% 0.0% 
Try all other options before prescribing 
opioids 6.3% 9.1% 0.0% 
Understand how pain affects daily life 18.8% 18.2% 16.7% 
Gray font indicates responsibility was not in the top 10 for the group.  
Proportions are calculated by dividing the number of providers who reported the responsibility by the total 





Supplemental Table 5.2: Needs for difficult and easy responsibilities for primary care providers 
in urban and rural settings.  
 
Needs for Difficult and Easy 
Responsibilities 
Needs for Difficult 
Responsibilities 
  Urban Rural Urban Rural 
Total Number of Codes 162 91 129 67 
Engaged patient 4.3% 6.6% 6.6% 4.5% 
Availability of other options to 
use instead of opioids 3.7% 6.6% 5.5% 6.0% 
Set expectations about pain 4.3% 4.4% 5.5% 4.5% 
Knowledge of patient resources 2.5% 4.4% 4.4% 4.5% 
Evidence about different pain 
management treatments 3.1% 4.4% 4.4% 4.5% 
Patient medical history 
(comorbidities including, 
medications) 4.3% 4.4% 4.4% 1.5% 
Conversation about patient goals 4.9% 1.1% 6.6% 1.5% 
Knowledge of patient history with 
pain treatments 4.3% 2.2% 4.4% 3.0% 
Educate patients about pain 
treatments 3.7% 2.2% 6.6% 3.0% 
Patient who wants to change 
behaviors 3.7% 0.0% 6.6% 0.0% 
Institutional support 3.7% 2.2% 5.5% 3.0% 
Patient trust 3.1% 0.0% 5.5% 0.0% 
Geographic access to pain 
treatments and specialists 3.1% 0.0% 4.4% 0.0% 
Affordable pain treatments 1.9% 9.9% 2.2% 10.4% 
Good patient provider 
relationship 1.9% 4.4% 2.2% 6.0% 
Identify red flags 0.0% 0.0% 0.0% 6.0% 
Tolerate conflicts with opioid 
prescriptions 1.2% 3.3% 2.2% 4.5% 
Educate patients about pain and 
mental health 0.6% 3.3% 1.1% 4.5% 
Educate patients about opioids 1.9% 3.3% 3.3% 1.5% 
Patients need transportation to 
treatment 1.9% 2.2% 3.3% 3.0% 
Patient needs to be able to afford 
pain treatments 2.5% 0.0% 3.3% 0.0% 
Time to talk to patients 1.2% 2.2% 2.2% 3.0% 
Good communication with the 
patient 1.9% 1.1% 2.2% 1.5% 
Good communication with other 
pain providers 1.9% 0.0% 3.3% 0.0% 
Time and money for patient to 
exercise and eat well 1.9% 0.0% 3.3% 0.0% 




Needs for Difficult and Easy 
Responsibilities 
Needs for Difficult 
Responsibilities 
  Urban Rural Urban Rural 
Avoid side effects of treatment 
strategies 1.2% 1.1% 2.2% 1.5% 
Listening skills 1.9% 0.0% 2.2% 0.0% 
Provider needs to be honest and 
transparent 1.9% 0.0% 1.1% 0.0% 
Access to addiction treatment 1.2% 1.1% 2.2% 1.5% 
Empathy 1.2% 1.1% 2.2% 1.5% 
Do a physical exam 1.2% 0.0% 2.2% 0.0% 
Patient acceptance of treatments 1.2% 0.0% 2.2% 0.0% 
Address isolation 0.6% 1.1% 1.1% 1.5% 
Knowledge about pain 
management strategies 1.2% 0.0% 1.1% 0.0% 
Medication that is appropriate for 
the condition 1.2% 0.0% 1.1% 0.0% 
Provider knowledge about pain 0.6% 0.0% 1.1% 0.0% 
Support staff 0.0% 2.2% 0.0% 3.0% 
Way to evaluate progress with 
treatment 0.0% 2.2% 0.0% 3.0% 
Determine what is safe for the 
patient 0.6% 1.1% 0.0% 1.5% 
Educate patients about pain 
contract 0.0% 2.2% 0.0% 1.5% 
Knowledge about non-pharma 
modalities 0.6% 2.2% 0.0% 1.5% 
Method to prescribe medications 1.2% 0.0% 0.0% 0.0% 
Provider training about managing 
expectation 0.6% 1.1% 1.1% 1.5% 
Ask the right questions 0.6% 0.0% 1.1% 0.0% 
Convince patients to get off of 
opioids 0.6% 0.0% 1.1% 0.0% 
Educate patients about pain and 
obesity 0.6% 0.0% 1.1% 0.0% 
Establish partnership with patient 0.6% 0.0% 1.1% 0.0% 
Ethical obligation to not prescribe 
opioids 0.6% 0.0% 1.1% 0.0% 
Good communication with patient 
and physical therapist 0.6% 0.0% 1.1% 0.0% 
Home environment assessment 0.6% 0.0% 1.1% 0.0% 
Identify drug seekers 0.6% 5.5% 1.1% 0.0% 
Knowledge about how to do 
physical exam 0.6% 0.0% 1.1% 0.0% 
Non-judgmental attitude 0.6% 0.0% 1.1% 0.0% 
Patient and provider have to agree 0.6% 0.0% 1.1% 0.0% 




Needs for Difficult and Easy 
Responsibilities 
Needs for Difficult 
Responsibilities 
  Urban Rural Urban Rural 
Patient needs place to exercise 0.6% 0.0% 1.1% 0.0% 
Place to do physical exam 0.6% 0.0% 1.1% 0.0% 
Provider knowledge about how to 
implement modifications 0.6% 1.1% 1.1% 0.0% 
Provider's goals for the patient 0.6% 0.0% 1.1% 0.0% 
Provider's self-awareness about 
potential burn out 0.6% 0.0% 1.1% 0.0% 
Set boundaries on treatment 0.6% 0.0% 1.1% 0.0% 
Convince family members 0.0% 1.1% 0.0% 1.5% 
Patient satisfaction 0.0% 1.1% 0.0% 1.5% 
Reasons to counter patient 
excuses 0.0% 1.1% 0.0% 1.5% 
Work with patient early in pain 
experience 0.0% 1.1% 0.0% 1.5% 
Assess whether opioid therapy is 
appropriate 0.0% 1.1% 0.0% 0.0% 
Confidence in care plan 0.6% 1.1% 0.0% 0.0% 
Develop treatment plan 0.0% 1.1% 0.0% 0.0% 
Educate family about naloxone 0.0% 1.1% 0.0% 0.0% 
Educate patients about physical 
exam 0.6% 0.0% 0.0% 0.0% 
Literacy 0.0% 1.1% 0.0% 0.0% 
Patient who has done their 
research about their provider 0.6% 0.0% 0.0% 0.0% 
Provider's acceptance about what 
they can do about pain 0.6% 0.0% 0.0% 0.0% 
Time to get undressed 0.6% 0.0% 0.0% 0.0% 
Percent calculated by dividing the total number of times the code appears in a map by the total number of codes for 
the provider category. 
Gray font indicates need was not in the top 10 for the group   
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Supplemental Table 5.3: Supports, and barriers for difficult responsibilities for primary care 
providers in urban and rural settings.  
 






  Urban Rural Urban Rural 
Total Number of Codes 592 366 504 272 
Published literature 1.9% 2.5% 1.6% 1.8% 
Conversations with colleagues 2.4% 1.6% 1.8% 1.5% 
Patient education about opioids 2.2% 1.1% 2.2% 0.4% 
Previous patient records and outside records 1.5% 1.4% 1.4% 0.7% 
Conversation about goals 1.7% 1.1% 1.8% 0.7% 
Barrier: poor insurance coverage for alternatives to opioids 1.7% 1.6% 1.6% 1.5% 
NC controlled substance database 1.4% 1.4% 1.4% 1.5% 
Social worker 1.5% 0.5% 1.4% 0.4% 
Family caregivers 1.2% 0.8% 1.4% 1.1% 
Opioid treatment agreements 1.2% 1.1% 1.4% 0.7% 
Specialty referral 1.4% 0.8% 1.6% 0.7% 
Barrier: not enough time to talk about pain when there are 
other health concerns 1.4% 0.5% 1.6% 0.7% 
Motivational interviewing 1.4% 0.5% 1.4% 0.7% 
Barrier: patients don't want changes 1.4% 0.0% 1.6% 0.0% 
Setting expectations with pain and treatments 1.2% 0.0% 1.4% 0.0% 
Patient stories 1.4% 2.5% 1.2% 2.2% 
Barrier: transportation 1.0% 3.3% 0.8% 3.7% 
Behavioral health 0.8% 2.7% 1.0% 2.2% 
Use multiple visits to explore pain (follow up) 1.2% 2.2% 1.2% 2.2% 
Care manager 0.0% 3.0% 0.0% 3.3% 
Point of care references 1.2% 1.9% 1.2% 1.8% 
Prescribing guidelines to inform safe opioid prescribing 1.0% 1.9% 1.0% 2.2% 
Pharmacists 0.0% 1.9% 0.0% 1.8% 
Barrier: hard to get and interpret urine drug screen 0.0% 1.4% 0.0% 1.8% 
Strategy: use low risk treatments before opioids or other high 
risk treatments 2.2% 2.7% 1.2% 1.5% 
Medical school training and residency 1.4% 1.4% 1.2% 1.5% 
Barrier: stigma associated with mental health 0.8% 1.4% 0.8% 1.1% 
Public awareness of opioid epidemic 1.2% 0.8% 1.2% 0.0% 
Strategy: be transparent 1.2% 0.8% 1.2% 0.4% 
Barrier: patients want quick fixes 0.8% 1.1% 0.8% 1.5% 
EHR handouts 1.0% 0.8% 1.2% 0.7% 
Online resources 0.8% 1.1% 0.6% 1.5% 
Professional experience 1.4% 0.3% 1.2% 0.4% 
Charity care programs 1.0% 1.4% 0.8% 1.1% 










  Urban Rural Urban Rural 
EHR visit planning 0.7% 1.1% 0.6% 1.5% 
Home exercises 1.0% 0.8% 1.0% 0.7% 
State opioid prescribing policies impose limits for opioid 
prescriptions 1.2% 0.0% 1.2% 0.0% 
Strategy: understand and tailor treatment to preferences 0.7% 0.8% 0.6% 1.1% 
Strategy: validating patient pain 0.5% 1.1% 0.6% 1.1% 
Teaching aids (analogies, models) 0.7% 0.8% 0.8% 0.7% 
Barrier: conflict between patient and provider over pain 
management 0.3% 1.4% 0.4% 1.5% 
Barrier: expectation about pain and treatments 0.7% 0.8% 0.8% 1.1% 
Barrier: lack of training about specialty services for pain and 
addiction 0.8% 1.6% 0.6% 1.5% 
Barrier: poor insurance coverage for physical therapy 0.3% 1.1% 0.4% 1.5% 
Clinic staff 0.7% 0.5% 0.8% 0.7% 
EHR facilitates collaboration with provider 1.0% 0.0% 1.2% 0.0% 
Patient education about physical therapy 0.7% 0.5% 0.8% 0.7% 
Provider knowledge of community resources 0.8% 0.3% 0.8% 0.4% 
Strategy: use physical exam 1.0% 0.0% 0.4% 0.0% 
Use more medications (both opioid and non-opioid) 1.0% 1.1% 1.0% 1.1% 
Acupuncture 0.8% 1.1% 0.6% 1.1% 
Barrier: lack of patient trust 0.8% 0.3% 1.0% 0.4% 
Barrier: patients are sedentary 0.8% 0.0% 1.0% 0.0% 
Gives more time to the patient 0.7% 0.3% 0.4% 0.4% 
Barrier: belief that  there could be inconclusive evidence 
from test or exam 0.7% 0.0% 0.8% 0.0% 
Barrier: lack of patient education materials 0.7% 0.0% 0.8% 0.0% 
Barrier: poor insurance coverage for mental health 0.3% 0.5% 0.4% 0.4% 
Chronic pain support group 0.7% 0.5% 0.6% 0.4% 
Clinic policy not to prescribe opioids on the first visit 0.5% 0.8% 0.6% 1.1% 
Continuing Medical Education courses 0.5% 0.3% 0.4% 0.4% 
Conversation about costs 0.5% 0.3% 0.4% 0.4% 
EHR to find comorbidities and medications 0.7% 0.0% 0.4% 0.0% 
Pain specialists 0.0% 1.1% 0.0% 0.0% 
Patient education about pain and appropriate medications 0.0% 1.1% 0.0% 0.4% 
Patient education about pain and obesity 0.5% 0.3% 0.6% 0.0% 
Personality 0.7% 0.3% 0.8% 0.4% 
Pharmacy assistance 0.3% 1.1% 0.2% 0.7% 
Physical therapist 0.7% 0.0% 0.8% 0.0% 
Provider wellness program 0.7% 0.8% 0.8% 1.1% 
Screening for opioid risk behaviors 0.3% 0.5% 0.4% 0.7% 










  Urban Rural Urban Rural 
Sliding scale for services 0.3% 1.1% 0.2% 0.7% 
Strategy: build relationship with patient 0.3% 0.5% 0.0% 0.4% 
Barrier: burnout 0.5% 0.3% 0.6% 0.4% 
Barrier: cost of testing 0.5% 0.0% 0.6% 0.0% 
Barrier: culture of medicine leans toward pills 0.5% 0.0% 0.6% 0.0% 
Barrier: EHR diverts attention from the patient 0.0% 0.8% 0.0% 1.1% 
Barrier: family caregivers 0.0% 0.8% 0.0% 1.1% 
Barrier: lack of access to mental health services 0.5% 0.0% 0.6% 0.0% 
Barrier: lack of data about patient history 0.5% 0.0% 0.6% 0.0% 
Barrier: lack of standards for opioid therapy 0.0% 0.8% 0.0% 1.1% 
Barrier: patient clothing for physical exam 0.5% 0.0% 0.6% 0.0% 
Barrier: patient needs time for treatments 0.5% 0.0% 0.6% 0.0% 
Barrier: patient won't schedule appointment 0.3% 0.3% 0.4% 0.0% 
Barrier: patients don't think physical therapy with help 0.3% 0.3% 0.4% 0.4% 
Barrier: patients may not understand education materials 0.2% 0.8% 0.2% 1.1% 
Barrier: poor insurance coverage for specialists 0.3% 0.3% 0.4% 0.4% 
Barrier: provider needs time to schedule visit for the patient 0.5% 0.0% 0.6% 0.0% 
Community mental health provider 0.0% 0.8% 0.0% 0.0% 
EHR referral 0.5% 0.0% 0.6% 0.0% 
Imaging 0.3% 0.3% 0.4% 0.0% 
Learn strategies from pain clinic 0.5% 0.0% 0.6% 0.0% 
Mentors 0.3% 0.8% 0.4% 1.1% 
Nurses 0.0% 0.8% 0.0% 0.7% 
Nutritionist 0.5% 0.0% 0.6% 0.0% 
Pain committee 0.0% 0.8% 0.0% 1.1% 
Patient education about pain and mental health 0.2% 0.5% 0.2% 0.7% 
Peer support counselors 0.5% 0.8% 0.4% 0.7% 
Professional conferences 0.5% 0.0% 0.6% 0.0% 
Physical therapy referral 0.3% 0.3% 0.4% 0.0% 
Reputation of family medicine 0.3% 0.3% 0.4% 0.4% 
Specialists travel to rural communities 0.5% 0.8% 0.4% 0.7% 
Strategy: only manage pain/prescribe opioids for certain 
patients 0.5% 0.0% 0.6% 0.0% 
Strategy: prioritizing patient's concerns about pain over other 
medical concerns 0.5% 0.0% 0.6% 0.0% 
Substance use treatment providers 0.5% 0.3% 0.6% 0.4% 
Urine drug test 0.3% 0.3% 0.4% 0.4% 
After visit summary 0.3% 0.0% 0.2% 0.0% 
Barrier: hard to convince patients to consider treatment 0.2% 0.3% 0.2% 0.4% 










  Urban Rural Urban Rural 
Barrier: lack of access to substance use services 0.3% 0.5% 0.4% 0.7% 
Barrier: no place to exercise 0.2% 0.3% 0.2% 0.4% 
Barrier: patient cognitive abilities 0.3% 0.0% 0.4% 0.0% 
Barrier: patient communication about goals 0.3% 0.0% 0.4% 0.0% 
Barrier: patients don't respond to data 0.3% 0.0% 0.4% 0.0% 
Being a parent 0.3% 0.0% 0.2% 0.0% 
Case worker 0.3% 0.0% 0.4% 0.0% 
Clinic protocols for opioid treatment 0.0% 0.5% 0.0% 0.7% 
Community gyms 0.3% 0.0% 0.4% 0.7% 
Drive around to learn about community resources 0.0% 0.5% 0.0% 0.7% 
EHR alerts 0.3% 0.0% 0.2% 0.0% 
EHR notes to self 0.3% 0.0% 0.0% 0.0% 
EHR to document strategies patient has tried before 0.3% 0.0% 0.2% 0.0% 
EHR tracks problems and progress over time 0.3% 0.0% 0.4% 0.0% 
Empathy 0.0% 0.5% 0.0% 0.7% 
Epocrates 0.3% 0.0% 0.2% 0.0% 
Family systems theory 0.0% 0.5% 0.0% 0.7% 
High level of suspicion 0.3% 0.0% 0.4% 0.0% 
Home visit 0.3% 0.0% 0.4% 0.0% 
Internet searches 0.0% 0.5% 0.0% 0.7% 
Non-judgmental attitude 0.3% 0.0% 0.4% 0.0% 
Patience 0.2% 0.3% 0.2% 0.4% 
Patient conversation to find red flag 0.3% 0.0% 0.4% 0.0% 
Patient education classes about pain 0.3% 0.0% 0.4% 0.0% 
Patient portal 0.3% 0.0% 0.2% 0.0% 
Reduced cost alternatives for specialists 0.3% 0.0% 0.4% 0.0% 
Self-reflection 0.0% 0.5% 0.0% 0.7% 
Strategy: practice consistency with patients 0.2% 0.3% 0.2% 0.4% 
Strategy: wait to discuss reduction in opioids until patient 
trusts provider 0.3% 0.0% 0.4% 0.0% 
Strategy: skipping other health concerns 0.3% 0.0% 0.4% 0.0% 
Surgery or injection 0.3% 0.0% 0.4% 0.0% 
Telemedicine 0.3% 0.5% 0.2% 0.4% 
Time to develop the relationship 0.3% 0.0% 0.4% 0.0% 
Walking assistance devices 0.3% 0.0% 0.4% 0.0% 
Aqua exercises 0.2% 0.0% 0.2% 0.0% 
Ask about pain at every visits 0.0% 0.3% 0.0% 0.4% 
Ask about patient medical history 0.0% 0.3% 0.0% 0.4% 
Ask about social supports 0.2% 0.0% 0.2% 0.0% 










  Urban Rural Urban Rural 
Barrier: costly and side effects and patient preferences 0.2% 0.0% 0.2% 0.0% 
Barrier: difficult to collaborate with  mental health providers 0.2% 0.0% 0.2% 0.0% 
Barrier: EHR does not have alert 0.0% 0.3% 0.0% 0.4% 
Barrier: exam room furniture does not support patient during 
physical exam 0.2% 0.0% 0.2% 0.0% 
Barrier: expected to build relationship immediately 0.2% 0.0% 0.2% 0.0% 
Barrier: hard to explain how pain relates to obesity 0.2% 0.0% 0.2% 0.0% 
Barrier: hard to find records for patients who go outside the 
system 0.2% 0.0% 0.2% 0.0% 
Barrier: hard to interpret results from database 0.0% 0.3% 0.0% 0.4% 
Barrier: hard to navigate health system 0.2% 0.0% 0.2% 0.0% 
Barrier: isolation 0.0% 0.3% 0.0% 0.4% 
Barrier: lack of access to social services 0.2% 0.0% 0.2% 0.0% 
Barrier: lack of data on non-pharma modalities 0.0% 0.3% 0.0% 0.4% 
Barrier: lack of educational material about opioids 0.0% 0.3% 0.0% 0.0% 
Barrier: lack of internet access 0.0% 0.3% 0.0% 0.4% 
Barrier: lack of provider confidence 0.2% 0.0% 0.2% 0.0% 
Barrier: lack of training about pain 0.2% 0.0% 0.2% 0.0% 
Barrier: legislation turns provider into a cop 0.0% 0.3% 0.0% 0.0% 
Barrier: level of pain makes it difficult to complete physical 
exam 0.2% 0.0% 0.2% 0.0% 
Barrier: limited time 0.0% 0.3% 0.0% 0.4% 
Barrier: managing patient's emotions and pain treatment at 
the same time 0.0% 0.3% 0.0% 0.4% 
Barrier: negative patient satisfaction 0.0% 0.3% 0.0% 0.4% 
Barrier: negative patient satisfaction scores 0.2% 0.0% 0.2% 0.0% 
Barrier: no way to recommend for patients to keep track of 
progress 0.0% 0.3% 0.0% 0.4% 
Barrier: opioid prescribing policies which limit prescriptions 
shifts burden of long-term pain management to primary care 
providers 0.2% 0.0% 0.2% 0.0% 
Barrier: pain clinic can't handle volume of patients so primary 
care has to 0.2% 0.0% 0.2% 0.0% 
Barrier: patient literacy and SES 0.2% 0.0% 0.2% 0.0% 
Barrier: patient want doctor to have all the answers 0.2% 0.0% 0.2% 0.0% 
Barrier: provider doesn't think patients benefit from mental 
health care 0.0% 0.3% 0.0% 0.4% 
Barrier: provider has to focus on meeting quality measures 0.2% 0.0% 0.2% 0.0% 
Barrier: staff turn over 0.0% 0.3% 0.0% 0.4% 
Barrier: the patient's other provider recommendations for pain 0.2% 0.0% 0.2% 0.0% 
Barrier: unhealthy food is cheap 0.2% 0.0% 0.2% 0.0% 
Barrier; regulation 0.0% 0.3% 0.0% 0.0% 










  Urban Rural Urban Rural 
Blank need 0.2% 0.0% 0.0% 0.0% 
Clinic late policy 0.2% 0.0% 0.2% 0.0% 
Clustering appointments 0.2% 0.0% 0.2% 0.0% 
Confirm contact information 0.2% 0.0% 0.2% 0.0% 
Conversation about patient history with pain treatment 0.0% 0.3% 0.0% 0.4% 
Conversation about what worked in the past and what could 
work now 0.2% 0.0% 0.0% 0.0% 
Demonstrate exercises 0.0% 0.3% 0.0% 0.4% 
Education about insurance navigation 0.2% 0.0% 0.2% 0.0% 
EHR to order medication 0.2% 0.0% 0.0% 0.0% 
End of visit patient education 0.2% 0.0% 0.2% 0.0% 
Exercise to avoid burnout 0.2% 0.0% 0.2% 0.0% 
Family life cycle tool 0.0% 0.3% 0.0% 0.4% 
Federal drug pricing 0.0% 0.3% 0.0% 0.0% 
Finance department 0.2% 0.0% 0.2% 0.0% 
Functional goals assessment 0.2% 0.0% 0.2% 0.0% 
Handout about opioids 0.2% 0.0% 0.2% 0.0% 
Have awareness that provider is doing the right thing 0.2% 0.0% 0.2% 0.0% 
Have patient get undressed before provider arrives 0.2% 0.0% 0.0% 0.0% 
Have students see patients 0.2% 0.0% 0.2% 0.0% 
Home health nurses 0.2% 0.0% 0.2% 0.0% 
Internal medicine podcast 0.2% 0.0% 0.2% 0.0% 
Intuition 0.0% 0.3% 0.0% 0.4% 
Inventory of activities 0.2% 0.0% 0.2% 0.0% 
Lab staff 0.0% 0.3% 0.0% 0.4% 
Local health department 0.2% 0.0% 0.2% 0.0% 
Mayo clinic 0.0% 0.3% 0.0% 0.4% 
Mental health econsults 0.2% 0.0% 0.2% 0.0% 
Mm calculation formula 0.2% 0.0% 0.2% 0.0% 
Not afraid of conflict 0.2% 0.0% 0.2% 0.0% 
Nurse practitioner 0.2% 0.0% 0.2% 0.0% 
PACE program for physical therapy 0.2% 0.0% 0.2% 0.0% 
Pain scale 0.2% 0.0% 0.2% 1.5% 
Patient education about exercise 0.2% 0.0% 0.2% 0.0% 
Patient education about long term benefits 0.2% 0.0% 0.2% 0.0% 
Patient education about tests 0.2% 0.0% 0.2% 0.0% 
Patient education about the mechanisms of pain 0.2% 0.3% 0.2% 0.4% 
Patient education about treatment plan 0.2% 0.0% 0.0% 0.0% 
Patient education about violations of opioid treatment 0.0% 0.3% 0.0% 0.4% 










  Urban Rural Urban Rural 
Patient recommendations about providers 0.0% 0.3% 0.0% 0.4% 
Patient reviews 0.0% 0.3% 0.0% 0.0% 
Patients get meds from other source 0.0% 0.3% 0.0% 0.4% 
Patient's resources 0.0% 0.3% 0.0% 0.0% 
Pharmacy educators 0.2% 0.0% 0.2% 0.0% 
Population health specialist 0.2% 0.0% 0.2% 0.0% 
Pre authorization 0.0% 0.3% 0.0% 0.4% 
Print out from controlled substance database 0.2% 0.0% 0.0% 0.0% 
Print out from previous visit 0.2% 0.0% 0.2% 0.0% 
Print out of yoga and mindfulness 0.2% 0.0% 0.2% 0.0% 
Psychologist 0.2% 0.0% 0.2% 0.0% 
PT will see patients after 3 visit limit with Medicaid 0.2% 0.0% 0.2% 0.0% 
Referral list 0.2% 0.0% 0.2% 0.0% 
Referral resource 0.0% 0.3% 0.0% 0.4% 
Screening brief intervention referral therapy 0.0% 0.3% 0.0% 0.4% 
Strategy- provider recognizes what he can and cannot do 0.0% 0.3% 0.0% 0.4% 
Strategy: limit diagnostic testing to save costs 0.2% 0.0% 0.2% 0.0% 
Strategy: no discussion on why opioids are not prescribed 0.2% 0.0% 0.2% 0.0% 
Strategy: normalize the relationship between pain and mental 
health 0.0% 0.3% 0.0% 0.0% 
Strategy:  Does not accept new patients 0.2% 0.0% 0.2% 0.0% 
Strategy: patient conversation to assess readiness for change 0.2% 0.0% 0.2% 0.0% 
Strong home support system for provider 0.2% 0.0% 0.0% 0.0% 
Substance use task force 0.0% 0.3% 0.0% 0.0% 
Teaching residents and students 0.2% 0.0% 0.2% 0.0% 
Time off 0.2% 0.3% 0.2% 0.4% 
Training on communication 0.2% 0.0% 0.2% 0.0% 
Training on falls prevention 0.2% 0.0% 0.2% 0.0% 
Training on musculoskeletal pain 0.2% 0.0% 0.2% 0.0% 
Training on opioid prescribing 0.2% 0.0% 0.2% 0.0% 
Van to transport patients 0.0% 0.3% 0.0% 0.4% 
Walk club 0.2% 0.0% 0.2% 0.0% 
Work hour restrictions 0.2% 0.3% 0.2% 0.4% 
Percent calculated by dividing the total number of times the code appears in a map by the total number of codes 
for the provider category. 





Supplemental Table 5.4: Wishes for easy difficult responsibilities for primary care providers in 
urban and rural settings.  
  Total Urban Rural 
Better patient education materials about pain and treatments 6.0% 7.9% 9.5% 
More mental health providers 6.0% 6.6% 7.1% 
More time to talk about pain 8.0% 7.9% 4.8% 
Improve access to pain treatments 7.0% 9.2% 4.8% 
More allied health professionals to address all concerns with pain 8.0% 5.3% 9.5% 
Better medication for pain 5.0% 6.6% 4.8% 
Better access to interventions for obesity 5.0% 6.6% 0.0% 
More training on pain diagnosis and treatment 5.0% 5.3% 7.1% 
Use more non-pharmacologic options for pain 5.0% 5.3% 7.1% 
Better insurance coverage 4.0% 1.3% 7.1% 
More community resources 4.0% 0.0% 9.5% 
Video or written materials about opioids and naloxone 5.0% 3.9% 4.8% 
Learn more strategies from pain clinic 4.0% 5.3% 0.0% 
Integrate mental health with pain 2.0% 2.6% 4.8% 
More evidence supporting efficacy for pain treatments 2.0% 2.6% 4.8% 
More standardization for pain management and opioid therapy 2.0% 0.0% 4.8% 
Address social determinants of pain 1.0% 0.0% 2.4% 
Better collaboration with primary care and emergency departments 2.0% 2.6% 0.0% 
Better reimbursement for mental health providers 2.0% 2.6% 0.0% 
Care coordination team 1.0% 1.3% 0.0% 
Diagnostic test to track pain over time 2.0% 2.6% 0.0% 
Easier access to Narcan 2.0% 2.6% 0.0% 
Fewer policies that are a one size fits all approach 1.0% 1.3% 0.0% 
Identify high-risk patients who use ER 2.0% 2.6% 0.0% 
Improve EHR functionality 3.0% 2.6% 2.4% 
Safe space for physicians to talk about pain management 1.0% 0.0% 2.4% 
Value based health care to absorb costs 2.0% 2.6% 0.0% 
Way to figure out patient resources 3.0% 2.6% 2.4% 
Percent calculated by dividing the total number of times the code appears in a map by the total number of codes 
for the provider category. 




CHAPTER 6: CONCLUSION 
 The goal of this research was to understand if and how access to non-pharmacologic pain 
management treatments is associated with opioid prescriptions patterns for older adults suffering 
from chronic musculoskeletal pain. This study used quantitative and qualitative methods to 
examine whether access to two key, evidence based non-pharmacologic treatments (physical 
therapy and mental health services) are associated with short-term and long-term opioids 
prescription patterns among older adults with persistent musculoskeletal pain. Aims 1 and 2 used 
a retrospective cohort study design to empirically test the relationship between measures of 
access (supply of non-pharmacologic providers in a county and use of non-pharmacologic 
services) and opioid prescription patterns. Aim 3 used Systems Support Mapping, a Systems 
Thinking Method, to qualitatively describe the discrete tasks primary care providers do to care 
for older adults with chronic musculoskeletal pain, the resources support their practice, the 
barriers that block their practice, and their priorities for being better supported in the system.99  
 Aim 1 (Chapter 3) examined the relationship between access to non-pharmacologic 
services and the use of different pain management strategies during the Phase One (three months 
after the index pain diagnosis) and Phase Two (three months after Treatment Phase One). During 
both phases, about 10% of the cohort filled an opioid prescription or used physical therapy, but 
fewer than 2% of the cohort used mental health services. Greater supply of non-pharmacologic 
providers was associated with lower odds of filling an opioid prescription in Phase One (mental 
health adjusted odds ratio (aOR): 0.97, 95% confidence interval (CI): 0.96-0.98; physical therapy 
aOR: 0.98, 95% CI: 0.97-1.00). In Phase Two, greater supply of mental health providers (aOR: 
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0.97, 95% CI: 0.96-0.98) and use of physical therapy (aOR: 0.62,  95% CI: 0.58-0.67) in Phase 
One was significantly associated with lower odds of filling an opioid prescription in Phase Two. 
For both phases, measures of socioeconomic status (Medicaid Buy-in and county poverty rates) 
were significantly associated with greater odds of filling an opioid prescription. The estimates 
significantly differed between metropolitan and rural counties in Phase One but not Phase Two.  
 Aim 2 (Chapter 4) examined the geographic and temporal variations of long-term and 
high-dose prescriptions for Medicare beneficiaries with persistent musculoskeletal pain. About 
2.4% of the cohort had a long-term prescription, but about 12% had a high-dose prescription. 
The long-term prescription rate for beneficiaries with a new episode of persistent 
musculoskeletal pain was relatively stable from 2008 to 2014, but the rate of high dose 
prescriptions decreased by 35%. Rates of long-term and high-dose prescriptions varied 
substantially by hospital referral region. Across models, greater supply of mental health 
providers and pain specialists was associated with lower odds of long-term and high-dose 
prescriptions. In most models, the supply of physical therapists was not significantly associated 
with the odds of high-risk prescriptions. Evidence about the association between high-risk 
prescription patterns and the use of non-pharmacologic services during the first three months of a 
new episode of persistent musculoskeletal pain was mixed. However, filling an opioid 
prescription in the first three months of a new episode was significantly associated with greater 
odds of high-risk prescription patterns. 
 Aim 3 (Chapter 5) further explores the delivery of pain care by focusing on the 
experiences of North Carolina primary care providers who care for older adults with chronic 
musculoskeletal pain. We interviewed 16 primary care providers across North Carolina with 
varying levels of training and experience and who serve diverse populations. Primary care 
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providers reported that they try to avoid or minimize opioid therapies for older adults, 
recommend non-pharmacologic treatments (e.g. mental health treatment or physical therapy), 
encourage changes in health behaviors like weight loss and exercise, and assess and educate 
patients about the relationship between mental health and pain. To fulfill these responsibilities, 
providers’ needs included an engaged patient, alternatives to opioids, and setting expectations 
about pain. Common supports linked to their needs included published literature, conversations 
to education patients about opioids and other pain related topics, electronic health records, and 
allied health professionals. Barriers included lack of insurance coverage for the patient and 
limited time to educate patients. Primary care providers expressed that better patient education 
materials, more mental health providers, and better access to pain management treatments would 
help them in delivering care.  
 The findings from this research addressed the three gaps in literature in the following 
ways:  
1. Opioid prescriptions were more frequent than physical therapy or mental health 
services among older adults with persistent musculoskeletal pain, a large subset of 
the population suffering from persistent pain in the US.  
This is the first study to our knowledge to use population-based data to examine the 
initiation of pain treatments from the onset of a new episode of persistent musculoskeletal pain. 
Aims 1 and 2 show that opioids and physical therapy are used about five to ten times more than 
mental health services. While initiation rates of opioid prescriptions and physical therapy visits 
are relatively similar during the first six months of a new episode, during the year after the index 
pain diagnosis, the opioid prescription rate was six percentage points higher than the physical 
therapy use rate and 28 percentage points higher than the mental health service use rate.  
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The utilization rates for non-pharmacologic treatments from Aims 1 and 2 are similar to 
previous estimates of utilizations rates for older adults with chronic pain.29,85 Compared to 
younger adults with chronic pain, older adults with chronic pain were more likely to use physical 
therapy and less likely to use mental health services.29,57 The data show that beneficiaries may be 
exposed to opioids early in their experience of pain, even when non-pharmacologic treatments 
like physical therapy are used. Furthermore, long-term pain management treatments often 
incorporates opioids over physical therapy or mental health services.  
High-dose prescriptions and long-term prescriptions occurred in 11.9% and 2.4%, 
respectively, of the cohort. However, among beneficiaries with an at least one opioid 
prescription, the proportion of high doses prescriptions was about three time greater than long-
term prescriptions (38.3% vs 7.6%).The average dose was 32.7 MME/ day for long-term users. 
While the rate of long-term prescriptions is similar to a previous study on all older adults with an 
opioid prescription,62 the average daily dose for long-term prescriptions was lower than previous 
estimates.33,74 High-dose prescriptions were common among beneficiaries with a long-term 
prescription (approximately 44%), but only lasted about a month on average. This suggests that 
while older adults may typically have low average doses of opioids, there may be temporary dose 
increases which could lead to periods of long-term prescriptions that are risky.  
Consistent with previous studies of chronic pain management, the rate opioid 
prescriptions was greater than the utilization rate of physical therapy and mental health services 
use.29,31,57 This finding could indicate that the psychosocial factors that are typically addressed 
with non-pharmacologic treatments may not be addressed in pain treatments for older adults.25 It 
could also indicate that older adults may be exposed to potentially risky treatments such as 
opioids, over safer alternatives like non-pharmacologic treatments. However, without knowledge 
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of the severity, function, and psychosocial characteristics, it is difficult to conclude whether the 
utilization rates for either opioids or non-pharmacologic services are ideal. Opioids may be 
appropriate for certain patients, but require careful monitoring and clear understanding of 
associated risks.18 
2. Measures of access to non-pharmacologic services were associated with initiation of 
opioid prescriptions and high-risk prescriptions among older adults with a new 
episode of persistent musculoskeletal pain.  
The supply of mental health providers was significantly associated with greater odds of 
filling an opioid prescription during Phase One and Two as well as long-term prescriptions, and 
high-dose prescriptions. However, the supply of physical therapists was only associated with 
greater odds of an opioid prescription in the Phase I, and was not significantly associated long-
term or high-dose prescriptions. These finding extend the evidence from previous studies by 
demonstrating that the association between the supply of providers and opioid prescription 
outcomes depends on the type of provider and study population.34,35,40 
The results from Aims 1 and 2 regarding the use of non-pharmacologic services during 
the first three months of an episode of persistent musculoskeletal pain and opioid prescription 
outcomes were mixed. While the use of physical therapy during the first three months of an 
episode was associated with lower odds of an opioid prescription in the next three months which 
is consistent with previous literature, these results were not consistent for high-dose and long-
term opioid prescriptions.79,94,95 Furthermore, contrary to previous literature, use of mental health 
services during the first three months of an episode was associated with greater odds of opioid 
prescriptions in Phase Two, but inconsistent for high risk prescriptions.80  We also found that an 
opioid prescription during the first three months of a new pain episode was significantly 
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associated with greater odds of an opioid prescription during Phase Two, long-term 
prescriptions, and high-dose prescriptions. Extending the literature on predictors of high-risk 
prescriptions, this finding shows that timing of the first opioid prescription with respect to the 
start of a new persistent pain episode may be a modifiable factor to prevent high-risk patterns 
like long-term and high-dose prescriptions.6-8,93  
The differences in the association between access to non-pharmacologic treatments and 
short and long-term opioid prescriptions outcomes may indicate difference in treatment needs as 
pain progresses over time. Specifically, these studies showed that a greater supply and use to 
physical therapists was associated with lower odds of short-term opioid initiation, while a greater 
supply of mental health services was significantly associated with lower odds of both short-term 
and high-risk opioid prescription patterns. Therefore, access, in terms of supply and use, to 
physical therapy might be especially important to prevent early opioid prescriptions, but the 
supply of mental health providers might be important to throughout the course of a pain episode.  
3. After controlling for indicators of health status and measures of access to health 
care resources, socioeconomic indicators at the individual (Medicaid buy-in) and 
county-level (poverty rate) were positively associated with initiation of opioid 
prescriptions and long-term prescription patterns.  
Having Medicaid insurance was significantly associated with greater odds of opioid 
prescriptions in Phase One and Two as well as long-term opioid prescriptions. Increases in the 
county level poverty rate was associated with greater odds of an opioid prescription in Phase One 
and long-term prescriptions. This relationship between socioeconomic indicators and opioid 
prescriptions in Phase One and Two persisted in subgroup analyses for rural counties. Our 
findings are similar to previous studies which a similar relationship between socioeconomic 
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indicators and opioid prescription patterns among different adult populations.35,36 Beyond 
availability of non-pharmacologic providers, patients may have other barriers to accessing non-
pharmacologic care such as high costs of treatments, limited insurance coverage for non-
pharmacologic treatments, and few community resources.50,51,54 
4. Primary care providers reported that they struggle with avoiding or minimizing 
opioid prescriptions and encouraging non-pharmacologic service use when they care 
for patients with chronic musculoskeletal pain.  
In the both urban and rural settings, primary care providers reported that they struggled to 
fulfill several responsibilities: minimizing or avoiding opioid prescriptions, encouraging use of 
non-pharmacologic treatments, referring patients to physical therapy, and educating patients 
about pain and mental health. These responsibilities align with the content present in clinical 
guidelines.18,19,55,171  Common needs linked to these responsibilities include an engaged patient, a 
good patient provider relationship, and setting expectations about pain, and alternatives to 
opioids to meet their responsibilities. Furthermore, common resources include allied health 
professionals (e.g. physical therapists, behavioral health specialists, and social workers) and 
policies and guidelines for opioid prescribing are critical to support their practices. 
These qualitative results provide context to explain the treatment patterns for opioid 
prescriptions and non-pharmacologic service use from Aims 1 and 2. Specifically, it shows that 
recommendations are interrelated: avoiding opioid prescriptions necessitates substitution with 
alternative treatments. Similar to a previous study, we found that while providers try to 
recommend non-pharmacologic treatments, these treatments require commitment and interest 
from the patient, which differs for opioid treatments.54 Confirming the findings from Aims 1 and 
2, limited access to alternatives to opioids (e.g. available providers, transportation, and 
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insurance) was reported as a common barrier for providers. Lack of insurance coverage for 
alternatives to opioids was a common barrier for providers, and in rural settings, affordable 
treatments was the most frequent need. Not only do these results support the findings about 
socioeconomic indicators and opioid prescription patterns from Aims 1 and 2, but it 
demonstrates that limited patient resources hinders providers’ ability to follow guidelines for 
chronic pain treatment.  
Policy Implications 
This research reinforces the need for a comprehensive, systems-based policy approach to 
support patients who suffer from chronic musculoskeletal pain and the providers who care for 
them. Policies designed to reduce shortages of non-pharmacological providers such as mental 
health providers and physical therapists are a promising approach to addressing opioid 
prescription patterns. Based on this research, the modest improvements in opioid prescription 
patterns associated with increases in the supply of non-pharmacologic providers suggest that 
even after controlling for use of services, the presence of non-pharmacologic providers is a 
critical resource in the health care delivery system for pain. Increasing the number of non-
pharmacologic providers could not only increase the availability of alternatives to opioids and 
non-opioid medications, but it can also make it easier for providers to follow clinic guidelines for 
opioid prescriptions.18,19,55 
In addition to increasing the local availability of non-pharmacologic providers, engaging 
patients in non-pharmacologic services is also needed to impact opioid prescribing patterns. For 
example, the recent removal of the caps on physical therapy visits in February 2018 could 
improve access to physical therapy and potentially reduce opioid use.157 Furthermore, an 
integrated approach to care where physical therapists and mental health providers are closely 
linked to primary care providers may be another way to improve patient uptake of non-
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pharmacologic services.124,163 Not only could this approach improve access to non-
pharmacologic providers for the patients, but it can also provide additional organizational and 
practice-level support for primary care providers.163,164 The patient centered medical home model 
could be one approach to improve the coordination of services for pain patients.174 This model 
may be better equipped to address the multiple biopsychosocial factors that address pain and 
steer patients towards non-pharmacologic or multimodal approaches.124,174  
Addressing shortages of non-pharmacologic providers is a promising policy option to 
reduce opioid prescription and improve pain care because current approaches for opioid 
prescription policies (e.x. “prescription drug monitoring programs, patient review and restriction 
programs, prior authorization, pain clinic regulations, prescription limits, physical exams, 
clinical guidelines, and education for patients and providers”) have limited evidence for 
improving health care utilization patterns, high-risk opioid prescription patterns, and mortality, 
especially among older adults.62,83,162 As the Centers for Medicare and Medicaid considers 
policies like restricting Part D beneficiaries with high opioid use to one prescriber and pharmacy 
or denying coverage for prescriptions that exceed 90 MME, little attention has been given to 
providing alternatives to opioids and encouraging the use of non-pharmacologic services.82,175 
Furthermore, it is unclear whether current policy approaches result in harms such as undertreated 
pain, or whether they support safer care pathways like use of non-pharmacologic pain treatments 
instead of creating barriers to opioids as a treatment option. Therefore, improving access to non-
pharmacologic treatments would be one way to better support patients with chronic pain and 
their providers. 
Limitations 
There are several limitations to this study. First, this is an observational study which 
indicates that the results do not represent causal relationships. Omitted variable bias could also 
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occur as several variables at the individual and county levels were not observed or included in 
the model. For example, we lacked data on pain severity, function, education, and socioeconomic 
status for the beneficiary as well as data on the supply of substance use providers and 
information about physician networks at the county-level. However, previous studies have 
shown that pain severity did not significantly affect the prescription opioid use.176,177 
Furthermore, we did not assess temporality of use of non-pharmacologic services and opioid 
prescriptions. The hypothesized causal mechanism assumes that the pathway to individual 
prescription opioid use behaviors is mediated by the provider behaviors, which is not formally 
tested.  
The data used for this study also had several limitations. First, claims for individuals who 
received substance abuse treatment are redacted.158 While we can observe opioid prescriptions, 
we cannot observe services with a substance use diagnosis and control for comorbidities relating 
to substance use diagnoses. The redaction could affect our estimation of the utilization of mental 
health services, particularly those tied to substance use diagnoses. We also lack data on referral 
to mental health and physical therapy services, which may introduce selection bias as patients in 
certain counties may be more or less likely to choose certain pain management strategies even 
when they receive a referral. We used individual and county-level characteristics to control for 
this selection, but do not have data on patient beliefs and preferences which would likely 
confound the associations observed in this research. Similarly, individuals may use non-
pharmacologic services that may not be observed with claims data either because they pay for 
services out of pocket or because services are delivered outside of the health care system. The 
results of Aims 1 and 2 may not be generalizable to all adults with chronic musculoskeletal pain. 
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Furthermore, because we excluded patients with trauma and surgery from the cohort, these 
results may not be generalizable to such populations.  
The results presented in Aims 1 and 2 should be interpreted as population averages 
because they were estimated using generalized estimating models.154 In this case the population 
average implies that the associations applies across counties, and accounts for correlations 
between beneficiaries who live in similar counties.154 Therefore, inferences about the 
associations for specific counties cannot be made because the county-specific random parameters 
are not estimated.154 
There are several limitations for Aim 3. First, the results may not be generalizable to 
providers outside of North Carolina or providers that are not in a primary care setting such as 
post-operative pain providers or pain specialists. The comparisons between urban and rural 
providers is also limited. The sample size for the rural providers is small which may mean that 
thematic saturation was not achieved for that subgroup. The results are subject to selection bias 
because providers who participated may be the most eager and interested in pain management, 
and may not reflect the views of all providers. Furthermore, social desirability bias could affect 
the responses. Providers might have been wary with sharing information about their practice or 
may share information about what they think best practice might be because of the public 
awareness surrounding the current opioid epidemic.  
Future Research 
 There are several areas for future research that stem from the findings of this research. 
First, it is important to determine if the associations between access to non-pharmacologic 
services and opioid prescription outcomes persist in populations with commercial insurance or 
Medicaid. Examining the role of access in other populations who suffer from chronic 
musculoskeletal pain can help determine whether these populations may benefit from 
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improvements in the health system (e.g. increasing the supply of providers or programs designed 
to engage patients in non-pharmacologic services). Furthermore, because we found strong 
associations between socioeconomic factors and opioid prescribing patterns, it is important to 
determine the role of access to non-pharmacologic providers in a low-income population such as 
individuals with Medicaid.  
 Another area for future research would be to examine whether policies that are aimed to 
curb opioid prescribing encourage the use of non-pharmacologic services. While opioid 
prescribing policies may encourage safer prescribing practices, they could also lead to under-
treatment of pain. Therefore, investigating how policies aimed at opioid prescriptions affect the 
use of non-pharmacologic services is needed. Furthermore, a greater understanding on the role of 
access to non-pharmacologic services after opioid prescribing polices have been implemented 
could inform future efforts to strengthen the delivery of pain care.  
 Since this study did not explicitly assess the association between time, dose, and duration 
of non-pharmacologic services with opioid prescriptions, more research is needed to understand 
how and when patients should use physical therapy and mental health services, especially for 
patients who may be at risk for chronic pain or patients considering long-term opioid treatments. 
Such studies could examine the real-world effectiveness of the delivery of care to determine 
optimal treatment pathways.  
 Finally, another area of research is assessing how access to substance use treatments may 
impact long-term treatments strategies. Specifically, examining whether access to substance use 
treatments is associated with tapering opioid doses and discontinuation of long-term opioid 
therapies. This information could help inform future effort to strengthen the health care system 




 As the US population ages, the burden of chronic pain is likely to increase and policies 
will need to address the health care system’s capacity to support individuals with chronic 
pain.58,76,84 To inform future policies, we found that support for the overall hypothesis that 
limited access to non-pharmacologic services, as measured by the supply and use of non-
pharmacologic services, is associated with greater opioid prescriptions. We also found that other 
system-level factors such as the supply of pain specialists and county poverty rates were also 
significantly associated with opioid prescription patterns. Through interviews, we learned the 
primary care providers struggle to avoid and minimize opioids, recommend non-pharmacologic 
treatments, and educate patients about mental health. The interviews confirmed that providers 
perceive that patient’s ability to afford treatment and availability of non-pharmacologic providers 
makes these tasks difficult. Taken together, these findings demonstrate the need for a 
comprehensive policy approach to strengthen the delivery of a pain care, instead of piecemeal 
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